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ABSTRACT
Sheep pulmonary adenomatosis (SPA) is a naturally occurring contagious lung
tumour of sheep which has been associated aetiologically with a chimaeric type D/B
retrovirus known as jaagsiekte sheep retrovirus (JSRV). Studies on the aetio-
pathogenesis of this disease are extremely valuable in comparative pathology
because SPA represents a unique model of a naturally occurring lung cancer.
The role of JSRV in the aetio-pathogenesis of SPA is largely unknown. This is due to
several factors which have hampered research for a number of years, such as the lack
of a cell culture system for the propagation of JSRV and the lack of reagents and
techniques to detect JSRV. In addition, the presence in the sheep genome of 15 to 20
copies of JSRV-related endogenous sequences has impeded investigation at the
molecular level.
Studies directed at further understanding the biology of JSRV were undertaken in
this thesis. Initially, immunological techniques for the detection of JSRV were
developed and employed to establish JSRV sites of replication. In particular, a
blocking enzyme-linked immunosorbent assay (B-ELISA) was used to verify the
distribution of viral particles in several tissues collected from SPA-affected sheep
and unaffected controls. Immunohistochemistry was employed for the detection of
the JSRV major capsid protein at the cellular level. The results obtained at the end of
these studies pointed to epithelial tumour cells in the lungs of sheep affected by SPA
as major sites of viral replication. JSRV viral particles and viral proteins were never
detected in non-tumour tissues from SPA-affected sheep or in unaffected control
animals.
The relationship between the exogenous JSRV and the highly related endogenous
sequences present in the sheep genome (sheep endogenous retroviruses, enJSRV) was
then determined by RT-PCR coupled to sequencing and restriction enzyme analysis.
EnJSRVs were found to be transcriptionally active in a wide variety of tissues of
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both healthy and SPA-affected sheep. By sequencing a fraction of the gag gene of
enJSRVs, a Seal restriction site was found to be a molecular marker for the
exogenous form of JSRV. JSRV provirus was detected in tumour genomic DNA of
SPA-affected animals but not in non-tumour tissues of the same animals or in
unaffected controls. These results demonstrated that JSRV was a horizontally
transmitted virus, specifically associated with SPA, and it was not an endogenous
retrovirus reactivated as a downstream event of neoplasia.
Finally, a highly sensitive exogenous-specific hemi-nested PCR was developed
utilising primers in the U3 region of the JSRV LTR, where major differences
between endogenous and exogenous sequences were found. Employing this test, it
was demonstrated that JSRV established a disseminated infection of the lymphoid
tissues of sheep affected by SPA, although the epithelial tumour cells are the main
sites of viral replication. This finding could be extremely important in future studies
aimed at understanding the interaction of JSRV with the host immune system.
In conclusion, the data in this thesis present compelling evidence to specifically
associate the exogenous form of JSRV with sheep pulmonary adenomatosis,
strengthening the view that this virus has a role in the aetiology of the tumour.
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Chapter 1.
Introduction - Review of the Literature
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1.1 History of sheep pulmonary adenomatosis.
Sheep pulmonary adenomatosis (SPA) is a contagious and experimentally
reproducible lung tumour of sheep, which leads invariably to death of the affected
animals.
The disease was recognised for the first time in South Africa in the 19th century as a
cause of dyspnoea in sheep being driven, hence the origin of the Afrikaans name
"jaagsiekte", meaning driving (= jaagt) sickness (= ziekte) (Tustin, 1969). Since then,
it has been recorded in England (McFadyean, 1894), Germany (Eber, 1899) France
(Aynaud, 1926) and in almost all the sheep-rearing countries with the noteworthy
exceptions of Australia and New Zealand (Verwoerd et al, 1985).
SPA acquired notoriety in the thirties when it was introduced into Iceland by a
small number of sheep imported from Germany, along with scrapie, maedi-visna and
paratuberculosis (Sigurdsson, 1954). The obvious geographical "barriers" allowed
the establishment of the relationship between the imported sheep and the newly
emerging diseases.
Sigurdsson (1954) coined the term "slow" to describe this group of diseases because
they did not fit either the acute or the chronic pattern of a classical infectious disease.
He described slow diseases as diseases with a very long initial period of latency
lasting from several months to several years and a regular protracted course after the
onset of the clinical signs usually ending with the death of the affected animal.
The observations made in those years have been of great biological importance in
the study of the pathogenesis of viral infections and in understanding the complex
virus/host relationship .
1.2 Clinical and epidemiological features.
Sheep affected with SPA are likely to show clinical signs only when the tumour
volume becomes sufficiently large to interfere with normal lung function. Small
areas of tumour may be present without obvious clinical signs. The symptoms which
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develop are those of progressive respiratory embarrassment, which reflects the extent
of the loss of the normal alveolar function. A pathognomonic sign of SPA is the
accumulation of fluid within the respiratory tract (lung fluid). Up to 300 ml of lung
fluid can be collected when the rear limbs (and thus the chest) are elevated above the
head of the affected sheep ("wheel-barrow test") (Fig. 1.1). The affected sheep
usually die within a few weeks once signs become apparent and it is possible to
observe a progressive loss of weight and a general decline of the bodily condition of
the animal (Sharp and Angus, 1990). Secondary bacterial infections may complicate
the clinical picture and accelerate the death of the animal.
SPA is usually seen in sheep that are more than 2 years old with the peak of
incidence occurring at 3-4 years of age (Hunter and Munro, 1983). The incubation
period in nature is probably several months, based on the observations made by
Sigurdsson (1954) in Iceland, and those of early transmission studies by allowing the
cohabitation of healthy with diseased sheep (de Kock 1929a, 1929b referred to by
Tustin, 1969). However, SPA has occasionally been observed in lambs 3-6 months
old (J.M. Sharp, personal communication).
The incidence of the disease in an affected flock has been reported to be usually
between 1% and 5% per annum where the disease is endemic (Aliev, 1967; Ceretto
and Deiana,1967; Tustin, 1969; Wandera, 1971; Verwoerd et al, 1985; De las Heras,
personal communication). However, when SPA was first introduced in Iceland there
were losses in some flocks ranging from 50% to 80% within 1 to 2 years (Dungal et
al, 1938) after which it gradually decreased. An analogous situation has been
described in Kenya where losses were initially as high as 30% (Shirlaw, 1959) and
dropped subsequently (Wandera, 1967).
In Sc9tland, prospective longitudinal studies on two flocks have shown that SPA
occurred in up to 30% of sheep during the commercial life of the flock and was
responsible for over 50% of the mortality (Sharp and Angus, 1990).
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Fig 1.1: Nasal discharge of "lung fluid" from a SPA-affected sheep. Up to 300 ml
of lung fluid can be collected from a sheep during the "wheel-barrow" test.
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1.3 Gross pathology, histopathology and ultrastructure of the tumour.
At necropsy, SPA-affected sheep have lungs that fail to collapse when the thorax is
opened and are 2-4 times heavier than normal. Usually it is possible to observe a
frothy fluid exuding from the end of the trachea. There is normally a grey firm mass
in the cranio-ventral portions of one or both lungs which in some cases can extend to
the intermediate and the lateral margins of the posterior lobes (Fig 1.2). When a
neoplastic lung is incised a clear or foamy fluid may exude from the airways and the
cut surface shows numerous small, slightly-elevated whitish grey nodules in section.
There may be necrosis or ulceration involving the tumour or evidence of secondary
bacterial infections in affected lungs. Pleural adhesions are often observed. In early
cases, solitary tumour nodules may be the only evidence of disease (DeMartini et al,
1988; Rosadio et al, 1988; Sharp and Angus, 1990).
The lesions are characterised microscopically by the formation of nodular lesions in
which the alveoli are lined with cuboidal or columnar cells often forming papillary
growths which produce a complicated adenomatous pattern. The foci are supported
by a sparse connective tissue stroma. In the majority of cases the presence of large,
swollen macrophages in the alveoli contiguous to the focal neoplasia can be detected.
Metastases are a major reason for the designation of SPA as a pulmonary carcinoma
(OPC) by some authors (Hod et al, 1974 and 1977; Perk et al, 1974; DeMartini et al,
1988; Rosadio et al, 1988a and 1988b). The World Health Organisation classifies
SPA as a bronchioloalveolar carcinoma (Stunzi et al, 1974). In the Awassi sheep of
Israel, metastases were found in up to 50% of the cases and were distributed in
pulmonary lymph nodes, kidney and skeletal muscle (Nobel et al, 1969). In Scotland,
South Africa and Peru, the rate of metastasis is reported to be rare and in no more
than 10% of SPA cases (Hunter and Munro, 1983; Snyder et al, 1983; Verwoerd et
al, 1985).
Ultrastructural studies have shown the cell types from which the tumour originates
to be the type II pneumocytes and the non-ciliated bronchiolar (Clara) cells (Nisbet et
al, 1970; Perk et al, 1971a; Payne and Verwoerd, 1984; DeMartini et al, 1987).
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The SPA tumour cells maintain the appearance of the cells from which they
originated, with microvilli, desmosomes and intracellular lamellar bodies for the type
II pneumocytes and cytoplasmic dense bodies for the Clara cells.
Both the type II pneumocytes and the Clara cells are secretory type cells. Type II
pneumocytes are extremely important cells regulating the homeostasis of the
functional unit of the lung, the alveolus. These cells synthesise, store and secrete the
lung surfactant which is a phospholipid-rich substance with the putative function to
lower surface tension during expiration (Voelker and Manson, 1989; Chander and
Fisher, 1990). The lamellar bodies of the type II pneumocytes are believed to be the
site of synthesis and storage of the alveolar surfactant (Massaro, 1981) and, therefore,
it has been proposed that the lung fluid secreted by SPA-affected sheep is composed
mainly of such material. Type II pneumocytes also have the function of regulation
the volume of alveolar fluid by transepithelial solute transport and of re-
epithelialization of the alveolar wall after injury (Voelker and Manson, 1989).
The Clara cells of the bronchioles are thought to have as a major function the
synthesis, storage and secretion of protein components of the extracellular lining
layer of bronchioles (Massaro, 1989).
1.4 Aetiology: contagious nature of the tumour and its experimental
transmission.
The contagious nature of SPA has been suspected since the first observations of the
disease were made. This was confirmed in 1929 when DeKock (1929a, b) was able to
transmit SPA by cohabitation of healthy with diseased sheep.
An elegant experiment performed by Dungal (1946) demonstrated that SPA could be
transmitted by aerosol. Dungal made an affected sheep breath through a 20% solution
of glycerine in normal saline for thirty minutes and used this solution to inoculate
three lambs intratracheally and intrapulmonary. Two of the lambs developed
jaagsiekte, one of them showing clinical signs, four months after the experimental
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Fig. 1.2: Sheep lungs with typical SPA lesions. Note the frothy fluid exuding from
the end of the trachea ("lung fluid"). Arrows indicate the neoplastic tissue.
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infection. This result was also reproduced with cell-free material after filtering the
glycerol-saline solution through a gradacol membrane with pores 0.9 pm in diameter.
Several other authors have been able to reproduce the disease by exposing sheep to
droplet infection by means of an aerosol spray (Markson and Terlecki, 1964) or by
intratracheal or intrapulmonary inoculation of lung tumour homogenates or lung
secretions (Sigurdsson, 1958; Enchev 1966, 1968; Cuba-Caparo' et al, 1967;
Wandera, 1968; Tustin, 1969). All these experiments had a low rate of success and
an incubation period of more than 280 days. In contrast, Wandera (1970) had an high
success rate (8/10 sheep) using an inoculum more concentrated with respect to the
previous experiments.
Transmission of SPA to laboratory animals has failed with the exception of
transplantation studies of SPA tumour cells into nude mice (Verwoerd et al, 1977;
Zimber et al, 1984; Jassim, 1988).
More recent experiments, including those where the incubation period has been
dramatically reduced to three-six weeks will be described in 1.9.
1.5 Viruses associated with SPA: herpesviruses.
From the beginning of the century onwards several macro/micro-organisms have
been hypothesised to be associated with SPA such as the sheep lungworm Muellerius
capillaris, Mycoplasma and Chlamydia but none of them was demonstrated to be the
aetiological agent of SPA (McFadyean, 1894 and 1920; Taylor, 1938; Mackay, 1966;
Tustin, 1969).
An interesting finding was the isolation of herpesviruses from lungs of SPA sheep in
geographically distinct locations such as Scotland (Mackay 1969a and 1969b; Martin
et al, 1979), Yugoslavia (Nevjestic et al, 1971), Kenya (Malmquist et al, 1972) and
South Africa (De Villiers et al, 1975). These viruses were all antigenically related
and could be differentiated by restriction endonuclease analysis (Scott, 1984). It was
remarkable that this agent, designated initially caprine herpesvirus 1 (CHV-1) and
subsequently ovine herpesvirus-1 (OF1V-1) (Roizman, et al 1992), was isolated only
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from SPA-tumours, although not from every case and in some studies only in a
small minority (Martin et al, 1979).
Numerous attempts to reproduce SPA experimentally by the inoculation of sheep
with OHV-1 have failed (De Villiers et al, 1975; Martin et al, 1976 and 1979; Scott,
1984). In addition, the presence of antibodies towards OHV-1 in the sheep
population is widespread both in countries where SPA is endemic and in countries
where SPA has never been reported (Scott, 1984; De Villiers, 1979); this observation
rules out a primary role for this virus in the aetiology of SPA.
The detection of intranuclear inclusion bodies and virions only in pulmonary
macrophages suggests that these are the main sites of OHV-1 replication (Scott et al,
1984). The increased number of pulmonary macrophages in SPA sheep could explain
the isolation of this virus in some of these cases.
1.6 Viruses associated with SPA: retroviruses.
In the early 1970's, virus particles morphologically similar to retroviruses, were
detected in SPA tumours by electron microscopy (Perk et al, 1971; Bucciarelli, 1973;
Hod et al, 1977). Since then, circumstantial evidence that a retrovirus may be the
aetiological agent of SPA has been accumulating.
An overview of the Retroviridae and their association with neoplastic diseases will
be given in 1.6.1 to 1.7.3 due to the importance of these viruses in the context of this
thesis.
Sections 1.6.1, 1.6.2 and 1.6.3 deal with the structure, genomic organisation,
replication cycle and classification of retroviruses. The literature on the fundamental
and molecular biology of retroviruses is very extensive and therefore difficult to cite
properly. For these sections I refer only to some of the key papers which gave a
major contribution to the understanding of this complex group of viruses and to the
following reviews: Teich, 1984; Weiss, 1984, 1993 and 1996a; Stoye and Coffin,
1985; Coffin, 1990a, 1990b, 1991 and 1992; Luciw and Leung, 1992; Coffin et al,
1995; Weiss and Tailor, 1995; Kupiec and Sonigo, 1996.
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1.6.1 Structure and genomic organisation of retroviruses.
The Retroviridae comprises a large family of RNA viruses of vertebrates extremely
widespread in nature. The initial observations leading to the discovery of this class of
viruses were all related to tumour-associated viruses (Ellerman and Bang , 1908;
Rous, 1911a and 1911b; Staff of Roscoe B. Jackson Memorial Laboratory, 1933;
Bittner, 1936; Gross, 1951), however, retroviruses are indeed capable of inducing
many different diseases such as immunodeficiencies, neuropathies, pneumonia, bone
and joint diseases as well as lifelong viremia in the absence of any obvious clinical
symptom. Despite the wide variety of species infected, routes of transmission and
disease manifestation, retroviruses are all quite similar in terms of virion structure,
genomic organisation and replication cycle.
Virions are spherical with a diameter of about 100 nm. The viral particles are
surrounded by an envelope often with prominent spikes composed of virus-encoded
glycoproteins (Rifkin and Compans, 1971). The internal core is a spherical to rod-
shaped capsid and contains the viral genome. The genome consists of two identical
molecules of positive sense single-stranded RNA (7 - 10 kb in length) (Beemon et al,
1974; Billeter et al, 1974; Quade et al, 1974), held together by hydrogen bonds, with
a structure reminiscent of cellular mRNA with a cap structure at the 5' end and
polyadenylated at the 3' end (Kung et al, 1975; Bender et al, 1976, 1978) . Each
RNA molecule is associated with a specific molecule of tRNA that is base-paired to a
region (termed the primer binding site, PBS) near the 5' end of the RNA (Taylor and
Illmensee, 1975). In all retroviruses there are four main genes encoding for the virion
proteins invariably in the same order: 5'-gag-pro-pol-env-V (Wang et al, 1976a and
1976b) (Fig 1.3). The gag gene encodes for at least three proteins: the MA (matrix)
protein, the major capsid protein (CA) and the NC (nucleocapsid) protein. The pro
gene encodes for a protease (PR) while the pol gene is responsible for the synthesis
of the reverse transcriptase (RT) and of the integrase (IN). The env gene contains the
information necessary for the synthesis of the envelope protein, the SU (surface) and
the TM (transmembrane) glycoproteins.
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Fig. 1.3: Features of the retrovirus genome. The proteins encoded from each gene
are also indicated (see page viii for abbreviations used).
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Figure 1.4 shows a schematic diagram of the structure of a retrovirus. All retroviruses
contains non-coding regions at the ends of the genome which are essential for the
replicative strategy of these viruses (see below). These regions are the U5, a region
unique for the 5' end of the viral genome, the U3, unique for the 3' end of the
genome and R, repeated at both ends of the viral genome.
Some retroviruses ("complex" retroviruses; see 1.6.3) encode non virion proteins
which are important for the regulation of expression. Others have the ability to
incorporate fragments of certain cellular genes (known as c-one or proto-oncogenes)
into their genome and to alter their structure and expression in ways that enable them
to directly transform a normal cell into a malignant one (see 1.7.1) (Hanafusa et al,
1977; Stehelin et al, 1976; Oskarsson et al, 1980; Blair et al, 1981).
1.6.2 Retroviral life cycle.
The most disparate biological characteristics of retroviruses, such as their oncogenic
potential or the ability of these viruses to establish a latent infection, can be fully
appreciated when the retroviral life cycle is analysed.
Two major events characterise the life cycle of retroviruses: the reverse transcription
of the single stranded RNA genome into double stranded DNA and the integration of
this DNA copy into the cell genome.
The retroviral replication cycle can be divided into the following steps: viral entry,
synthesis of negative strand DNA, synthesis of positive strand DNA, integration,
transcription, translation, assembly and budding.
• Viral entry
The replication cycle starts with binding of the virion to specific receptors at the cell
surface. A number of retroviral receptors have been identified. These include the
CD4 cell surface protein for HIV (Dalgleish et al, 1984; Klatzmann et al, 1984;
Madden et al, 1986); a cationic amino acid transporter for murine ecotropic
leukaemia virus (Kim et al, 1991; Wang et al, 1991); a phosphate permease for











Fig 1.4: Schematic diagram of the retrovirus virion (modified from Coffin, 1990a).
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subgroup A receptor which is a molecule related to the low density lipoprotein
receptor (Bates et al, 1993). Thus, retroviruses appear to take advantage of host-
encoded cell-surface proteins that play important roles in cellular function and
metabolism. The use of different receptors by related viruses helps to classify some
retroviruses into cross-neutralisation subgroups (e.g. avian leukosis viruses and
murine type C retroviruses - see 1.6.3).
The SU glycoprotein mediates binding to the cellular receptor. Conformational
changes of the cellular receptor and of the envelope proteins follow and lead to the
exposure of hydrophobic domains of the TM protein that are believed to influence
viral fusion (Weiss, 1993 and 1995).
Usually a retroviral receptor is composed by a single molecule. However, for HIV it
has been demonstrated that the CD4 molecule is not sufficient for entry but requires
fusion cofactors on the target cell which have been identified as the chemokine
receptor CC-CRK-5 (Alkhatib et al, 1996; Deng et al, 1996; Dragic et al, 1996) and
a related protein known as "fusin" (Feng et al, 1996).
After binding and fusion there is viral penetration into the cell by mechanisms not
completely understood. Once inside the cell, viral uncoating takes place. The
nucleocapsid (comprising the diploid genome, primer tRNA, reverse transcriptase,
integrase and at least some capsid proteins) is responsible for the next steps of
replication which involves a DNA intermediate (the provirus) initially hypothesised
by Temin (1963).
• Synthesis ofnegative-strand DNA
The reverse transcriptase associated with the nucleocapsid synthesises double-
stranded DNA using the viral genomic RNA as a template (Baltimore, 1970; Temin
and Mizutani, 1970). In this process two steps can be identified: synthesis of negative
strand DNA (minus DNA, complementary to the positive RNA genome) and
synthesis of positive strand DNA (plus DNA, complementary to the minus DNA).
Synthesis of minus DNA is primed by the tRNA coupled to the PBS at the 5' end of
the retroviral genome and proceeds towards the U5 and R (Fig. 1.5 [a]) (Verma et
al, 1971; Dahlberg et al, 1974; Harada et al, 1975; Taylor and Illmensee, 1975). The
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newly synthesised DNA (called at this stage negative strand "strong-stop" DNA
[Coffin and Haseltine, 1977]) "jumps" to the 3' end of the genome (Fig. 1.5 [b])
driven by the strong affinity of the RT for its template. This jump is made possible
by the redundancy of the R region at the 5' and 3' ends of the viral genome (Gilboa
et al, 1979) and by the RNase (H) activity of the RT which removes the newly copied
RNA (at the 5' end), leaving the DNA free to pair with the R sequence at the other
end (the 3' end)(Molling et al, 1971). The transfer of the strong-stop DNA can occur
both to the same strand on which synthesis started or it can switch to the other strand
of the bimolecular RNA genome (Panganiban and Fiore, 1988). This jump can lead
to viral recombination between two different retroviruses co-infecting the same cell
(Coffin, 1979). Once the jump has occurred, the synthesis of the negative strand
proceeds to the 5' end of the template, which is now the 5' end of the PBS because R
and U5 have been removed by RNase H (Fig 1.5[c]).
• Synthesis ofpositive-strand DNA
The RT now has to copy the minus-strand DNA to form a double-stranded molecule.
There is therefore the necessity for a second primer which is provided by a purine-
rich sequence (polypurine tract or PPT) situated immediately 5' of the 3' LTR. The
RNA sequence of the PPT is resistant to the retroviral RNase H activity, which
degrades the RNA genome after minus strand cDNA synthesis (Fig. 1.5 [d]) (Varmus
et al, 1978; Finston and Champoux, 1984; Rattray and Champoux 1987 and 1989;
Huber and Richardson, 1990; Luo et al, 1990; Pullen et al, 1993). In some
retroviruses, it has been shown that purine-rich sequences in the genome resembling
the PPT can provide additional initiation sites (Finston and Champoux, 1984; Rattray
and Champoux, 1987). In the avian retroviruses the plus strand DNA contains
multiple discontinuities suggesting a multiple priming mechanism (Boone and
Skalka, 1981a and 1981b; Rung et al, 1981; Hsu and Taylor, 1982) while MMTV
seems to utilise only one PPT in a single priming event (Rung et al, 1981). In
Antiviruses and spumaviruses the PPT is duplicated at the end of the pol open
reading frame suggesting a dual-priming model for these viruses (Sonigo et al, 1985;
Rupiec et al, 1988).
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After initiation, elongation of the positive strand DNA is carried out by the RT to the
5' end of the minus-strand including the PBS (Fig. 1.5[d]). The newly formed
positive DNA (positive-strand, strong-stop) needs another 'jump' to permit complete
synthesis. The PBS of the 3' end of the positive strand is in this case the redundant
sequence which binds the PBS at the 3' end of the negative strand (of the same
molecule) (Fig.l.5[e]) (Gilboa et al, 1979). Completion of the full length, double
stranded DNA, can now be accomplished by the synthesis of each strand until
completion. This model of replication seems to be accepted for most retroviruses.
However, lentiviruses and spumaviruses seem not necessarily to fit this model due to
the dual PPT priming (Li et al, 1993; Kupiec and Sonigo, 1996) .
The linear dsDNA thus contains at both ends identical long terminal repeats (LTRs)
formed in order by U3, R and U5 (Fig. 1.5[f]) (Hughes et al, 1978). Along with the
linear double-stranded DNA two additional forms appear, the covalently closed DNA
circles with one or two LTRs; these are thought to be a by-product of viral DNA
synthesis (Brown et al, 1987).
The LTRs, and in particular U3, contain a transcriptional promoter. Also contained
within U3 are the enhancer elements which potentiate the transcriptional activity of
the adjacent promoter (Khoury and Gruss, 1983) by binding specific cellular proteins
(transcription factors) (Herr and Clarke, 1986; Fromental et al, 1988).
The RT lacks a 31—> 5' exonuelease proof-reading activity and therefore it has no
means of correcting occasional errors that arise during polymerisation. This is a
major cause of the high frequency of retroviral mutation (0.05-1 mutations per
genome per replication cycle) (Preston and Dougherty, 1996) leading to the
generation of 'quasispecies'. The RT of some viruses seem to be more error prone
than others for example HIV-RT has a misincorporation rate higher than MLV-RT or
ALSV-RT (Preston et al, 1988; Roberts et al, 1988).
• Integration of the provirus into the cell DNA
The viral DNA is then transferred to the nucleus and integrated into the chromosomal
DNA of the host to form a provirus by a mechanism involving the viral IN protein.
Integration appears to be a prerequisite for replication of at least the great majority of
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Fig. 1.5: Viral DNA synthesis. Thin lines represent RNA, medium lines represent negative-strand
DNA, and thick lines represent positive strand DNA. (a-c): synthesis of negative strand DNA; (a),
tRNA priming; (b), first RT jump; (c), completion of minus strand DNA. (d-f): synthesis of positive
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Fig. 1.6: Diagram representing some features of retrovirus integration. The top
part shows the juxtaposed ends of unintegrated viral DNA. The middle portion shows
the target cell DNA with the integration site; the integrated provirus is shown below.
Note the loss of two base pairs from each end of the provirus and the duplication of
the cellular base pairs (redrawn from Coffin, 1990a).
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retroviruses although it is very difficult to detect integrated proviruses of maedi-visna
virus and spumaviruses (Harris et al, 1981; Kupiec et al, 1988). Retroviral
integration is essentially a random event (Brown, 1990). However, DNAsel-
hypersensitive sites are used for integration at a frequency much greater than
expected (Vijaya et al, 1986; Rohdewohld et al, 1987) and integration in vivo occurs
preferentially in cells that are actively replicating their DNA (Varmus et al, 1977;
Humpries et al, 1981). It has also been reported that transcriptionally active regions
of the genome are preferred as sites for integration (Scherdin et al, 1990).
The exact mechanisms of integration are not completely understood, however some
steps have consistently been found with all retroviruses (Fig. 1.6). The linear double-
stranded DNA is the integrated form. Two bases at both 3' termini of the provirus are
removed by the IN protein, leaving recessed 3' ends. A staggered cut is then made in
the target DNA with 4-6 bases of overhanging 5' ends which are then ligated to the
3' ends of the provirus. A cellular repair system then removes the two mismatched
bases at the 5' ends and fills in the resulting gap and ligates the remaining ends. In
this way the cellular DNA flanking the proviral genome is not grossly changed
except for the duplication of a short sequence (4-6 base pairs) immediately adjoining
the viral DNA (Fig. 1.6). Once integrated the provirus appears to be incapable of
transposition (Brown, 1990).
• Transcription
Once integrated, the provirus uses the cellular machinery of transcription for its
expression. The 5' LTR provides the signals which are then recognised by the
cellular transcriptional machinery.
As indicated earlier U3 contains the viral promoter and enhancer sequences.
Promoters are DNA sequence elements that contain binding sites for various protein
factors that initiate and regulate transcription (Lewin, 1990). All known retroviruses,
in common with many viral and cellular genes, have a TATA box in the U3. In the
cellular model of transcription the TATA box binds a cellular factor (TATA-binding
protein, TBP) which interacts with other cellular factors and RNA polymerase II to
















R U5 PBS U3 R
|AA„
gag pol env
Fig. 1.7: Nucleic acid species during the replication cycle of a "simple"
retrovirus. A: viral genome; B: provirus; C:full length transcript; D: single spliced
transcript.
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1991). The viral enhancers are another class of cw-acting sequences that regulate
viral transcription indirectly by enhancing or activating transcription from the
adjacent promoter. The enhancers are usually located 100 - 200 bp upstream of the
TATA box (Athas et al, 1994) (for their influence on retroviral pathogenesis see
1.7.2).
Proviruses contain a single transcriptional unit. All genomic and mRNA species
derive from a primary transcript that starts at the 5' U3-R junction (where the
capping group is placed) and proceeds through the 3' LTR, with the final 3' end
determined at the end of R by cleavage and poly adenylation (Fig. 1.7[c]). All
retroviruses use full-length transcripts for their genomes and for the mRNA encoding
the gag, pro and pol products. A spliced mRNA consisting of the 5' end of the
genome, the env gene and the U3 and R regions is produced for translation of the
precursor of the envelope proteins (Fig. 1.7[d]) (Hayward, 1977; Weiss et al, 1977).
Retroviruses which use only these two transcripts are generally addressed as
"simple" retroviruses in contrast to "complex" retroviruses (see 1.6.3) where other
subgenomic spliced transcripts encoding for regulatory proteins such as the trans-
activating tat or tax in HIV and HTLV are observed (Fig 1.8). The subgenomic
messages {env included) are made by splicing a leader sequence at the 5' end of viral
RNA to an acceptor sequence within the viral genome; in this way all spliced viral
messages utilise a common splice donor and share 5' and 3' ends.
A distinct replication pathway has been recently discovered for foamy viruses (HFV;
see 1.6.2) where the Pol protein is translated from a spliced mRNA and lacks Gag
domains. Interestingly, HFV infectious particles contain double-stranded DNA
similar in size to full length provirus, suggesting that reverse transcription takes place
in viral particles before a new round of infection (Yu et al, 1996).
• Translation
The translation of retroviral mRNA follows the standard cellular "scanning" model in
which ribosomal subunits bind initially to the capping group and move along the
RNA until an AUG initiation codon (Petersen and Hackett, 1985).
24
In all retroviruses the gag, pro, and pol genes can be viewed as forming a single
translation unit. This is probably to assure the correct ratio of the various proteins
and to provide that the Pro and Pol proteins are strictly associated with the structural
proteins to be incorporated into virions. For pro and pol, translation is made possible
by ribosomal frameshifting or by suppression of the stop-codons at the gag-pro
and/or the pro-pol boundaries of translational termination signals (Jack and Varmus,
1985; Coffin 1990a).
The Env precursor product is synthesised on polyribosomes associated with the
rough endoplasmic reticulum and then is cleaved by cellular enzymes, at the Golgi
apparatus level, into the SU and TM which will remain associated with one another
and anchor at the cell surface.
• Virion assembly and budding
This process is a poorly understood aspect of retroviral replication.
It is assumed that assembly involves the interaction of an RNA motif (s) , 'v|/'
('psi'), situated at the 5' end of the genome, with the gag precursor protein and in
particular with the NC. The CA interacts with the CA region of other precursor
molecules and the MA precursors interact with the cell membrane acquiring the
envelope of the virion. In type B and D retroviruses (see 1.6.3) the nucleocapsid
structure is formed before they acquire the envelope while in the other retroviruses
the virion assembles while budding and acquiring the envelope (Bolognesi et al,
1978; Rein et al, 1994). Following assembly, around the point of budding, viral
particles undergo "maturation" under the action of PR protein which cleaves the




Fig. 1.8: Genomic organisation of HIV as an example of "complex" retrovirus.
Seven different mRNA species are visible. Note that all spliced viral messages utilise
a common splice donor and share 5' and 3' ends (modified from Coffin et al, 1995).
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1.6.3 Classification of retroviruses.
The family of the Retroviridae comprises all the RNA viruses with a RNA-dependent
DNA polymerase (Fenner, 1975). Different parameters have been used over the years
to classify the members of this family.
Traditionally, retroviruses have been divided, on the basis of their pathogenicity, into
three subfamilies: (i) Oncovirinae, including all the oncogenic viruses and many
related non-oncogenic viruses; (ii) Lentivirinae, including the "slow" viruses like
maedi-visna virus and (iii) Spumavirinae, (spuma = foamy) which induce
vacuolisation in vitro but are not associated with any disease in vivo.
Based on morphology, retroviruses, have been further classified into type-A, -B, -C
and -D (Teich, 1984; Coffin, 1992) (Fig. 1.9). Type-A particles are defined as an
intracellular form only; they have a diameter of 60-90 nm and are spherical with an
electron-lucent centre and a double mantle. A-type particles are not infectious. They
are the intracytoplasmatic forms of type-B and -D (see below). Similar particles are
seen in some rodent cell lines and are the product of endogenous (see below)
elements known as IAP (intracisternal A particles) which contain two LTRs, gag and
pol but their env is defective in all forms. IAPs with associated RT activity, contain
polyadenylated RNA and accumulate in the cisternae of the endoplasmic reticulum
but they have no extracellular phase and are not infectious (Kuff and Lueders, 1988).
IAP-related envelope encoding proviral elements have also been demonstrated in
mice ( Reuss and Schaller, 1991; Reuss et al, 1996).
Type-B particles are the extracellular forms of MMTV. Assembly occurs within the
cytoplasm as type-A particles prior to budding. Mature extracellular mature particles
have an eccentric condensed core and prominent surface spikes. The size of the
particles is about 125 nm in diameter.
Type-C particles differs from type-B because the assembly occurs at the inner surface
of the cell membrane at the same time as budding and therefore no immature forms
are observed in the cytoplasm. An electron-dense crescent-shaped form is the first
distinct virion structure to be seen at the electron microscope level. As viral
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maturation proceeds it is possible to observe a spherical core with an electron lucent
centre surrounded by the plasma membrane which will form the envelope. The
mature extracellular forms (80-110 nm diameter) have a centrally located electron-
dense core with barely visible surface projections (Bouillant and Becher, 1984).
Type-D particles are associated with both intracellular and extracellular particles.
The intracellular particles are 60-95 nm in diameter and ring-shaped. The
extracellular particles measure 100-120 nm in diameter and contain a characteristic
cylindrical core with surface projections which are less prominent than type B-
particles.
This classification is still used to a certain extent although some of the viruses
described in recent years, such as human immunodeficiency virus (HIV) or human T
cell leukaemia virus (HTLV), do not fall completely into any of these categories.
On the basis of their lifestyle retroviruses can be divided into "exogenous",
horizontally transmitted viruses, and "endogenous" (see 1.6.4), vertically
transmitted from parent to offspring as a provirus integrated into the germline.
Another division is "simple" and "complex" retroviruses, which refers to the
genomic organisation. Simple retroviruses have only gag, pol, and env genes while
complex retroviruses have additional genes that are important for the regulation of
expression (Cullen, 1992; Felber and Pavlakis, 1993; Peterlin, 1995). Complex
retroviruses include HIV, HTLV, BLV, spumaviruses and others. For example, HIV
has three regulatory proteins: tat, rev and nef which play a positive role in viral
expression.
The classification adopted from the International Committee for the Taxonomy of
Viruses is based on nucleotide sequence relationship and genome structure of
retroviruses but also takes into consideration previous criteria. Retroviruses are thus
divided into the following 7 genera:
a) Mammalian type B oncovirus group
• prototype: MMTV
This group includes only mouse mammary tumour virus (MMTV), the aetiological





Fig. 1.9: Morphologic classification of retroviruses into type A —> D. Type A
particles are shown as rings and are exclusively intracellular. Type B and D
retroviruses assemble into the cytoplasm in forms similar to type A. In type C
retroviruses the assembly occurs at the inner surface of the cell membrane at the
same time as budding.
29
Susceptible strains, such as C3H, acquire the virus through milk-born infection and
can be freed of this route of infection by foster-nursing on non-viremic mothers,
while other strains inherit an endogenous copy of the provirus that is activated in the
mammary gland in situ and cannot be freed of the virus by foster-nursing. For
example, GR mice appear to activate one endogenous provirus (Mtv-2) that is shed
into milk and can infect other strains as an exogenous, milk born virus (Bentvelzen
and Hilgers, 1980; Michalides et al, 1983). Although endogenous MMTV proviruses
are present in the germ line of all inbred mice and there are multiple proviral
sequences found at different chromosomal locations in different mouse strains, the
majority of these do not produce virus. At least 10 different exogenous and greater
than 30 endogenous MMTVs have been identified (Kozak et al, 1987).
MMTV is associated primarily with mammary carcinoma (Bentvelzen and Hilgers,
1980; Michalides et al, 1983) but variants of the virus have been shown to induce T
cell lymphoma (Michadelis et al, 1982 and 1985; Ball et al, 1988; Hsu et al, 1988)
and be associated with kidney adenocarcinomas (Garcia et al, 1986; Wellinger et al,
1986). As the name of the genus indicates, the morphology is of type B with a
simple genomic organisation.
Among the retroviruses, MMTV has recently gained a particular interest for its
interaction with the host immune sy stem through the expression of a "superantigen"
(Sag) (Acha-Orbea and MacDonald, 1993; Held et al, 1994; Huber, 1995). A
superantigen differs from a conventional antigen because it crosslinks directly the
major histocompatibility complex (MHC) class II and the Vp domain of the T-cell
receptor (TCR) outside the peptide binding groove causing strong activation of the
responsive T cells. A Sag is not actually "recognised" by a T cell clone expressing a
particular TCR but elicits a multiclonal response, which is restricted to T cells
expressing a certain TCR Vp chain. In the mouse there are about 20 different TCR
Vp, therefore a superantigen stimulates about 5% of the total T cells; approximately
104 fold more T cells than those ones activated by a classical peptide/MHC complex.
Paradoxically, Sag activation is a requisite step in the MMTV infection pathway
(Acha-Orbea and MacDonald, 1993; Held et al, 1994; Huber, 1995).
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b) Mammalian type C retrovirus group (MLV-related viruses)
• prototype: murine leukaemia virus (MLV)
This group includes a large number of exogenous and endogenous viruses isolated
from many groups of mammals, including rodents (murine leukaemia viruses -
MLV), carnivores (feline leukaemia virus - FeLV), primates (gibbon ape leukaemia
virus), as well as some exogenous viruses of birds (Avian reticuloedotheliosis virus)
and reptiles (viper retrovirus).
The murine viruses can be further designated by the species distribution of their
receptors; "ecotropic" viruses replicate only in mouse cells, they are found both as
endogenous and as exogenous viruses; "xenotropic" viruses are found as endogenous
viruses in some mice strains and replicate only in non-murine cells; "polytropic" and
"amphotropic" viruses use different receptors found in both mouse and non-murine
species. Polytropic viruses (also termed MCF MLVs, for mink cell focus-forming
MLVs) are exogenous viruses arising de novo as recombinants between infectious
ecotropic viruses and endogenous polytropic MuLV-related sequences. They are
typically isolated from high leukaemic strains of mice which chronically express
high levels of ecotropic virus, such as AKR mice, or from mice inoculated with
various exogenous ecotropic MuLVs. Amphotropic viruses have been isolated
exclusively from wild mice in southern California (Kozak and Ruscetti, 1992).
Recently, on the basis of sequence analysis ofpro and pol it has been proposed to
divide this group into two subgroups (Tristem et al, 1996). All of the exogenous
MuLV-related retroviruses which have been isolated to date, as well as several
endogenous viruses (e.g. baboon endogenous virus) fall into the first subgroup,
whereas the second group includes only endogenous retroviruses included HERV-E
(see 1.6.4).
The genomic organisation of this group of viruses is that one of "simple"
retroviruses.
c) Type D retrovirus group
• prototype: Mason-Pfizer monkey virus (Simian retrovirus type 3 - SRV-3)
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This group of viruses comprises exogenous viruses of asian macaques (simian
retroviruses, SRV) and endogenous viruses in the Old World spectacled langur (PO-
I-Lu) and the New World squirrel monkey (squirrel monkey retrovirus, SMRV). A
type D virus isolated from a human lymphoblastoid line, very closely related to
SMRV, is referred to as SMRV-H (Oda et al, 1988).
Only the exogenous type D viruses of macaques are pathogenic and are now
classified into five distinct neutralisation serotypes SRV-1—>5 (Gardner et al, 1994).
SRVs cause a profound depletion of T and B cells and a fatal immunodeficiency
syndrome in macaques which should not be confused with the SIV induced
immunosuppression in macaques (Letvin et al, 1985).
SRVs are not oncogenic although the original type D retrovirus (Mason-Pfizer
monkey virus -SRV-3) was isolated from a mammary carcinoma of a rhesus monkey
(Chopra and Mason, 1970). SRV-2 is associated with a proliferative disorder called
retroperitoneal fibromatosis (RF) which has some features in common with Kaposi's
sarcoma (Bryant et al, 1986).
They have a type-D morphology and the genetic organisation is that one of simple
retroviruses with no accessory genes or oncogenes (see 1.7).
d) Avian type C retrovirus group (ALV-related viruses)
• prototype: avian leukosis virus (ALV)
This group contains the widespread exogenous and closely related endogenous
viruses found in chickens and other birds (Payne, 1992). Viruses in this group are
associated with a number of neoplastic diseases and some other diseases such as
wasting and osteopetrosis. They are further classified according to the host range into
seven subgroups (A —> J). A to D are exogenous viruses of chickens (A and B
common strains, C and D rare ones); ubiquitous endogenous leukosis viruses of
chickens belong to subgroup E. Endogenous viruses of pheasant are included in
subgroups F (isolated from the ring-necked pheasant) and G (isolated from the
Golden pheasant). Endogenous viruses of subgroup H have been isolated from the
Hungarian partridge and that of subgroup I from Gambel's quail. A recently isolated
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strain of an exogenous ALV of chickens (strain HPRS-103) has been classified into
the new subgroup J (Payne et al, 1992).
Avian type C retroviruses have a simple genomic organisation. Many oncogene-
containing members (e.g. Rous sarcoma virus) have been isolated in this genus.
e) Foamy virus group
• prototype: human foamy virus
Foamy viruses (FV) were originally isolated as agents that cause vacuolation in cell
culture. This group comprises exogenous viruses of different animal species
including monkeys, cats, cattle and humans. The presence of exogenous human
foamy viruses has been recently questioned after the finding that the sequence of the
'human' isolate is indistinguishable from that ones of the chimpanzee isolates
(Herchenroder et al, 1994). In addition, evidence of human foamy virus infection
has been confirmed only in a few persons in contact with monkeys (Schweizer et al,
1995). Endogenous elements related to FV have been recently discovered (HERV-L;
Cordonnier et al, 1995).
Foamy viruses are able to induce a persistent infection of the host but they are not
conclusively associated with any disease. As mentioned in 1.6.2, FV have attracted
recently the interest of many retrovirologists for some peculiarities which clearly
differentiates the replication cycle of FV from any other retrovirus (Weiss, 1996b).
The morphology of this group is also characteristic, having long and evenly spaced
surface projections (Gelderblom and Frank, 1987). The genomic organisation of FV
is similar to that one of "complex" retroviruses with accessory genes such as bel-1
which acts as a viral trans-activator (Lochelt and Fliigel, 1995).
f) HTLV-BLV group
• prototype: bovine leukaemia virus
This group includes exogenous viruses such as bovine leukaemia virus (BLV) which
is associated with B-cell lymphoma in cattle (Kettman et al, 1994) and human T-
lymphotropic virus 1 (HTLV-I), associated with adult T-cell leukaemia and
neurological disorders in man (Poiesz et al, 1980). Other components of this group
are HTLV-II which has not been conclusively linked to any disease and simian T-
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lymphotropic virus I (STLV-I) which is closely related to HTLV-I and infects non-
human primates both in Africa and Asia (Fultz, 1994). No endogenous viruses
belong to this group.
The morphology is similar type-C retroviruses in terms of virion appearance and
assembly. Regulatory genes such as tax and rex in HTLV-I have been identified in
this genus (Green and Chen, 1994). Of particular interest are the mechanisms of
oncogenesis of HTLV-I and BLV which appear to differ from other oncoviruses (see
1.7.3)
g) Lentivirus group
• prototype: human immunodeficiency virus (HIV)
Lentiviruses are probably among the most extensively studied viruses of all time
since HIV, the cause of the AIDS pandemic (Barre-Sinoussi et al, 1983; Gallo et al,
1984 ), is classified in this genus. Also included in this group are other viruses which
induce immunodeficiency such as simian immunodeficiency virus (SIV) (Letvin et
al, 1985) and feline immunodeficiency virus (FIV) (Pedersen et al, 1987).
Lentiviruses are also associated with several other diseases such as neurological
disorders in sheep and goats when infected with maedi-visna virus (MVV) (Narayan
and Jolly, 1990) and caprine arthritis/encephalitis virus, CAEV (Crawford et al,
1980); arthritis induced by CAEV in goats; anaemia in horses infected with equine
infectious anaemia virus (EIAV) (Montelaro et al, 1993) and others. No oncogenic
viruses are included in this group.
Lentiviruses have a characteristic morphology with a bar or truncated cone-shaped
core. Assembly occurs at the cell membrane as type-C retroviruses. The genomic
organisation is that one of "complex" retroviruses with several regulatory genes.
No endogenous lentiviruses have been described.
1.6.4 Endogenous retroviruses.
A unique feature of retroviruses is their presence as inherited elements in the
germline of most eukaryotes. These elements, known as endogenous retroviruses
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(ERV), are transmitted through the germline as stable Mendelian genes, yet they
exhibit structural and sequence similarities to infectious exogenous retroviruses
(Stoye and Coffin, 1985).
The eukaryotic genome contains several sequences which have been generated by
reversing RNA to DNA. This RNA-mediated movement of genetic material is called
'retrotransposition' and the transposed sequences are called 'retroelements' (Hull and
Will, 1989). Retroelements can be classified into two groups according to the
presence of the LTRs (Fig. 1.10). Retroelements without LTRs can be further divided
into elements without reverse transcriptase, which may have used cellular
mechanisms for reverse transcription, and elements with reverse transcriptase. The
first category contains elements such as short interspersed elements - SINE (the Alu
family for example) - and processed pseudogenes while the second category contains
the long interspersed elements (LINEs). Both SINEs and LINEs have an internal
promoter but only the LINEs have coding capacities possessing an open reading
frame coding for an uncharacterised protein in addition to a pol gene (Hull and Will,
1989).
Retroelements with LTRs can be divided into 'retrotransposons' and 'retroviruses'.
Retrotransposons have LTRs, gag and pol genes but lack the env gene and therefore
can not be infectious. Retroviruses differ from retrotransposons by the presence of at
least one additional gene, the envelope gene, which confers, after budding, the
capacity to recognise a cellular receptor and start a new replication cycle. Thus, env
adds to the retroelements the ability to spread between cells and individuals (Larsson,
1989; Wilkinson et al, 1994; Lower et al, 1996; Leib-Mosch and Seifarth, 1996).
Many ERV have retroviral-like structures with LTRs, gag, pol, and env. It is
assumed that ERVs derive from integration events during evolution of exogenous
retroviruses into the germline of the host animal species. Another theory proposed
by Temin (1992), envisages that ERVs have evolved from an RT gene predecessor
through the acquisition of additional enzymatic activities as well as the successive





















Fig. 1.10: Classification of retroelements (from Wilkinson et al, 1994).
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The biological significance of these elements is debatable. The best definition is
probably one that considers ERVs as a "type of selfish element specifically adapted
to residence in the germline" (Coffin , 1990). However, both pathogenic and
beneficial effects to the host have been envisaged for some ERVs.
Generally, endogenous proviruses are transcriptionally silent and are often defective,
typically differing from the exogenous counterpart by deletions or point mutations
that render them incapable to form infectious virus. In general ERVs are non¬
pathogenic; it is easy to understand that viruses of significant pathogenicity would be
counterselected during the evolution. Exception to this rule are some endogenous
MMTV such as Mtv-1, Mtv-2 and Mtv-4 [MMTV(SHN)] (Kozak et al, 1987)
present in some strains of mice which have been selected for a high incidence of
mammary tumours. Mtv-1 is expressed as an infectious virus and is associated with
late-occurring tumours (Van Nie and Verstraeten , 1975; Verstraeten and Van Nie,
1978) while Mtv-2 is associated with tumours which occur early in life and are
pregnancy dependent (Van Nie et al, 1977; Morris et al, 1986). Mtv-4 is also
associated with early tumour development (Imai et al, 1983; Luther et al, 1994).
A more complex example of ERV pathogenicity is that of spontaneous leukaemia in
AKR mice caused by MCF viruses which are generated by recombination between
endogenous murine retroviruses (Stoye et al, 1991; DiFronzo and Holland, 1993).
In humans, a particular interest is given to a class of ERVs called HERV-K10 (Ono
et al, 1986) which contains open gag, pol, and env reading frames and possess a
complex mRNA expression (Lower et al, 1993; Mueller-Lantzsch et al, 1993). A
high percentage of patients with seminoma have Gag- and Env-specific antibodies at
high titre towards HERV-K10 while very rarely these antibodies are identifiable in
healthy people or in patients with other tumours (Sauter et al, 1995 and 1996).
Although no information is available regarding the role of HERV-K10 in the
development of the tumour, these data indicate a possible role of HERVs in human
pathology. The presence of HERV-K-related sequences packaged into retroviral
particles in the placenta of Old World and New World monkeys (Simpson et al,
1996) makes this group of ERVs one of the more interesting to study.
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As mentioned above, ERVs can also have a beneficial effect for the host. It has been
shown that the expression of env proteins by endogenous viruses can block the
receptors used by their exogenous counterparts therefore conferring protection to the
host (Weiss, 1993). Chickens for example harbour several polymorphic ev loci and
some of them express subgroup E envelope proteins which confer resistance to
subgroup E RSV infection. This was first proposed by Payne et al (1971) who
described a gene that was dominant for specific resistance to RSV subgroup E. A
similar situation has been observed in some feral mice where the Fv-4r locus blocks
MLV-E receptors through an endogenous ecotropic gp70 synthesis (Kozak et al,
1984).
An interference mechanism through gag-like proteins, has recently been
hypothesised after another of the MLV-resistant loci in mice, Fv-1 (Lilly, 1970) was
cloned and sequenced and found to be related to the gag region of HERV-L, an
endogenous retrovirus unrelated to MLV (Best et al, 1996).
Another beneficial effect for the host has been suggested for the human endogenous
retrovirus ERV-3 (Venables et al, 1995) which is a single-copy full-length HERV
with an open reading frame for the Env protein. This open reading frame is
conserved throughout primate evolution suggesting a beneficial effect to the host. In
addition, ERV-3 is highly expressed in placental trophoblasts which is the cell layer
separating mother and child (Boyd et al, 1993). Due to the similarity of the TM
region of ERV-3 with a putative immunosuppressive region (termed pl5E)
(Haraguchi et al, 1995) of C-type retroviruses, it has been speculated that ERV-3
may serve to protect the foetus from immune attack by the mother (Venables et al,
1995).
Endogenous interference through the immune system has been well established in the
MMTV model. In mice, endogenous MMTV expression of its Sag induces clonal
deletions of most of the T cells expressing the respective reactive TCR Vp (Kappler
et al, 1988; MacDonald et al, 1988). Challenge of mice at birth with an exogenous
MMTV expressing a homologous Sag will result in an abortive infection due to the
lack of the Sag reactive T cells which in turn stimulate the amplification of the
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infected B cells making in this way possible the colonisation of the mammary gland
by MMTV. Thus endogenous MMTV can protect mice from infection by an
exogenous MMTV expressing an homologous Sag sequence (Held et al, 1993;
Golovkina et al, 1992).
A relevant biological characteristic of endogenous retroviruses is the possibility of
recombination with their exogenous counterparts which often results in broading the
viral host range. This has been demonstrated for example in cats and mice with FeLV
and MMTV respectively (Neil et al, 1991; Golovkina et al, 1994). Possible
recombination between endogenous and exogenous viruses have to be taken into
consideration when retroviral vectors are used for gene transfer.
Endogenous retroviruses thus deserve attention for both their potentially beneficial
and harmful effects to the host and for the possibility of interacting with exogenous
retroviruses.
1.7 Retroviruses and cancer.
Historically, retroviruses were first isolated and studied because they cause tumours
in domestic animals. In 1911, Peyton Rous was able to experimentally reproduce a
spontaneous chicken sarcoma by the inoculation of cell-free tumour homogenate.
Since then, retroviruses have presented profound implications in the understanding of
the multistep process which leads to oncogenesis of both viral or non-viral origin.
With regard to oncogenesis, retroviruses can be divided into two classes: 'acutely
transforming retroviruses' and 'non-acute retroviruses' (Teich, 1984; Fan, 1994). The
acute transforming retroviruses cause tumours rapidly (1 week to a few weeks) and
are able to transform cells in culture, whereas the non acute retroviruses induce
diseases slowly (months to years) and cannot transform target cells in vitro. In
general, carcinogenesis has to be considered as a multi-step process and retroviruses
can be responsible for one or more steps of the process. The different mechanisms of
retroviral oncogenesis will be discussed in the following sections.
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1.7.1 Acutely transforming retroviruses.
This class of retroviruses are probably among the most powerful carcinogens present
in nature. They carry a cellular oncogene (known as proto-oncogenes or c-one) into
their genome which has been altered in its structure (deletions, point mutations etc.)
and expression (Fig. 1.11) (Duesberg and Vogt, 1970; Stehelin et al, 1976; Bishop
and Varmus, 1984; Rasheed, 1995). Proto-oncogenes are usually conserved over long
evolutionary distances, suggesting that they are indispensable for some fundamental
function that does not allow much changes (Benjamin and Vogt, 1990). The altered
proto-oncogenes inserted into the viral genome are called 'viral-oncogenes' or v-onc
and they always work through the synthesis of proteins (oncoproteins) which by
definition have the potential to transform a normal cell into a neoplastic one.
Tumorigenesis by acutely transforming retroviruses therefore can be considered as
the viral introduction of a powerful transforming gene into cells which induces them
to be transformed into tumours. The discovery of the cellular origin of retroviral
oncogenes is of paramount importance because it revealed that cellular genes could
also play important roles in non-viral induced cancers.
Most oncogenes have homology with cellular genes which encode for proteins that in
some way play a role in normal cell growth control and differentiation. For example,
the sis oncogene of the simian sarcoma virus (SSV) encodes a protein which has 88%
sequence identity with the P-chain of the human platelet-derived growth factor
(PDFG) (Williams, 1986). Avian erythroblastosis virus (AEV) strain H carries erbB
oncogene which has close homology to the chicken epidermal growth factor receptor
(Downward et al, 1984). AEV strain ES4 carries, in addition to erbB, the erbA
oncogene which is derived from a thyroid hormone receptor gene (Weinberger et al,
1986).
As mentioned above, structural changes of the proto-oncogene determine functional
changes in the oncogene. However, for some oncogenes, such as mos, structural
changes of the transduced proto-oncogene are not necessary for transformation as








Fig. 1.11: Genomic organisation of an acute transforming retrovirus compared
to a replication competent retrovirus. Note the derivation of the viral oncogene (v-
onc) from a proto-oncogene (c-onc). Often, viral oncogenes derive from exons of the
proto-oncogene (modified from Fan, 1994).
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As a result of the introduction of the proto-oncogene, the acutely transforming
retroviruses lack portions of their structural genes and become replication-defective.
Transforming retroviruses are thus propagated in conjunction with a replication-
competent virus called "helper" because it synthesises all the proteins necessary to
encapsidate the defective virus genome. An exception to this rule is given by RSV
which contains its oncogene (src) at the end of the complete gag-pol-env and before
the 3' LTR (Wang and Hanafusa, 1988).
Although the introduction of a viral oncogene is probably one of the most powerful
ways to transform a cell, usually it is not the only step required for tumorigenesis.
For example, Abelson MuLV carries the abl oncogene but it is able to induce
lymphoma only if the virus helper Moloney MuLV integrates in the proximity of a
second cellular oncogene (ahi-1) (Poirier et al, 1988).
1.7.2 Oncogenesis by non-acute retroviruses: insertional activation.
Most retroviruses do not carry an oncogene in their genome but are still capable of
inducing tumours in animals (Teich et al, 1984; Benjamin and Vogt, 1990; Kung et
al, 1991; Fan, 1994). These viruses are called 'non-acute retroviruses' because the
incubation period of the resulting neoplasia is usually of several months or even
years. Non-acute retroviruses are replication-competent.
Tumour induction appears to occur through multiple steps with similarities to non-
virus induced cancer. The best understood mechanism of nonacute retroviral
carcinogenesis is LTR activation of a proto-oncogene also known as cA-activation or
insertional activation or insertional mutagenesis. Most important in the genesis of
this tumour is the fact that the provirus is integrated in the vicinity of a cellular proto-
oncogene. Under the influence of the viral LTR, the transcription of the proto-
oncogene is elevated and triggers the transformation of the normal cell. Two
principal mechanisms of insertional activation have been identified: promoter
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Fig. 1.12: Insertional activation during non-acute retrovirus oncogenesis. In the
promoter insertion mechanism (top), transcription initiates in the proviral LTR and
proceeds into the proto-oncogene coding sequences. In the enhancer activation
(bottom), the LTR enhancer activates the protooncogene own promoter. In this case
the provirus can also be in the opposite transcriptional orientation respect the proto-
oncogene (modified from Fan, 1994).
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In the promoter insertion mechanism, a chimaeric mRNA is formed by the viral LTR
and sequences of the viral oncogene. The transcription can be driven by the 5' LTR
(in this case viral sequences can also be present in the chimaeric transcript) or by the
3' LTR (in this case the provirus may have suffered extensive deletions which
include the 5' LTR). In the enhancer activation mechanism, the enhancers present in
the proviral LTR activate transcription of the proto-oncogene own promoter. In this
case, the provirus can be inserted even several kb apart from the proto-oncogene and
be in the opposite transcriptional orientation with respect to the proto-oncogene. This
is consistent with the fact that enhancers are cA-acting DNA elements that can
activate adjacent promoters independently from their position, orientation and
distance.
Retroviruses which act by insertional activation generally induce tumours with a long
incubation period because retroviral integration in the host DNA can be considered
as a random event (Luciw and Leung, 1992). Thus, multiple rounds of infection are
necessary for the virus to integrate near a proto-oncogene.
Several well studied retrovirus models act by insertional activation. ALV induces B-
lymphomas by promoter insertion of the c-myc proto-oncogene (Hayward et al,
1981). ALV is also capable of inducing erythroblastosis in a certain line of chicken,
by promoter insertion of erbB sequences (Fung et al, 1983).
Moloney MuLV activates c-myb in mice with myeloid tumours (Shen-Ong and
Wolff, 1987; Nason-Burchenal and Wolff, 1993) but activates another set of proto-
oncogenes in M-MuLV-induced T-lymphomas (c-myc; pim-1; pim-2; and pvt-1)
(Cuypers et al, 1984; Selten et al, 1984; Steffen, 1984; Graham et al, 1985).
As a general rule, different viruses can induce the same kind of tumour by interacting
with the same proto-oncogene. On the other hand, the same virus can induce different
tumours by activating different proto-oncogenes. In addition, multiple proto-
oncogenes can be activated in the same type of tumour by the same virus. MMTV
integrates preferentially in proximity to a group of genes known as the int genes (int-
l/wnt-1; int-2\ int-3; wnt-3; Fgf-4/Hst/k-FGF) activated mainly by enhancer insertion
(Nusse and Varmus, 1982; Dickson et al, 1984; Gallahan and Callahan, 1987; Peters
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et al, 1989; Roelink et a\, 1990). Some of the int genes have been shown to be
important in normal development processes (Nusse, 1988; McMahon and Bradley,
1990; Thomas and Capecchi, 1990) and normally they are not expressed in the
mammary gland. The expression of these genes under the control of the MMTV LTR
leads to an abnormal cell growth. It is interesting to note that most of the MMTV-
induced tumours are hormone dependent in the initial stages of the disease. In the
LTR of MMTV there are glucocorticoid response elements that bind the
glucocorticoid receptor (Scheidereit and Beato, 1984) and MMTV transcription is
strongly activated by glucocorticoids such as dexamethasone (Ringold et al, 1975).
Thus cancer has always to be considered as a multi-step event; in the MMTV system,
hormones can therefore be considered a co-factor for tumorigenesis.
Besides the type of proto-oncogene activated, the pathogenicity and tumour
specificity of nonacute retroviruses is strongly influenced by the virus LTRs and in
particular by their enhancers (Fan, 1990; Athas et al, 1994). One of the best examples
to explain this important concept is given by the MuLV system and by the generation
of chimaeric viruses by molecular cloning. Moloney-MuLV causes T cell lymphoma
while Friend MuLV causes erythroleukaemia. However, M-MuLV with F-MuLV
LTRs will cause erythroleukaemia and viceversa (Chatis et al, 1983 and 1984). This
is in line with the notion that the enhancers in the LTRs contribute to cell-type-
specific transcription of retroviruses.
Another example of the presence in the LTR of specific pathogenic determinants is
given by the MMTV system. As described above MMTV causes mammary tumours.
However, it can also induce T lymphomas especially in males of some strains of
mice that spontaneously activate endogenous MMTVs. MMTVs isolated from T
lymphomas show deletions/alterations in the LTR which lead to high level
expression in T lymphocytes and probably insertional activation of proto-oncogenes
(although they have not yet been identified) (Michalides and Wagenaar, 1986; Lee et
al, 1987; Hsu et al 1988).
Direct repeats of the enhancer elements seem to be a pathogenic determinant in
nonacute retroviruses. One example is given by FeLV which causes a wide spectrum
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of neoplastic and degenerative disease in domestic cats with the most common
tumour being a thymic lymphosarcoma of T-cell origin (Rezanka et al, 1992). In a
study conducted to compare the enhancer regions in different isolates it has been
found that two or three copies of enhancer elements were present in all the thymic
lymphosarcoma examined, in 38 to 66% of other lymphosarcomas, but only in 17%
of animals with non-neoplastic disease. On the basis of these observations , it was
suggested that enhancer repeats arise de novo during the infectious process and are
associated with tumour induction (Matsumoto et al, 1992). The evolution of FeLVs
with multiple enhancers could increase the probability of upregulating a host proto-
oncogene during insertional mutagenesis.
An alternative way to induce tumour by non-acute retroviruses is the "inactivation"
of cellular genes which normally regulate the cell growth. Friend virus-induced
erythroleukaemia is a multi-step process. One of these steps is due to an abnormal
expression or inactivation of p53, a cellular tumour suppressor gene (Ben-David and
Bernstein, 1991; Marshall, 1991). Inactivation of p53 has also been observed in a
proportion of non-B, non-T-cell lymphomas induced by Cas-Br-E virus (Bergeron et
al, 1993). A similar mechanism of retroviral "inactivation" has been proposed in
some tumours induced by MMTV where the expression of a cellular gene,
denominated int-6, was found to be altered (Marchetti et al, 1995) by the integration
of MMTV, although the normal function of int-6 is still unknown.
1.7.3 Other mechanisms of retroviral oncogenesis.
Other mechanisms involved in retroviral carcinogenesis have been proposed for
HTLV-I in adult T-cell leukaemia, and BLV in bovine leukaemia. Both viruses lack
oncogenes and do not show common sites of viral integration in the induced tumours.
The tumours are monoclonal or oligoclonal and viral expression in the tumour cells
is minimal (Kinoshita et al, 1989). The tumours of both humans and cattle appear
after a very long incubation period (many years) (Sugamura and Hinuma, 1993).
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The HTLV model has been studied in great detail. HTLV contains at least two trans-
regulatory genes, tax and rex (Green and Chen, 1994) which are essential for viral
expression. Tax in particular seems to play a role in HTLV oncogenesis. Tax is a
/ra^s-activator of viral transcription and its function depends on czT-acting
sequences, known as the Tax response element (TRE), located within the U3 region
of the viral LTR (Felber et al 1985; Paskalis et al, 1986; Brady et al 1987; Rosen et
al, 1987). Besides activating viral transcription, tax also activates the expression of
cellular genes involved in T-cell growth and differentiation such as IL-2, IL-2
receptor, IL-3 and GMCSF (Green and Chen, 1994). Many properties of tax, such as
the ability to transform rodent fibroblasts (Tanaka et al, 1990) or to be oncogenic
when expressed in mice as a transgene (Neremberg et al, 1987; Grossman et al,
1995), indicate the oncogenic potential of this gene and of its product. Analogies
have been found with the Tax protein of BLV (Kettman et al, 1994).
However the precise mechanism by which HTLV transforms T lymphocytes is
unclear mostly because tax is critical for viral replication and therefore it has been
impossible to mutate tax in the context of an infectious virus and dissociate viral
replication from cellular transformation. Recently, an infectious chimaeric HTLV-2
(HTLVc_enh) that replicates by a /ax-independent mechanism has been constructed by
the replacement of the TRE with the cytomegalovirus immediate-early promoter
(Ross et al, 1996). This chimaeric virus was able to maintain the capacity to
transform human T lymphocytes in vitro with an efficiency similar to the wild type
HTLV-2. However when the tax gene was deleted in a chimaeric clone (HTLVC.
enhATax) the transformation properties were lost even though HTLVc.enhATax was
still able to replicate. HTLV Tax protein has also been shown to interact with int-6
which was found to be a common integration site for MMTV(Marchetti et al, 1995;
Desbois et al, 1996). Taken all these data together it is possible to conclude that the
viral tax plays a necessary functional role in T-cell transformation mediated by
HTLV. However other genetic alterations are required within the transformed cell to
maintain the phenotype considering that in vivo there is a very low HTLV
expression (Ishibashi et al, 1987; Bhagavati et al, 1988; Kinoshita et al, 1989).
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Presumably HTLV gene products are required to initiate transformation but not for
maintaining the leukaemic phenotype.
Thus, the action of trans-activating proteins is another mechanism of retroviral
tumour induction besides the most common insertional activation or transduction of
oncogenes.
Structural proteins have also been implicated in retroviral tumorigenesis such as
leukaemogenesis induced by the Friend erythroleukaemia complex virus. This virus
mixture consists of an acute transforming virus (Friend spleen focus forming virus
[F-SFFV]) and a helper virus (F-MuLV). The SFFV can induce erythroleukaemia in
the absence of the helper virus by expression of an altered gp55 env protein which
binds to the erythropoietin receptor rendering erythroid precursors independent of
erythropoietin and stimulating autocrine growth (Li et al, 1990).
1.8 Jaagsiekte sheep retrovirus (JSRV).
The major candidate to be the aetiological agent of SPA is a chimaeric type D/B
retrovirus known as jaagsiekte sheep retrovirus (JSRV) or sheep pulmonary
adenomatosis retrovirus (SPARV) or ovine pulmonary carcinoma retrovirus
(OPCRV). The term JSRV will be used throughout this thesis considering that this
name has been used for the only complete nucleotide sequence so far published (see
below, York et al, 1992) and in the recent literature (Bai et al, 1996; Hecht et al,
1996; Palmarini et al, 1995, 1996a and 1996b).
The first evidence for the association of a retrovirus with SPA derived from electron
microscopy studies. The epithelial tumour cells of the lungs of sheep affected by
SPA were shown to contain particles with a morphology consistent with the
intracytoplasmatic type A particles (Perk et al, 1971; Bucciarelli, 1973; Sharp et al,
1983). In close proximity to the tumour cells, extracellular retroviral particles with a
cylindrical core and short envelope projections (described either as type-B or -D)
were also observed.
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Reverse transcriptase (RT) activity was demonstrated in lung tumour and lung
2+
secretions of SrA affected sheep. RT activity was found to have preference for Mg
and to be associated with particles with a density in sucrose gradient similar to other
type-B and -D retroviruses (Perk et al, 1974; Martin et al, 1976; Herring et al, 1983).
SPA was reproduced experimentally in lambs by the inoculation of cell free tumour
extract or lung fluids of SPA-affected sheep. The detection of RT activity was found
to be present both in the inoculum used to reproduce SPA experimentally and in the
resultant tumour lesions of the inoculated lambs (Martin et al, 1976; Verwoerd et al,
1985). In addition, the incubation period of the experimentally-induced SPA was
reduced dramatically to a few weeks using new-born lambs inoculated intratracheally
with ultracentrifuged and concentrated lung fluid collected from SPA-affected sheep
(Verwoerd et al, 1980; Sharp et al, 1983); the incubation period was shown to be
inversely related to the reverse transcriptase activity in the inoculum (Verwoerd et al,
1985).
A significant step towards the identification of the retrovirus associated with SPA
was due to the detection in tumour homogenate and lung secretions of SPA-affected
sheep of a 25 kDa polypeptide cross-reacting with antisera raised against the CA
protein of MPMV and MMTV (Sharp and Herring, 1983). However, several attempts
to isolate this virus in tissue culture failed (Sharp, 1987) hampering virological
studies.
Finally, in 1992 the complete sequence of JSRV was obtained from a cDNA library
constructed from isopycnic-gradient-purified virus derived from the lung secretions
of a SPA-affected sheep (York et al, 1991 and 1992). New opportunities for research
in this field were opened.
1.8.1 Genomic organisation of JSRV.
The genome of JSRV is 7,462 nucleotides long and exhibits a simple genetic
organisation characteristic of the replication competent type D and type B
retroviruses, with pro in a different open reading frame from pol (Fig. 1.13).
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Virus type % Identical amino acids
JSRV gag pro pol env
MPMV 53.1 51.9 56
SRV-1 53.5 51.9 55.4
SMRV 36.7 48 52.5
MMTV 37.7 44.4 49.5 27.1
HERV-K 34.8 41.8 45.6 23.9
Fig. 1.13: Genomic organisation of JSRV (top) and its similarity with other type
D and B retroviruses (bottom). Note the lack of similarity between the JSRV env
gene and the env genes of other type D retroviruses (see page ix for abbreviations
used).
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Gag, pro andpol have around 50% (52 to 56 %) identity at the amino acid level with
SRV-1 and MPMV and 38% (gag) to 50% (pol) identity with MMTV. JSRV Env
proteins do not, in contrast, align reliably with the type-D retroviruses but are
homologous to the env proteins of MMTV and HERV-K. This homology is not very
high in terms of amino acid identities (24-27%), but the relationship is evident in
terms of overall structural organisation, particularly for the second half of the
molecules where numerous cysteines and glycosylation sites are shared (York el al,
1992).
In the JSRV sequence there is also present an additional open reading frame (orf-x)
of 683 bp overlapping pol. The location and the codon usage of this open reading
frame are very unusual, the predicted amino acid sequence is very hydrophobic and
gives no meaningful homologies with sequences submitted to GenBank. It will be
necessary to sequence different isolates of JSRV to establish if this open reading
frame is a real viral gene or it has been generated by pure chance.
The LTRs of the provirus are 397 bases in length; U3 is 271 bp long, R is 13bp and
U5 is 113bp. In the U3, two 19 bp tandemly repeated sequences have been identified
and a putative NF-1 binding site, and a core C/EBP (CAAT/ enhancer binding
protein) putative binding site.
Phylogenetic analysis of the RT suggests that JSRV evolved from the A-B-D
lineage and diverged from it before MPMV but after MMTV and HERV-K. In
contrast, for the TM domain, JSRV groups with the type B clade (York et al, 1992).
Therefore it is not straightforward to classify JSRV into the currently recognised
seven genera of the family Retroviridae. Although the last ICTV report includes
JSRV in the type D genus (Coffin et aR 1995), it is probably more correct to define
JSRV a chimaeric type D/B retrovirus.
1.8.2 JSRV-related endogenous retroviruses of sheep.
York et al (1992), showed that the sheep genome contains endogenous JSRV-related
sequences (enJSRV) by hybridisation with probes derived from JSRV cDNA clones.
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Subsequent studies employing both gag, pol and env probes estimated the number
of these sequences in the domestic sheep (Ovis aires) to be between 15 and 20 (Hecht
et al, 1994). Several sheep breeds in different geographical locations such as Kenya,
Peru and the United States were tested, indicating that probably all the sheep
population contains these endogenous sequences as expected for an outbred animal
species. Moreover, endogenous JSRV-related sequences were also found in goats
(Capra hircus) (York et al, 1992), therefore these viruses became integrated into the
germline before the speciation between sheep and goats. However, Hecht et al (1996)
showed that the restriction pattern of enJSRVs in domestic and wild sheep was
different from that one found in domestic and wild goats. This finding leads to the
hypothesis that two distinct but closely related viruses became integrated into the
germline of sheep and goats and much of the amplification of the original viruses in
the respective genomes happened after the divergence of goats and sheep (4 to 10
million years ago) (Hecht et al, 1996).
The presence of enJSRVs does not permit straightforward interpretations about the
detection of the exogenous JSRV in tumour and lung secretions of SPA sheep. JSRV
could indeed derive from the reactivation of endogenous sequences prior to or after
the neoplastic events and may not be aetiologically related to SPA. In support of this
hypothesis, there are the results obtained by Hecht et al (1994) with Southern
hybridisation analysis of SPA tumour and non tumour genomic DNA using a
JSRVgag probe. No additional bands were detected in tumour DNA in comparison
with non-tumour DNA. However the background formed by the endogenous copies
could have masked additional sites of integration of the exogenous JSRV. In
addition, that study did not employ tumour and non-tumour material collected from
the same animal and therefore it does not allow conclusive interpretations due to
possible minor variations among different individuals in the enJSRV restriction
pattern.
EnJSRVs could play a role in the pathogenesis of SPA by influencing the immune
response towards JSRV. Sheep with naturally or experimentally-induced SPA do not
show detectable circulating antibodies (by western blotting) towards JSRV (Sharp et
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al, 1983). This has led to speculation that endogenous JSRV antigens are expressed
in the neonatal period during ontogeny, leading to the depletion of JSR.V-specific
lymphocytes and therefore establishing a state of tolerance for the endogenous and
the exogenous virus (York et al, 1992).
1.9 Lentiviruses associated with SPA.
The earliest electron microscopy studies conducted on SPA tumour sections also
showed retroviral particles with a type-C morphology (Perk et al, 1971).
Subsequently, two groups in Israel and South Africa isolated a lentivirus from lung
tumour of SPA-affected sheep (Irving et al, 1984; Payne et al, 1986)
immunologically related to maedi-visna virus (MVV). The nucleotide sequence of
one of these two isolates (South African - ovine maedi-visna virus [SA-OMVV])
confirmed that the virus was related to maedi-visna virus (Querat et al, 1990).
MVV causes a slow progressive fatal disease with pulmonary involvement
(interstitial pneumonia) and/or neurological disorders known as maedi-visna (MV)
(Narayan and Jolly, 1990), but it does not directly induce SPA. SA-OMVV failed to
experimentally reproduce the tumour when inoculated intratracheally in sheep (Payne
et al, 1986).
The isolation of a lentivirus in SPA tumours was not surprising considering that
maedi-visna and SPA have been detected in the same flock and in the same sheep in
several countries (Al-Zubaidy and Sokkar, 1979; Cutlip and Young, 1982; Deng et
al, 1983; Snyder et al, 1983; Stevenson et al, 1982; Rosadio et al, 1988; Di Guardo
et al, 1992) but in Britain, while SPA has been present throughout the century
maedi-visna has been introduced only in the late seventies (Dawson et al, 1979).
SPA and MV have therefore to be considered as two separate entities. However, the
close association of these diseases in different geographical locations could reveal
interesting pathogenic mechanisms arising from a double retroviral infection. It has
been proposed that the presence of an abundant population of macrophages in the
SPA lesions could represent a large population of susceptible cells for MVV (Payne
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et al, 1986; Dawson et al, 1990), considering that alveolar macrophages have been
shown to be an important target for MVV (Narayan et al, 1982).
1.10 Enzootic nasal tumour virus of sheep and goats.
Enzootic nasal tumour (ENT) of sheep and goats is an infectious adenocarcinoma of
the ethmoid turbinates (Cohrs, 1953) which shows several similarities to SPA. Like
SPA, the tumour originates from secretory epithelial cells (De las Heras et al, 1991a)
and it is experimentally reproducible by inoculation of cell free tumour homogenate
or nasal secretions (in this case intra-nasal) (Cohrs 1953; De las Heras et al, 1995).
Retrovirus-like particles have been observed by EM and RT activity has been
detected in tumour extracts (McKinnon et al, 1982; De las Heras et al, 1991a;
Vitellozzi et al, 1993; De las Heras et al, 1991b). Like JSRV, the retrovirus
associated with nasal tumours of sheep and goats (ENTV) cross reacts with MPMV-
CA indicating that ENTV has a type-D retroviral capsid (De las Heras et al, 1991b).
Although no studies have been reported to determine if ENT and SPA are different
manifestations of disease caused by the same agent, studies of ENT cases have not
found any tumours in the lung, nor have nasal tumours been reported in SPA-affected
animals (De las Heras et al, 1991; Vitellozzi et al, 1993).
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1.11 Aims of the present project.
Research on the aetiology and pathogenesis of SPA has been hampered for years by
the lack of an in vitro system for the propagation of JSRV and by the lack of
appropriate immunological reagents and techniques for the detection of the virus.
The availability of the complete sequence of one strain of JSRV opened new
possibilities for research. However, the presence in the sheep genome of 15-20 copies
of endogenous JSRV-related sequences has curtailed studies at the molecular level.
The ultimate goal of the scientists working in the SPA field is to determine the
pathogenesis and oncogenesis of SPA. In this thesis two basic questions were asked
in order to help to understand what role JSRV plays in the aetio-pathogenesis of
SPA:
i) What are the sites of JSRV-replication in SPA-affected and unaffected control
sheep?




General Materials and Methods
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2. Introduction.
In this chapter, the general materials and methods which have been used throughout
the work of this thesis will be described. To facilitate the reader, the following
chapters (3 to 6) will also contain a 'Materials and Methods' section where methods
unique to that single chapter will be described.
2.1 Animals employed in this study.
In this study, SPA sheep were defined as animals which showed typical clinical
signs, particularly the production of an abundant sero-mucoid fluid (lung fluid) from
the nostrils when the rear limbs were elevated above the head. Diagnosis was
confirmed by macroscopic and histological examination of the lungs.
The histological diagnosis was conducted either at the Histopathology Diagnostic
Service at Moredun Research Institute or by Dr. M. De las Heras (Zaragoza
University, Spain).
Sheep with naturally acquired SPA were obtained from farms throughout Scotland
and Northern England. Frozen tissues collected from SPA-affected sheep in Spain
were obtained from Dr. M. De las Heras. Frozen tissues from SPA-affected sheep
and goats with enzootic nasal tumour were obtained from Prof. G. Vitellozzi
(University of Perugia, Italy) and Dr. M. De las Heras.
Unaffected control animals were obtained from the Moredun Research Institute's
farm; in these animals SPA was ruled out by the absence of the characteristic
macroscopical and histological lesions in the lungs.
The number of animals and the tissues employed in each experiment will be specified
in the relevant chapters.
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2.1.2 Experimental reproduction of SPA.
Eight one-day old lambs were experimentally infected in order to increase the
availability of infected tissues for this thesis and for related projects.
Lambs were infected as described previously (Sharp et al, 1983). Briefly, lung fluid
collected from several SPA-affected sheep was pooled, filtered through a double
layer of sterile gauze and clarified by centrifugation at 10000 x g for 1 h at 4 °C.
The supernatant was ultracentrifuged at 100000 x g for 1 h at 4°C. The resultant
pellet was resuspended in a volume of PBS (137 mM NaCl, 2.7 mM KC1, 4.3 mM
Na2HP04-7H20, 1.4 mM KH2P04, pH 7.3) equivalent to 1/15 that of the initial
volume. Lambs were inoculated intratracheally with 5 ml of this suspension. Live age
and breed matched controls were inoculated with 5 ml of PBS.
Lambs were killed after 4-16 weeks. All the eight infected animals developed SPA.
Sterile instruments were used to dissect each individual organ at post-mortem to
avoid cross-contamination. Tissue samples were snap-frozen in liquid nitrogen and
stored at -70°C.
Tissues collected from lambs experimentally infected in the past years at MRI and
stored at -70°C were also employed in this study.
2.2 Bacteriological techniques.
Strains DH1 (Hanahan, 1984) and JM109 (Yannisch-Perron et al, 1985) of E. coli
were used in this thesis for cloning purposes. Bacteria were grown in L-broth (lOg
tryptone, 5g yeast extract, 5g NaCl for litre of solution) or L-agar (L-broth containing
15g agar per litre).
Ampicillin was used at a concentration of 50 pg per ml when required.
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2.2.1 Preparation of competent E. coli.
Competent cells were either purchased (JM109 High Efficiency Competent Cells;
Promega) or prepared by the calcium chloride method (Sambrook et al, 1989).
Briefly, 10 ml of L broth was inoculated with a single colony of DH1 and incubated
at 37°C in a shaking incubator overnight. A 500 pi aliquot of overnight culture was
added to 50 ml of L-broth and incubated at 37°C until the OD600 of the culture
reached 0.6. The culture was centrifuged at 2000 x g for 20 min at 4°C and the
bacterial pellet resuspended in 25 ml ice-cold 100 mM CaCl2 and incubated on ice
for 20 min. Bacteria were pelleted by centrifugation as above, and resuspended in 5
ml 100 mM CaCl2. After 10 min on ice the bacteria were ready for transformation.
Alternatively, after the addition of 15% glycerol, cells were snap frozen in liquid
nitrogen and stored at - 70°C.
2.3 Molecular biology techniques.
2.3.1 Optimisation of PCR reactions and precautions taken to avoid cross-
contamination.
Each PCR reaction described in this thesis was optimised by varying several
parameters of the reaction like MgCl2 concentration and pH of the reaction buffer,
primer and dNTP concentrations, annealing and extension temperature and number
of cycles (Innis and Gelfand, 1990; Kidd and Ruano, 1995).
The computer program 'Primer' of the GCG package was used as an aid to select the
correct combinations of primers (Genetics Computer Group, 1994).
Contamination of PCR was checked by the use of appropriate distilled water controls
in each step of the work. Isolation of nucleic acids, preparations of PCR reactions
and analysis of PCR products were conducted in separate rooms. Sterile instruments
were used to dissect each individual organ at post-mortem to avoid cross-
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contamination between different tissues. Samples were placed in individually sealed
plastic bags prior to being snap-frozen and stored at -70°C.
2.3.2 Agar gel electrophoresis of DNA.
DNA (plasmid preparations, PCR products, genomic DNA) was analysed by
conventional agarose gel electrophoresis. Agarose concentrations ranged from 0.8 to
2.0% w/v in TBE electrophoresis buffer (45 mM Tris/borate, 1 mM EDTA pEl 7.3)
in the presence of 0.5 pg of ethidium bromide per ml. Gels were run in TBE buffer at
30-100 V. DNA fragments were visualised by their fluorescence under UV
illumination. The size of the DNA fragments was determined by comparison with
known commercially available molecular weight standards (DNA molecular weight
standard VI, VII and IX [Boehringer]).
A record was obtained by photographing the gels on heat sensitive paper using a
video camera (Mitsubishi video copy processor, UVP).
2.3.3 Purification of DNA fragments from agarose gels.
PCR products utilised for cloning were electrophoresed in a low melting point
agarose (Boehringer), identified by UV illumination, purified by excision of the
band of the expected size and subsequent standard phenol/chloroform extraction.
Briefly, after excision the agarose band was incubated at 67 °C for 15-30 min until
the agarose slice was completely melted. Five volumes of TE buffer (10 mM Tris-
HC1, 1 mM EDTA pH 8.0) were then added, followed by the addition of an equal
volume of water saturated phenol. Samples were mixed and centrifuged at 13,500 x g
for 5 min. The aqueous phase was collected, put in fresh microfuge tubes and an
equal volume of phenol was added for a second time and centrifuged as above. The
aqueous phase was removed and to this was added one volume of
phenol/chloroform/isoamyl-alcohol (25:24:1) and centrifuged again. The last
extraction was then performed adding chloroform/isoamylalcohol (24:1) to the
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collected aqueous form. After another centrifugation the aqueous phase was collected
and 0.1 volumes of 3 M sodium acetate pH 4.8 and two volumes of ethanol added.
DNA was then precipitated at -20°C for at least one hour and subsequently
centrifuged at 13,500 x g for 20 min at 4 °C. Pellets were washed twice with 70%
ethanol, dried and resuspended in distilled water.
Alternatively, due to the high purity of the low melting point agarose, a variation of
the "freeze and squeeze" method (Polamn and Larkin, 1989) was also used
employing Costar's Spin-X tubes™. These tubes are formed by an upper and a lower
chamber separated by a microfilter. Excised agarose slice were put into the upper
chamber and incubated at -20°C for 15 min. Afterwards the tubes were spun at 5,600
x g for 30 min. During the centrifugation, the agarose is retained in the upper
chamber while the DNA (in TBE) passes through the filter in the lower chamber
ready to use.
2.3.4 Quantification of DNA and RNA.
Nucleic acid was quantified by the use of a spectrophotometer. DNA and RNA have
a peak of absorbance at 260 nm, while contaminating proteins have their peak at 280
nm (Sambrook et al, 1989). The absorbance at 260 nm reflects the amount of nucleic
acid present in the sample. An absorbance of 1 OD260 corresponds to 50 pg ml"1 of
double stranded DNA and 40 pg ml"1 for RNA. The ratio OD260/OD280 should be
between 1.8 and 2.0 for a clean nucleic acid preparations. Samples were diluted to
give an OD260 between 0.1 and 0.5 to be within the range of accuracy of the
spectrophotometer. An automatic spectrophotometer (Beckman DV650) was used in
this study. This has a software which automatically calculates the concentration of
nucleic acid and the OD260/OD280 ratio.
In some cases, when the amount of DNA available was very limited, the estimation
of DNA was carried out by visual comparison of the fluorescence of electrophoresed
DNA samples with known weight DNA standards in an agarose gel electrophoresis.
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2.3.5 Southern blotting.
Southern blotting analysis (Southern. 1975) was performed on PCR products to
confirm their specificity by hybridisation with oligonucleotide probes internal to the
PCR products. The DNA was denatured by soaking the agarose gel in 0.4 M NaOH
for 5-10 min. The DNA samples were then transferred in a 0.4 M NaOH buffer (Reed
and Mann, 1985; Ausbel et al, 1992) by capillary action overnight onto nylon filters
(Hybond-N, Amersham International). Filters were then rinsed briefly in 2 x SSC
(20x SSC = 3M NaCl, 0.3M sodium citrate, pH 7) to remove any possible piece of
agarose and the DNA fixed either by baking at 80°C for 2 hours or by UV
crosslinking using a Stratalink UV transilluminator (Stratagene). Filters were then
used straight away for hybridisation or wrapped in a plastic bag and kept in the dark
at room temperature for further use.
2.3.6 Labelling of oligonucleotide probes.
32
Oligonucleotides used for hybridisation were labelled with either "P or digoxygenin
(DIG).
32
Synthetic oligonucleotides were labelled with [y- PJATP using T4 polynucleotide
kinase which catalyses the transfer of the y-phosphate group from ATP to the 5'-OH
termini of the oligonucleotide. Reactions were carried out in a total volume of 20 pi
composed of 1 pi of oligonucleotide (10 pM), 1 pi polynucleotide kinase (MBI
Fermentas), 4 pi 5 x reaction buffer (250mM Tris-HCl pH 7.6, 50 mM MgCl2, 25
mM DTT, 0.5 mM spermidine, 0.5 mM EDTA), 5 pi [y-32 PJATP (specific activity
5000 Ci/mmol; 10 mCi/ml in aqueous solution), 9 pi distilled water. Reactions were
32incubated at 37°C for an hour. The efficiency of P transfer was determined by
chromatography by spotting 0.5 pi of labelling reactions into the lower end of a strip
of cellulose impregnated with polyethyleneimine (Polygram® CEL 300PEI). The
bottom of the strip was then dipped into 750 mM solution of K2P04, pH 3.5. After
the buffer had migrated about 10-20 cm, the strip was wrapped in Saran Wrap and
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autoradiographed. The film was developed after about 30 min. P labelled
oligonucleotides are visualised as a spot remaining at the origin while unincorporated
32
P-ATP migrates up the strip and it is seen as a smear.
Accurate calculations can be done by measuring the amount of radioactivity at the
origin and on the total strip. This has not been necessary for the hybridisation
purposes during the course of this thesis.
The unincorporated 32P was removed from the radiolabeled oligonucleotides using a
Sephadex® G-50 DNA grade Nick Column (Pharmacia) according to the
manufacturer's protocol.
DIG-labelled (5'-DIG) oligonucleotides were purchased from Oswel DNA Service.
2.3.7 Hybridisation.
32
With P oligonucleotide probes, hybridisation was performed overnight in a
hybridisation buffer composed of 4 x SSC, 0.1% sodium pyrophosphate, 0.2% SDS,
50 pg/ml heparin (Singh and Jones, 1984). Alternatively, 'rapid hyb' buffer
(Amersham) was also used.
Hybridisation using DIG-labelled oligonucleotides was performed using 'DIG easy
Hyb' buffer (Boehringer).
Filters were hybridised in tubes in a Hybaid oven with a rotating wheel. Temperature
of hybridisation varied depending on the melting temperature of the oligonucleotide
used. Filters were washed at high stringency as follow: twice with 2 x SSC (0.1%
SDS) at room temperature for two minutes, three times with 1 X SSC (0.1% SDS) at
the hybridisation temperature for 15 min each, followed by the three washes with
0.1% SSC (0.1% SDS) for 15-20 min each at the hybridisation temperature. For the
washings, the filters were put in a tray and excess washing buffer was used. This is
particularly true for filters hybridised with DIG-labelled probes where the use of 400-
500 ml of washing buffer for each washing decreased the non-specific background.
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2.3.8 Autoradiography.
Detection of 32P labelled probes was done by autoradiography. After the last wash
the filters were wrapped in Saranwrap™ and autoradiographed at -70°C using Kodak
X-Omat S films.
2.3.9 Detection of DIG-labelled probes.
Immunochemical detection of DIG-labelled oligonucleotides bound to an
immobilised target was performed using the 'DIG nucleic acid detection kit'
(Boehringer) essentially as described by the manufacturers. Briefly, filters were
washed in 0.1 M maleic acid, 0.15 M NaCl, pH 7.5 (buffer 1) plus 0.3%, Tween 20.
Non-specific binding was blocked by incubating the membrane for 30 min in buffer 1
containing 1% blocking reagent (buffer 2). Filters were then incubated for an hour at
room temperature with an anti-DIG alkaline phosphatase conjugate (1:5000 v/v in
buffer 2). Unbound conjugate was removed by two washes (thirty minute each) with
an excess of buffer one. Filters were then equilibrated in 100 mM Tris/HCl, 150 mM
NaCl, 50 mM MgCl2, pH 9.5. The enzyme substrates were added; 45 pi NTB (75
mg/ml nitroblue tetrazolium salt in dimethylformamide) and 35 pi X-phosphate (50
mg/ml 5-bromo-4-chloro-3-indolyl phosphate toludinium salt in
dimethylformamide). Filters were put in a box in the dark until the colour developed
(2-16 hours).
2.3.10 pGEM-T cloning vector.
In this thesis recombinant DNA techniques have been used solely to clone PCR
products. A convenient vector to facilitate PCR cloning is represented by pGEM-T
(Promega). The pGEM-T vector is prepared by the manufacturer cutting pGEM-
5Zf (Promega) with EcoRV and adding a 3' terminal thymidine to both ends. The
overhang 3'-T at the insertion site improve the efficiency of ligation of a PCR
64
product into the plasmid because of the non-template dependent addition of a single
deoxyadenosine to the 3'-end of PCR products by Tag DNA polymerases (Clark,
1988). pGEM-T contains the multiple cloning site in the a-peptide coding region of
the enzyme p-galactosidase. When the appropriate strains of E. coli are used,
insertional inactivation of the a-peptide allows recombinant clones to be directly
identified by colour screening on plates containing X-gal (5-bromo-4-chloro-3-
indolyl-P-D-galactopyranoside; a lactose analogue) and IPTG (isopropyl-
thiogalactoside; an inducer of the lac operon). The non-recombinant colonies will
synthesise P-galactosidase, which breaks down X-gal to a product that is coloured
deep blue (blue colonies), whereas the recombinant colonies will be unable to
produce P-galactosidase and will be white.
2.3.11 Ligation of the pGEM-T vector and PCR product.
Ligation reactions were performed using the enzyme T4 DNA ligase which catalyses
the formation of a phosphodiester bond between a 5' phosphate group and a 3'
hydroxyl group resulting in the covalent linking of two DNA molecules which have
compatible ends. Ligation reactions were set up in a total volume of 10 pi ligation
buffer (30mM Tris-HCl, pH 7.5; 100 mM MgCl2; 10 mM DTT; 10 mM ATP)
containing 50 ng of vector, insert DNA at a insert:vector ratio of approximately 3:1
and 1 pi T4 DNA Ligase (Promega). Parallel controls were performed using a control
insert supplied by Promega. Ligation reactions were incubated at 15°C overnight.
2.3.12 Transformation of competent E. Coli.
A 100 pi aliquot of competent bacterial cells (prepared as described in 2.2.1) were
mixed with 5 pi of the ligation reaction and placed on ice for 20 min. The mixture
was then heated for 45-50 seconds at 42°C. A 500 pi aliquot of L-broth plus 10 mM
CaCl2 was then added and the cells were incubated at 37 °C for one hour. At the end
of the incubation period, 200 and 100 pi of each sample was spread on L-agar plates
65
containing ampicillin (100 pg/ml), X-gal (80 pg/ml) and IPTG (0.5 mM). The plates
were incubated at 37°C overnight. White colonies were picked with a sterile tooth¬
pick, inoculated into 10 ml of L-broth containing ampicillin and incubated in a
shaking incubator at 37°C overnight.
2.3.13 Small scale preparation of plasmid DNA.
Small scale preparation of plasmid DNA was performed essentially as already
described (Serghini et al, 1989).
Ten ml of overnight bacterial culture was centrifuged at 3,800 x g for 20 min at
room temperature. The bacterial pellet was resuspended in 700 pi distilled water and
transferred to a microcentrifuge tube. One volume of phenol/chloroform/
isoamylalcohol (25:24:1) was added, the samples were thoroughly mixed by
vortexing and centrifuged at 13,500 x g for 5 min. The aqueous layer was transferred
to a clean tube and 60 pi of 3M sodium acetate (pH 4.8) and 1 ml of ethanol was
added. After incubation at -20°C for at least one hour, DNA was precipitated by
centrifugation at 13,500 x g for 20 min at 4°C. The resultant pellet was washed twice
with 70% ethanol. The final pellet was air dried, resuspended in 20 pi of lOmM Tris-
HC1, pH 7.5, 1 mM EDTA plus 5 pi RNAse A (20 mg/ml, Sigma) and incubated at
37°C for half an hour.
Alternatively, the QIAprep™ kit (Quiagen) was used according to the inanufactuiei's
protocol. The QIAprep plasmid kit procedure is based on a modified alkaline lysis
(Birnboim and Doly, 1979) where the bacterial cells are lysed in NaOH/SDS buffer
in an optimised lysis time which allows maximum release of plasmid DNA without
release of chromosomal DNA. After neutralisation the plasmid DNA is adsorbed
onto silica gel in the presence of high salt (Vogelstein and Gillespie, 1979) and after
washings the DNA is eluted by TE buffer or distilled water.
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2.3.14 Restriction endonuclease digestion of DNA.
Restriction enzymes were purchased from Boehringer and used with the appropriate
incubation buffers as recommended by the manufacturer. The final concentration of
the enzymes was at least 10 units per pg of DNA.
2.3.15 Sequencing.
DNA sequencing was performed by the dideoxy chain termination method of Sanger
T7 ?
et al (1977) using the Pharmacia Sequencing kit™ according to the manufacturer's
protocol.
Double stranded plasmid DNA was denatured in alkaline solution prior to the
annealing reaction. Approximately 2 pg of plasmid DNA in a volume of 22 pi was
incubated at 37°C for an hour with an equal volume of 0.4 M NaOH, 4 mM EDTA.
The mixture was then neutralised by the addition of 4.4 pi sodium acetate and 100 pi
of ethanol and precipitated at -20°C for at least one hour. DNA was pelleted by
centrifugation, washed twice with 70% ethanol and air dried. DNA was finally
dissolved in 10 pi distilled water ready for annealing.
Two set of sequencing reactions were performed respectively with a 'forward' and a
'reverse' primer to allow sequencing of both DNA strands. Initially, 10 pi of
template were added to 2 pi of the forward or the reverse primer (5 pmol/pl) and 2 pi
of annealing buffer. This mixture was incubated at 65 °C for five minutes, 37°C for
10 min and 5 min at room temperature. The following reagents were added to the
primed template: 3 pi of labelling mix (1.375 pM each of dCTP, dGTP, dTTP in 333
mM NaCl), 1 pi of 35S-dATP (10 pCi) and 2 pi of T7 DNA polymerase diluted 1:5
in enzyme dilution buffer which contains glycerol, bovine serum albumin and DTT
in Tris/HCl, pH 7.5. Following incubation at room temperature for five minutes, 4.5
pi aliquots were added to each of four tubes (a, g, c, t) which contained 2.5 pi of the
corresponding dideoxynucleotides and non-limiting concentrations of all four
deoxynucleotides. After five minutes incubation at 37°C , the reactions were stopped
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by the addition of 5 pi of stop solution (deionised formamide containing 10 mM
EDTA, xylene cyanol and bromophenol blue dyes) and the reactions were kept on ice
until loading.
2.3.16 Sequencing gel electrophoresis.
Sequencing gel electrophoresis was carried out in an IBI model STS 45 sequencing
tank. A 6% polyacrylamide gel was prepared by dissolving 42g of ultrapure urea in
20 ml of 30% w/v acrylamide / 0.8% w/v bis-acrylamide stock solution, 10 ml of
lOxTBE buffer and water to 100 ml. Polymerisation was started by the addition of
150 pi of 25% w/v ammonium persulphate and 150 pi of N,N,N,N-
tetramethylethelenediamine (TEMED). The running buffer was 1 x TBE and the gel
was pre-run for 30-40 min at 80W to heat to 50°C. The samples were denatured at
94°C before loading. A 2.5 pi aliquot of each sample was loaded. After
electrophoresis for 2-6 h the gel was fixed in 10 % v/v methanol, transferred to a
supporting sheet of Whatman® 3MM filter paper, covered with Saranwrap™ and
dried under vacuum at 80 °C. The dry gel was exposed to Fuji Medics X-ray film for
12 to 36 hours.
2.3.17 Sequence analysis.
Sequence analysis was done using various softwares of the Genetics Computer
Group package (Deveroux et al, 1984; Genetics Computer Group, 1994) on the
SEQNET facility of the Science and Engineering Research Council. Daresbury
Laboratory, Warrington, England.
2.3.18 Preparation of total cellular RNA.
Total cellular RNA was extracted by the acid guanidinium thiocyanate-phenol-
chloroform method as already described (Chomczynski and Sacchi,1987).
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Briefly, solid tissues (0.2 - 0.5 g) were pulverised with a pestle and mortar under
liquid nitrogen and each tissue was added to 500 pi of solution D (4M guanidinium
thiocyanate, 25 mM sodium citrate. pH 7; 0.5% sarcosyl. 0.1 M B-mercaptoethanol)
in a 1.5 ml microfuge tube. Ultraspeed pellets of lung fluid (2.5 to 5 ml) or 107 cells
(leukocytes or other cells) were suspended directly in 500 pi of solution D. The pH of
the solution was then lowered by the addition of 50 pi of sodium acetate, pH 4. Five
hundred pi of water-saturated phenol was then added followed by the addition of 100
pi of chloroform/isoamyl alcohol (49:1). The samples were then placed on ice for 15
min. Between each step the samples were mixed by vortexing. Samples were then
centrifuged for 20 min at 13000 x g in a refrigerated microfuge at 4 °C. The upper
aqueous layer was transferred to a new microfuge tube and an equal volume of
isopropanol was added. The samples were then placed at -20°C for at least 2 hours.
In lung fluid samples; 20 pg of glycogen (Boehringer) or 2 pg of MS-2 RNA
(Boehringer) was added as a carrier.
The RNA was pelleted by centrifugation at 17000 g for 20 min. The RNA pellets
were washed twice with 75% ethanol and then dried. RNA pellets were resuspended
in 20-50 pi of distilled water.
To avoid RNAse contamination, distilled water and solutions used for RNA
extraction and analysis were treated with 0.1% of diethylpyrocarbonate (DEPC)
overnight followed by autoclaving to inactivate the DEPC.
Each RNA sample was treated with 10 U of DNAse I, RNAse free (Boehringer) for
30 min at 37 °C in a solution containing 50 mM sodium acetate , pH 6.5, 10 mM
magnesium chloride and 80 U of RNAsin (Promega). DNAse was inactivated by
94°C for 3 min or the RNA was re-extracted by the phenol-chloroform method.
2.3.19 PolyA+ RNA selection.
Isolation of polyA+ RNA was performed employing the Micro-FastTrack™ kit
(Invitrogen) as recommended by the manufacturer. Briefly, tissues were pulverised
with a pestle and mortar under liquid nitrogen and 200 mg were added to a lysis
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buffer containing RNAse/protein degrader in a microfuge tube. After incubation at
45°C for a time variable between 20 min and 2 h the lysate was applied directly to
oligo (dT) cellulose for adsorption. The DNA, degraded proteins and cell debris were
washed off with a high salt buffer. Non polyadenylated RNA was washed off with a
low salt buffer and the polyA+ RNA then eluted in the absence of salt.
2.3.20 RNA electrophoresis.
The RNA concentration of the samples was estimated spectrophotometrically at
260/280 nm using a Beckman DV650 spectrophotometer.
The quality of the RNA extracted was assessed by running an aliquot of the sample (2
pi) in a 1% denaturing formaldehyde/agarose gel (Fig. 2.1 [a] and [b]). The gels were
prepared by dissolving 0.4g of agarose in 34 ml of distilled water and heating in a
microwave oven. Once the agarose had cooled to approximately 65°C, 4 ml of lOx
MOPS buffer (0.2M MOPS 3-[N-Morpholino] propanesulphonic acid (Sigma), 50
mM sodium acetate and 10 mM EDTA pH7) and 2 ml of formaldehyde (39%, Sigma)
were added. Electrophoresis was performed in a horizontal gel apparatus using lx
MOPS as running buffer. A 2 pi aliquot of the RNA samples were added to 6 pi of
sampling loading buffer (750 pi formamide, 150 pi lOx MOPS, 240 pi formaldehyde,
100 pi glycerol, 0.10 pi 10% (w/v) bromophenol blue. 10 pi ethidium bromide [10
mg/ml], 100 pi distilled water) and denatured at 65 °C for 10 min prior to loading on
the gel. Electrophoresis was carried out at 80 V for approximately 30 min. RNA was
then visualised with a UV transilluminator.
The presence of two sharp bands representing the 18S and 28S ribosomal RNA is an
index of a good quality preparation. An example of the quality of the total cellular
and the poly A+ selected RNA preparations obtained is given in figure 2.1.
70
a) Total RNA
Fig. 2.1: Agarose gel electrophoresis of RNA. (a) shows an example of the total cellular RNA
preparations obtained during this study; about 95% of the total RNA is represented by the ribosomal
RNA which is visible in the figure as the 28S and the 18S subunits. Lane 1, lung tumour; lane 2,
spleen; lane 3, kidney; lane 4, mediastinal lymph node; lane 5, thymus. Poly A+ selected RNA is
shown in (b) as a smear. Lane A, B and C, mediastinal lymph node; lane D, kidney; lane E, spleen;
lane F, lung. Lane M, Gibco RNA molecular marker (numbers represent kilobases).
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2.3.21 Preparation of genomic DNA.
High molecular weight DNA from sheep tissues was obtained employing the
QIAamp Tissue Kit® (Quiagen). This kit was chosen because it allows the handling
of several samples at the same time. Solid tissues were ground under liquid nitrogen
using a pestle and mortar. The tissues (10-25 mg) were then added to 180 pi lysis
buffer (Quiagen buffer ATL) and 20 pi of proteinase K (20 mg/ml), mixed by
vortexing and incubated at 55°C overnight. A 20 pi aliquot of RNAse A (20 mg/ml)
was then added and the samples were incubated at room temperature for two
minutes. Buffer AL was then added and the samples were incubated at 70 °C after
mixing by vortexing. After the addition of 210 pi of ethanol the samples were placed
in QIAamp spin column which contains a silica gel membrane. Salt and pH
conditions given by the different buffers used ensure the DNA is adsorbed onto the
silica membrane while protein and other contaminants flow through after
centrifugation at 6000 x g for one minute. After a series of washing with buffer AW
the samples were eluted with pre-heated (70 °C) buffer AE.
Some of the tumour and kidney DNA samples collected from SPA sheep were
obtained from Dr. C. Cousens (MRI. Edinburgh) and were prepared by a standard
proteinase K-phenol extraction (Sambrook et al, 1989).
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Chapter 3.
Localisation of JSRV Sites of Replication by the
Development of Immunological Techniques.
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3.1 Introduction.
Although the association between JSRV and SPA has been established for a number
of years (see 1.8), the role of this virus in the pathogenesis of SPA is not understood.
The sites of viral replication are largely unknown and some indications have been
obtained only by ultrastructural observations of retrovirus-like particles in the
tumour cells, or in close association with them, in the lungs of SPA-affected animals
(Perk et al, 1971, Bucciarelli, 1973; Sharp et al, 1983). The principal problem in
identifying the sites of JSRV replication has been the lack of appropriate reagents
and techniques for the detection of the virus.
Western blotting, employing a goat antiserum towards the CA protein of MPMV, has
been the main technique used successfully for the detection of JSRV (Sharp and
Herring, 1983; Herring et al, 1983). With this technique it has been possible to detect
JSRV in lung fluid and in most of the lung tumour extracts of SPA-affected sheep
(Sharp and Herring, 1983; Herring et al, 1983; Rosadio et al, 1988a and 1988b; J.M
Sharp, personal communication). The sensitivity of this test is decreased by the use
of a heterologous antiserum and in practice it has been necessary to concentrate the
infected samples (lung tumour, lung fluid) several fold to obtain a clear result. A
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heterologous competition radioimmunoassay employing I-labelled langur
retrovirus (LRT) major capsid protein and goat antiserum to squirrel monkey
retrovirus (SMRV) also has been described (Kajikawa et al. 1990); the use of
heterologous reagents and radioisotopes did not make the use of this technique more
advantageous.
The sequencing of one strain of JSRV (York et al, 1992) offered new possibilities for
research through the generation of JSRV recombinant antigens and homologous
antisera.
This chapter describes the generation of new immunological reagents, the
development of a blocking enzyme-linked immunosorbent assay (B-ELISA) and an
immunohistochemical technique for the detection of JSRV major capsid protein at
tissue and cellular levels. Studies were then undertaken to examine the distribution
74
and sites of replication of JSRV in SPA-affected and unaffected sheep to better
define the role of this virus in the pathogenesis of the disease.
3.2 Materials and Methods.
The constructs expressing the recombinant JSRV-CA proteins, the homologous
rabbit antiserum and the protocols to purify JSRV-CA recombinant proteins were
available at Moredun Research Institute before the start of this thesis as result of the
work of Ms. P. Dewar and Mr. N. F. Inglis. A brief description on how these
reagents have been produced is included in 3.2.1 and 3.2.2 for a better understanding
of this chapter.
3.2.1 Subcloning and expression of clone JS382.
Plasmid pBluescript-Js382 containing a part of the JSRV gag gene (bases 953 to
3030 of the nucleotide sequence published by York et al, 1992) was a gift from Dr.
G. Querat (Marseilles). Briefly, the insert fragment was excised by £coRI restriction,
subcloned into plasmids pMSIS (Sherf et al. 1990, supplied by M. Shreiber) and
pGEXlAT (Pharmacia) and expressed in E. coli host strain NM522 as P-
galactosidase (Pgal-CA, plasmid pMCA) and glutathione-S-transferase (GST-CA,
plasmid pGCA) fusion proteins respectively.
Confirmation that the gag gene was in the correct reading frame was obtained by
sequencing across the vector-insert junction, as well testing clones for production of
P-galactosidase and GST fusion proteins of the appropriate size by western blotting
(immunoblot) analysis with a goat antiserum to Mason-Pfizer monkey virus major
capsid protein (MPMV-CA) (ref. 75S - 148, National Cancer Institute Repository)
(Sharp and Herring, 1983).
Transformed bacteria were grown and induced with IPTG for the expression of
recombinant proteins.
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Bacteria were pelleted (5000 x g for 10 min) and resuspended in 20 ml TE (lOmM
Tris pH7.5, ImM EDTA). Phenylmethylsulphonylfluoride (2 mM) was added before
lysing the cell suspension in a French press at 1500 psi (10.35 MPa). The lysate
obtained was sonicated and clarified at 100000 x g at 4°C for 10 min.
Bgal-CA fusion protein was purified by affinity chromatography using a 4 ml column
of aminobenzyl-1 -thio-B-galactopyranoside (ABTG) agarose (Sigma). The column was
washed with 20 ml of 300 mM NaCl-50mM Tris/HCl pH 8, 10 ml of 600 mM NaCl -
50 mM Tris/HCl pH8, and 20 ml of 50 mM Tris/HCl pH8 and the Bgal-CA eluted
with 20 ml of 100 mM sodium borate pH 10 and collected on ice into a tube containing
1 ml of 2M tris-HCl pH 7. The eluate was dialyzed against PBS overnight at 4°C and
then concentrated to 2-3 ml with PEG 20000 (Cameron et al, 1994). The yield of
soluble Pgal-CA was approximately 9 mg/1 of bacterial culture. Protein
concentration was estimated using the BCA™ Protein Estimation Assay (Pierce), as
recommended by the manufacturer.
GST-CA was purified by affinity chromatography using a 4 ml column of
glutathione sepharose (Pharmacia) as recommended by the manufacturers.
GST-CA could not be eluted with free glutathione from the sepharose beads as
recommended by the manufacturers and therefore rabbits were immunised with the
fusion protein coupled to the beads.
3.2.2 Production of rabbit polyclonal antiserum to JSRV-CA.
A specific rabbit antiserum to JSRV-CA was prepared by immunising rabbits with
500 pg Pgal-CA combined with Freund's incomplete adjuvant. After 15 days the
rabbit was boosted with 500 pg of GST-CA bound to the glutathione sepharose beads
in the absence of adjuvant. A third injection of GST-CA (500 pg) was given after 4
weeks and the rabbit was bled 15 days after the last injection.
To avoid non-specific reactions in the B-ELISA and in the immunohistochemical
study, the antiserum obtained was absorbed overnight at 4°C in a rotating wheel with
a lysate of IPTG-induced NM522-pMSlS cells (400 pi serum + 15.6 ml washing
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fluid B + 4 ml lysate). The serum was then centrifuged at 100000 x g for 30 min to
pellet any bacterial debris, aliquoted and stored at -20°C until used.
3.2.3 Preparation of samples tested.
To determine the best conditions for the B-ELISA. to assess its specificity and its
inter- and intra-assay standard deviation the following samples were employed:
i) two different pools of lung fluid (LFP#1 and 2) collected from SPA sheep.
LFP#1 was filtered through a double layer of gauze and clarified by centrifugation at
10000 x g for lh at 4°C. The resultant supernatant was aliquoted and stored at -70
°C until use. Part of the supernatant (60 ml) was further ultracentrifuged at 100000 x
g through a double layer of glycerol (25/50% v/v) for lh at 4°C and the resultant
pellet was resuspended in 150 pi of TNE. A 10 pi aliquot was checked for the
presence of JSRV by SDS-PAGE/ western blotting employing the rabbit antiserum to
JSRV-CA and a goat antiserum to MPMV-CA (as described in 3.2.5).
LFP#2 was filtered, clarified and ultracentrifuged as above. An aliquot of the
supernatant was stored at -70°C before and after the ultracentrifugation step. The
pellet obtained by ultracentrifugation was resuspended in TNE buffer (100 mM
NaCl, 10 mM Tris, 1 mM EDTA) and further purified by isopycnic centrifugation
(100000 x g for 16h at 4°C) on 20 to 55% (w/w) continuous sucrose gradient. The
gradient was fractionated and each 0.5 ml fraction was resuspended in 4.5 ml TNE
buffer, centrifuged at 100000 x g for 1 h at 4°C and the resultant pellet resuspended in
100 pi TNE.
ii) A pool of lung washings collected from healthy sheep.
Lung washings were obtained immediately after the lungs were excised from the
thoracic cavity of the sheep at post-mortem examination by introducing 250-500 ml
of TNE into the trachea, the lungs were then gently massaged and the washings were
finally collected in a sterile beaker. The washings were then filtered through a double
layer of sterile gauze, clarified by centrifugation at 10000 x g for lh at 4°C and
ultracentrifuged at 100000 x g for lh at 4°C through a double layer of glycerol
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(25/50% v/v). The resultant pellet was resuspended in TNE as a 400 times
concentrate, aliquoted and stored at -70°C.
iii) Sucrose gradient purified maedi-visna virus (MVV; gift of Dr. R.G. Dalziel,
Edinburgh);
iv) A lysate of NM522-pMSlS cells induced with 1PTG to provide a (3-galactosidase
control.
v) A lysate of a NM522-pGexlLT cells induced with IPTG to provide a GST
control.
For analysis of the distribution of JSRV in affected and unaffected animals, samples
were collected from:
a) 9 sheep naturally affected by SPA;
b) 16 lambs, experimentally infected as described in 2.2.;
c) 16 age and breed-matched unaffected sheep.
Samples of lung, lung tumour, mediastinal and retropharyngeal lymph nodes,
thymus, tonsils, Peyer's patches, spleen, bone marrow, kidney and lung washings
were collected during the post-mortem examination and snap frozen in liquid
nitrogen before storage at - 70°C. Lung fluid and heparinised blood samples were
taken immediately before the sheep were killed. In addition, tumour samples
collected in Italy from three goats which died from enzootic nasal tumour were also
tested. Lung fluid samples were filtered, clarified at 10000 x g for lh at 4°C and the
resultant supernatants were stored at -70°C. Lung washings from control animals
were collected and processed as described above in point (i). Plasma samples (8 ml
per sample) were clarified as above and further centrifuged at 100,000 x g/ 1 h / 4°C
and the pellets resuspended in 65 pi of TNE before storing at -70°C until use.
Leukocytes were obtained from blood samples in which the red cells had been lysed
with a hypo-osmotic solution (144 mM NH4; 17 mM Tris, pH 7.65). Each leukocyte
sample (7 x 107 cells) was diluted in TNE, freeze/thawed three times, and clarified
and centrifuged as described above. After the ultracentrifugation step, pellets were
resuspended in 65 pi of TNE and stored at -70°C.
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Tissues samples were homogenised (10% w/v suspension in TNE buffer) with a
pestle and mortar, filtered, clarified and ultracentrifuged as above. All tissue samples
were concentrated 400 times except tonsils which were concentrated only 100 times
due to the small size of this organ. One hundred pi of bone marrow samples extracts
were further purified by isopycnic centrifugation in sucrose gradients as described for
LFP#2 above in point (ii). Tissues extracts were kept at -70°C until further use.
3.2.4 Development of a blocking enzyme linked immunosorbent assay (B-
ELISA).
The SPA B-ELISA depends on the presence of JSRV in the test samples to inhibit
the binding between purified Pgal-CA and the rabbit antiserum to JSRV-CA. A
schematic diagram of the B-ELISA is represented in Fig. 3.1 and 3.2.
Equal volumes of the test sample and WFB were reacted at room temperature for 1
hour in order to disrupt the envelope of JSRV and release the capsid of the virions.
WFB was also used as washing buffer for the ELISA plates and as dilution buffer for
the reagents of the reaction.
Microtitre plates were coated with lOOpl of purified Pgal-CA (1.5 pg/ml), diluted in
carbonate buffer (pH 9.6), by incubating overnight at 4°C in a humid chamber (Fig.
3.1 [1] and 3.2 [1]). After incubation, the plates were washed three times with WFB
and blocked by incubation for lh at 37°C with a 1% (w/v) solution of bovine serum
albumin in PBS (Fig 3.1 [2] and 3.2 [2]).
The antiserum and test samples were reacted first in a V-bottom "transfer" plate
(65pl of 1:800 dilution of rabbit antiserum to JSRV-CA + 65 pi of test samples pre-
treated with WFB) for one hour at 37°C (Fig 3.1 [ 1 a] and 3.2 [la]). Thereafter, 100 pi
of the resulting mixture (rabbit serum + sample) were transferred to the pre-coated
ELISA plates, which had been washed three times with WFB (Fig 3.1 [3] and
3.2[3]).
The ELISA plates were incubated at 37°C for lh and, after washing three times, 100
pi of pig antiserum to rabbit IgG conjugated to horse radish peroxidase (DAKO -
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1:1000 in WFB) was added to each well (Fig 3.1 [4] and 3.2[4]). After incubation at
37°C for lh, the plates were washed four times with WFB and lOOpl of substrate
(orthophenyldiamine, Sigma) + 0.05% H2O2 (30% v/v) were added to each well (Fig.
3.1 [5] and 3.2[5]). The colour development was stopped with 2.5M H2SO4 and the
plates read using a Dynatech MR5000 apparatus at 490 nm.
Samples were tested in duplicate in each test. Controls included wells with no
inhibitor (0% blocking) and wells with neither inhibitor nor serum (100% blocking)
the missing component being replaced with diluent (WFB).
Results are expressed as a percentage blocking value using the following formula:
%blocking value= [(ODo - ODtest) / ( ODo - OD100)] x 100
Where ODo is the OD at 0% blocking control , OD100 is the OD at 100% blocking
control and ODtest is the OD of the test sample.
The optimal concentrations of Pgal-CA and the rabbit antiserum were predetermined
by a checkerboard analysis. Two ELISA plates were coated with increasing amounts
of pgal-CA (500 ng to 3 pg). Then, two parallel reactions were performed where
doubling dilutions of the rabbit antiserum (1:100 to 1:3200) were reacted either with
LFP#1 (positive control) or with a pool of lung washings collected from healthy
sheep (negative control). The optimal concentration of both Pgal-CA and rabbit
antiserum was the combination which gave the greatest difference in the blocking
values between the positive and the negative controls.
The best format for the test was also pre-determincd, considering that the test can be
done in two ways, namely, simultaneous addition of test sample and rabbit anti
JSRV-CA serum to the pre-coated ELISA plate leading to a "competitive" ELISA, or
pre-incubation of the test sample and the rabbit serum prior to addition to the ELISA
plate ("blocking" ELISA). Comparison between B-ELISA and competitive ELISA
was performed by assessing duplicates of LFP#1 and negative controls (lung
washings from healthy sheep) in the two different formats.
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Fig 3.1: Schematic diagram of the SPA B-Elisa. In this case the test sample contains
JSRV virions; note the lack of the colorimetric reaction after the addition of the
substrate (step 5). See text for details.
added BSA
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Fig 3.2: Schematic diagram of the SPA B-Elisa. In this case the test sample does not
contain JSRV virions; note the presence of the colorimetric reaction (represented in
yellow) after the addition of the substrate (step 5). See text for details.
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The intra-assay standard deviation was evaluated testing LFP#1 across the ELISA
plate in five different plates and calculating the mean between the standard
deviations obtained in each plate. The inter-assay standard deviation was calculated
by assaying LFP#1 in ten independent tests performed on different days. LFP#1 was
located in the same wells on the ET1SA plate on each occasion.
3.2.5 SDS Polyacrylamide Gel Electrophoresis and Western blotting.
Proteins were separated on SDS gels essentially as described by Laemmli (1970).
Briefly, samples were denatured by heating at 100 °C for 90 sec in an equal volume
of x2 Laemmli sample buffer (0.5 M Tris/HCl pFT 6.8, 4% SDS, 8% (3-
mercaptoethanol, 20% [w/v] sucrose, 0.002% [w/v] bromophenol blue). Samples
were then loaded into the wells of an SDS PAGE gel comprising a 3% stacking gel
(3% [w/v] acrylamide. 125 mM Tris/ElCl , 3.5 mM SDS pH 6.8) and a 10% resolving
gel (10% [w/v] acrylamide, 375 mM Tris/HCl, 5 mM SDS pH 8.8) in Laemmli
electrode buffer (25 mM Tris, 192 mM glycine, 3.5 mM SDS pH 8.3). The gels were
run at a constant 200 V for 30-40 min using a Bio-Rad Mini Protean II™.
To immunologically characterise the new reagents developed, western blotting was
performed on the purified Pgal-CA, on LFP#1 and on LFP#2 sucrose gradient
purified fractions employing a goat antiserum to MPMV-CA and the rabbit
antiserum to JSRV-CA as described previously (Sharp & Herring, 1983).
Briefly samples were transferred from SDS PAGE gels onto nitrocellulose
membranes (Bio-Rad) by electroblotting in Tris/glycine blot buffer (25mM Tris, 192
mM glycine, 20% [v/v] methanol, pH 8.3), at a constant 100 V for 1 h. After staining
with Ponceau red to confirm transfer of the separated proteins, the membrane was
washed three times in WFB. Antisera, goat anti MPMV-CA diluted 1:40 in WFB, or
the rabbit anti JSRV-CA diluted 1:200 in WFB, were added and incubated for 1 h at
room temperature. After washing three times, rabbit anti-sheep or swine anti-rabbit
horse radish peroxidase conjugate diluted 1:1000 in WFB was added as appropriate
and incubated for a further hour at room temperature. After further washings, the
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reaction was visualised with diaminobenzidine as substrate (100 mM Tris/HCl pH
7.5, 0.15% (v/v) H202. 0.2% (w/v) diaminobenzidine [DAB, Sigma]).
Ten pi aliquots of bone marrow extracts prepared as described in 3.2.3 also were
tested by SDS-PAGE western blotting employing the rabbit anti JSRV-CA serum as
above.
3.2.6 Immunohistochemistry.
Tissue samples used in immunohistochemistry studies were collected during the
post-mortem examination from four SPA-affected sheep (three experimentally
infected lambs and one natural case of SPA) and three uninfected controls. Portions
of the same tissues that were collected for the B-ELISA were also fixed in 10%
neutral buffered formalin, processed routinely in an automatic tissue processor,
embedded in paraffin wax and sectioned at 4-6 pm. Selected sections were stained
immunohistochemically using a commercial avidin-biotin peroxidase complex kit
(Vectastain ABC kit™ -Vector laboratories) essentially as recommended by the
manufacturers. Sections were incubated at 60°C for 30 min and then deparaffmized
with xylene 3 times for 20 min and then hydrated through a series of alcohol
solutions (100% to 60%, v/v). After brief rinsing in tap and distilled water, sections
were treated with 1% (v/v) hydrogen peroxidase in methanol for 30 min at room
temperature to inactivate endogenous peroxidases. Sections were washed again in
tap water for 10 min, two times in distilled water for 5 min at room temperature,
once with TBS (100 mM NaCl, 10 mM Tris/HCl, 0.1 mM EDTA, pH 7.5) at room
temperature and twice at 37°C. Slides were then incubated at 37°C for 25 min with a
trypsin solution (solution 0.1% trypsin[w/v], 0.1% Cl2Ca in TBS[w/v], pH 7.8) and
washed afterwards as above. Possible non-specific binding of the conjugate used
(see below) was avoided by incubating the sections with normal goat serum (1:20 in
TBS) in a humid chamber for one hour at 37°C. Normal goat serum was then
removed by inverting the slides without further washings. Slides were then incubated
in a humid chamber with the rabbit anti JSRV-CA serum (at the optimal dilution of
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1:50) overnight at 4°C. As a control, this serum was substituted with TBS to detect
any endogenous peroxidase activity of the tissues or with rabbit pre-immunisation
serum to check for non-specific reactions of the rabbit serum. Sections were again
washed 3x10 min with TBS/Tween (TBS. 0.5% [v/v]Tween) and incubated with a
biotinylated goat anti rabbit immunoglobulin (1:100; Vector Laboratories). After
three washings of 10 min each with TBS/Tween, the ABC Vectastain complex™
containing avidin and biotinylated horse radish peroxidase was added to the sections
and incubated for one hour at room temperature. Washings were then performed as
above and finally the reaction was visualised by incubation of the sections with DAB
substrate solution (0.05% DAB [w/v] in TBS. activated with 0.15% [v/v] H202).
After one minute, the reaction was stopped with tap water and then the sections were
counterstained with Carazzi's haematoxylin, dehydrated and mounted with a
coverslip.
3.3 Results.
3.3.1 Development and validation of the JSRV B-ELISA.
• Specificity ofreagents
Both the rabbit anti-JSRV-CA (Fig. 3.3a) and the goat anti MPMV-CA (results not
shown) recognised pgal-CA and a single polypeptide of about 25 kDa in LFP#1
(Fig. 3.3b).
• The %blocking values of the B-ELISA are the result of the interaction between
JSR Vparticles and the specific rabbit antiserum produced.
A series of experiments were performed to demonstrate that the blocking values
obtained in the B-ELISA were the result of the interaction between JSRV-CA and the


















Fig. 3.3: Specificity of the rabbit serum antiserum to JSRV-CA. (a) Western blot showing the
detection of purified Pgal-CA (expected molecular weight = 188 kDa) with the rabbit antiserum to
JSRV-CA. Lanes 4-2, ABTG column flow through after washings with 300 mM NaCl-50mM Tris/HCl
pH 8 (lane 4), 600 mM NaCl -50 mM Tris/HCl pH8 (lane 3) and 50 mM Tris/HCl pH8 (lane 2); lane 1,
eluted Bgal-CA (arrow). Molecular weight marker is indicated (BDH, 42,700 - 200,000). (b): The
same antiserum reacts with a polypeptide of about 25 kDa in LFP#1; lane 1-4 = two fold serial
dilutions of ultracentrifuged LFP#1 prepared as described in point (i) of 3.2.3. In sucrose-gradient
purified JSRV (c) it is possible to note the reaction of the rabbit antiserum to JSRV-CA with a single
polypeptide of approximately 25 kDa; lane 1, fraction with 1.171 (g/cm3) density; lane 2, fraction
with 1.181 density; lane 3, fraction with 1.186 density; lane 4, fraction with 1.197 density; molecular
weight marker is indicated (BDH, 12,300 - 78,000).
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Analysis of the 18 fractions of LFP#2 separated by isopycnic centrifugation showed
that the greatest %blocking values corresponded to fractions having a buoyant
density between 1.16g/ml to 1.19g/ml. with a peak at 1.18g/ml which is the buoyant
density of JSRV (Sharp and Herring, 1983) (Fig. 3.4). The same fractions analysed
by western blotting, employing the rabbit antiserum to JSRV-CA produced in this
study showed a single polypeptide of about 25,000 Mr, the predicted molecular
weight of JSRV-CA (3.3c).
The blocking value of LFP#2 before ultracentrifugation was 63% which was reduced
to only 10% for the post-centrifugation supernatant, demonstrating that the blocking
activity was particle-associated, and did not arise as a result of antibodies specific
for JSRV-CA that might have been present in the lung fluid. In other experiments,
maedi-visna virus, another retrovirus of sheep which is occasionally found to
coinfect SPA affected animals (see 1.9), the (3-galactosidase control and the GST
control all gave %blocking values less than 7.
These data demonstrate that the blocking value of the SPA B-ELISA depends on the
presence in the test samples of the major capsid protein of JSRV.
• Test format, intra-assay and inter-assay standard deviation..
The B-ELISA format was chosen because it was found more sensitive than the
competitive format. The %blocking value of ultracentrifuged LFP#1 was 81 in the
blocking ELISA format and 73 in the competitive format; the negative control
%blocking value was respectively 8 and 9. The intra-assay standard deviation was
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Fig. 3.4: Percent blocking value of LFP#2 after isopycnic centrifugation in 20-55%
(w/w) sucrose gradients. The continuous line shows the %blocking values; the broken
line shows the density (g/ml) after sucrose gradient centrifugation.
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3.3.2 Distribution of JSRV viral particles in tissue extracts of SPA-affected and
unaffected sheep.
Following the successful development of the B-ELISA to detect JSRV-CA, this
assay was used to examine the anatomical distribution of JSRV in sheep. The
samples tested were obtained by ultracentrifugation and therefore reflected the
presence of JSRV viral particles.
Statistical analysis of the differences between SPA-affected and unaffected animals
was undertaken using the student t-test in the Minitab™ statistical computer package.
Results are summarised in Table 3.1.
Only tumour and lung samples showed a significant difference between affected and
unaffected sheep (pO.OOOl). The mean %blocking value of tumour samples was
77.8 with values ranging from 41 to 93 while normal lung samples had a mean
%blocking value of 17 with a range from 0 to 33.
A %blocking value of 36 was selected as the highest negative value calculated from
the mean blocking value of control lungs plus 2.5 standard deviations. When this
value was used no false positive or false negative samples were observed.
No significant difference was observed between the mean blocking values obtained
using lung tumour samples collected from natural or from experimentally induced
cases of SPA. Lung fluid samples from SPA cases showed a high %blocking value
(mean= 68.4) with values ranging from 49 to 92 but because healthy sheep do not
produce collectable quantities of lung fluid no direct control for this sample could be
obtained. The closest control for the lung fluid samples was broncho-alveolar lavages
from unaffected sheep (lung washings), which gave values ranging from 1.5 to 20.
In all the other tissues examined there was no statistically significant difference
between SPA-affected and unaffected sheep with the exception of a single
mediastinal lymph node sample, collected from a natural case of SPA. This sample
had a %blocking value of 53, markedly greater than the mean %blocking value of
equivalent tissues in control animals (6.2). Bone marrow samples showed a high
mean blocking value in both affected and unaffected controls. The mean %blocking
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values were 40.2 for SPA sheep and 45.2 for the unaffected controls. These high
%blocking values were probably an artefact due to the nature of the sample after
processing. The preparation of this tissue, as described in Materials and Methods,
resulted in a viscous pellet which therefore could have blocked the reaction non-
specifically. Further dilutions or sucrose gradient purified samples resulted in the
almost complete loss of blocking activity (< 16) and no specific reaction in this
tissue was found by immunohistochemistry (see below) or western blotting.
The mean %blocking value of the goat nasal tumour extracts was 74 (±3.5). This
result confirmed the strict similarity between ENTV and JSRV.
3.3.3 Cellular localisation of JSRV-CA.
Immunohistochemical analysis using the rabbit antiserum to JSRV-CA showed an
intense diffuse brown staining, due to the precipitation of the DAB, in the cytoplasm
of recognisable alveolar neoplastic cells in all four SPA lungs examined (Figs. 3.5
and 3.6). No staining was observed in the controls with pre-immune rabbit serum or
with TBS.
In the same lesion, not all the tumour cells were equally stained and some were not
stained at all (Fig. 3.5 [a], [b] and 3.6[c]).There was no staining of the epithelial non-
transformed cells (3.5[b]) nor of the interstitial cells (3.5[c]). Staining in the
extracellular airway spaces was observed very rarely.
No specific staining was detected in the lungs of control unaffected sheep (Fig.
3.6[a]), nor in any other tissue from both SPA-affected sheep and unaffected control
animals. An intracytoplasmatic granular staining was observed in the thymus samples
of both affected and non-affected animals. However this staining proved to be non¬
specific because it was also present when the rabbit pre-immunisation serum was used
instead of the rabbit anti-JSRV-CA (Fig. 3.5 [d-e]).
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Lung tumour/ Lung 77.8 (±4.8)5 13 17 (±1.8) 13
Lung fluid 68.4(±3.3) 15 9.9 (±2.1)® 11
Mediastinal lymph nodes 15.2 (±3.7) 12 6.2 (±2.1) 8
Retropharyngeal lymph nodes 6.6 (±1.4) 8 7.0 (±2.4) 7
Tonsils 4.7 (±2.3) 9 3.7 (±1.5) 9
Bone marrow 40.2 (±4.06) 6 45.2 (±5.7) 6
Thymus 18.7 (±3.8) 7 13.1 (±2.7) 13
Peyer's patches 12.6 (±1) 5 7.8 (±2.7) 6
Spleen 18.7 (±2.7) 9 16.1 (±3.9) 8
Kidney 6.5 (±2.9) 8 8.3 (±4.1) 7
Plasma 10.8 (±3) 10 7.6 (±3.1) 5
Leukocytes 12.4 (±2.2) 10 13.4(±l.l) 5
*= SPA-affected animals
x= unaffected controls
*= number of samples tested
5= standard error of the mean
@= this value is referred to lung washings.
91
Fig. 3.5: Immunohistochemistry; (a-c) show lung tumour sections of a sheep
affected by SPA. The brown staining represents the positive reaction and is confined
to the cytoplasm of the transformed cells and is clearly visible in (a)(magnification
250 x) and (c) (magnification 400 x). A papillary projection of the tumour in the
bronchiolus is visible in (b) (magnification 250 x). The brown staining is confined to
the neoplastic cells although not all the tumour cells are stained, as can be seen in (b).
No staining is observed in the interstitial cells or in the untransformed alveolar and
bronchiolar cells (b-c). Non-specific immunostaining in a thymus section of a SPA-
affected animal is visible in (d) and (e) (magnification 250 x). A granular brown
staining is visible in the cytoplasm of some cells when stained with either rabbit anti
JSRV-CA serum (d) or pre-immune rabbit serum (e).
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Fig. 3.6: Immunohistochemistry; (a) shows a lung section of a healthy control
sheep (magnification 100 x). No staining is visible in the section while staining is





The results of this study using immunological techniques have shown that JSRV
virions and CA were detected only in the respiratory tract of sheep affected by SPA.
These findings have confirmed earlier reports describing type D retrovirus antigens
or reverse transcriptase activity in respiratory tissues of SPA sheep (Perk et al, 1974;
Martin et al, 1976; Herring et al, 1983; Sharp & Herring, 1983; Verwoerd et al,
1983; Rosadio et al, 1988) and extended these observations by demonstrating that
JSRV was not detected in 172 samples from eight other tissues from 41 sheep,
although viral expression, below the detection limit of the B-ELISA, may be
occurring in other tissues.
Immunohistochemistry supported the above conclusion and further indicated that
JSRV replication occurred primarily in the transformed epithelial cells in the
pulmonary alveoli of SPA sheep. A notable exception was the positive result
obtained with a single lymph node from a field case of SPA that could have arisen
either as a consequence of metastatic events, which are known to occur in a
proportion of cases (Nobel et al, 1969), or as an occasional spread of JSRV in the
regional lymph nodes.
Previous immunohistochemical studies employing a heterologous antiserum to
MPMV-CA detected putative JSRV antigens in the alveolar lumina (Payne et al,
1986), rather than intracellularly and therefore conflict with those reported here.
However, the present study has used an homologous antiserum and the results
obtained are in agreement with earlier ultrastructural studies describing
intracytoplasmic type A particles in the epithelial tumour cells and, associated with
these cells, a few extracellular particles with typical type D morphology (Perk et al,
1971; Sharp et al 1983; Payne et al, 1983).
The above findings point to the epithelial tumour cells in the alveoli as the major site
of translation and assembly of JSRV and highlight the strict association between
JSRV and the tumour. These findings, therefore, provide further support for the
notion that JSRV is the aetiological agent of SPA. Although most type D retroviruses
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appear not to be oncogenic, a simian type D retrovirus (SRV 2) has been associated
aetiologically with retroperitoneal fibromatosis in macaques (Bryant et al, 1986) and
the other sheep and goat type D-related viruses have been implicated in tumours of
the nasal mucosa (De las Heras et al, 1991b, 1993 & 1995; Vitellozzi et al, 1993). As
expected ENTV cross-reacted with the rabbit antiserum to JSRV-CA demonstrating a
close relationship between these two viruses.
Whilst the circumstantial evidence implicating JSRV in neoplasia is compelling, the
existing information does not rule out other possibilities in which it may, or may not,
be involved in the neoplastic processes. JSRV may be acting only as a helper for
some other replication-defective, acutely transforming retrovirus or result from
reactivation of endogenous viral sequences as a consequence of neoplasia, as seen
with other endogenous retroviruses (see 1.6.3). The presence in the sheep genome of
up to 15-20 copies of sequences related to the gag, pol and env genes of JSRV (York
et al, 1992; Hecht et al, 1994) introduces major complications, particularly as
endogenous retroviruses have been demonstrated in mice, chickens and cats to be
involved in recombination events between each other or with their exogenous
counterparts (Weiss et al, 1973; Hartley et al, 1977; Golovkina et al, 1994;
McDougall et al, 1994; Bai et al, 1995).
In the next two chapters further studies aimed at determining the relationship
between the exogenous and endogenous viruses will be described.
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Chapter 4.




In Chapter 3 it was established that epithelial tumour cells in the lungs of sheep
affected by SPA are the major sites of JSRV replication.
The working hypothesis of this project is that JSRV is an horizontally transmitted
virus specifically associated with SPA. However, the presence of endogenous JSRV-
related sequences (enJSRV) in the sheep genome makes possible at least two different
scenarios: i) JSRV is an horizontally transmitted virus distinct from its endogenous
counterparts; ii) JSRV derives from the reactivation of one or more endogenous
retroviruses under pre- or post-neoplastic stimuli.
Little information is available about enJSRVs sequences. Studies conducted by
Southern hybridisation with JSRV gag, pol, or env probes showed the presence of
15 to 20 copies of cross-reacting bands in sheep genomic DNA (York et al, 1992;
Hecht et al, 1994). The degree of homology between JSRV and enJSRVs must be
very high because the filters in the Southern analysis were washed under high
stringency conditions.
In order to undertake any study at the molecular level, it was therefore necessary to
establish a difference (if this difference existed) between the exogenous JSRV,
apparently present only in tumours of sheep affected by SPA, and enJSRVs
transmitted vertically between all sheep.
When these experiments were started there were only two nucleotide sequences
available in the literature for JSRV: i) the complete nucleotide sequence of a South
African strain of JSRV (York et al, 1992; ii) a portion of gag from a Peruvian strain
of JSRV (Hecht et al, 1994).
The effort of searching possible differences between exogenous and endogenous
viruses was therefore initially concentrated on a portion of the gag gene where major
information was available. Thus, RT-PCR amplification of a portion of JSRV-gag
from tissues collected from SPA-affected sheep and unaffected controls was initially
performed. Differentiation between exogenous and endogenous RNA species was
then evaluated by sequencing and/or restriction enzyme digestion of PCR products
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obtained from viral pellets and tumour of SPA-affected sheep and tissues of
unaffected controls.
4.2 Materials and methods.
4.2.1 Sources and preparation of samples.
Samples were derived from the SPA-affected and unaffected sheep as described in
2.1.
Lung fluid samples (2.5-5 ml; n= 16) were collected during clinical examination of
SPA-affected sheep; two of the samples were collected from SPA-affected sheep in
Spain. Lung fluids were filtered, clarified and ultracentrifuged as described in 3.2.3
except that the resultant pellet was resuspended in 500 pi of solution D and stored at
-20°C until use. Leukocytes were obtained from blood samples (n=10 ) in which the
red cells had been lysed. Approximately 10' cells for each sample were resuspended
in 500 pi of solution D and stored at -20°C.
Lung tumour (n=5), normal lung (n=5), mediastinal lymph nodes (n=8), thymus
(n=5), bone marrow (n=6), spleen (n=5) and kidney (n=6) of both SPA-affected and
unaffected sheep were collected at post-mortem examination. Dog lung tissues were
obtained from the Veterinary Pathology Department of the Royal (Dick) School of
Veterinary Studies (Edinburgh) and were treated as the sheep tissues and used as
negative controls. An equine dermis cell line and primary foetal lamb lung and kidney
cells (107 cells for each sample) were obtained from the tissue culture service at
Moredun Research Institute and employed as further controls in this study. Cells were
lysed in 500 pi of solution D and stored at -20°C until examined.
4.2.2 RNA extraction.
Total RNA from ultraspeed pellets of lung fluid (2.5 - 5.0 ml), sheep tissues and dog
lung tissues, leukocytes (107), equine dermis cell line, foetal lamb lung and kidney
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cells (107 cells) was extracted as described in 2.3.18. In addition, RNA was extracted
from one goat nasal tumour viral pellet prepared as in 3.2.3.
Each RNA sample was treated with DNAse I (Sigma) as described in 2.3.18 to avoid
genomic DNA contamination. As a further control, some of the samples processed at
the beginning of the study were additionally treated with RNAse A (Sigma). RNAse
A was added to the RNA preparation at a final concentration of 50 p.g/ml and the
samples were incubated for an hour at 37°C.
The quality of the RNA extracted was assessed by running an aliquot of the sample (2
pi) onto a 1% denaturing formaldehyde/agarose gel as described in 2.3.20 and the
RNA concentration was estimated by the use of a UV spectrophotometer (see 2.3.4).
4.2.3 Genomic DNA extraction.
Genomic DNA was obtained from lung tumour and kidney collected from four SPA-
affected sheep and two unaffected controls as described in 2.3.21.
4.2.4 cDNA synthesis.
Synthesis of cDNA was carried out in 25 pi reaction volumes as follows: total RNA
(2 pg from tissues, leukocytes and cell cultures samples or total RNA obtained from
ultraspeed pellets of 2.5-5 ml of lung fluid) was diluted in 13.5 pi DEPC-treated
distilled water. RNA was denatured at 65°C for 10 min and immediately cooled on
ice. A 1 pi (40 U) of rRNAsin (Promega), 2 pi of 25 mM dNTPs, 2.5 pi lOOmM
DTT, 2.5 pi (62.5 A260 U/ml [Boehringer]) random hexamers, 2.5 pi 10X reaction
buffer (500mM Tris-HCl. pll 8.3, 75 mM KC1, 3 mM MgCl2) and 1 pi of
StrataScript™ reverse transcriptase (50 U, Stratagene) were added. The addition of the
reverse transcriptase was omitted in control samples to check for DNA contamination
of the RNA preparations. The reaction mixture was incubated at 37°C for 1 h, and
then the enzyme was inactivated by incubation at 94°C for 3 min.
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4.2.5 JSRV-gag PCR.
Amplification of the resultant cDNA was carried out by PCR. Primers were based
upon the published sequences of JSRV (York et al, 1992) and pCAl (Hecht et al,
1994). Primers PI and P2 spanned a 229 bp region internal to the gag gene
([position 1598-1826 of JSRV] (sense -P1-: 5'-GCTGCTTTRAGACCTTATCGAAA-3';
antisense-P2-: 5'-ATACTGCAGCYCGATGGCCAG-3'). PCR was optimised using
plasmid pJS382 (courtesy of Dr. G. Querat) containing part of the JSRV-gag gene (nt
953-3029) as template.
The optimised protocol was as follows: 3 pi of cDNA or 500 ng of genomic DNA
was added to 47 pi of 1 x PCR buffer (1.25U Tacj polymerase [Boehringer], 2.75 mM
MgCl2 , 50 mM KC1, 10 mM Tris-HCl. 200 pM of each dNTP, 6.25 pmol of each
primer). PCR cycles employed were 94°C for 1 min and 35X (94°C for 45 sec, 57°C
for 1 min, 72°C for 1 min ), with a final extension of 72°C for 2 min.
Amplified products were detected by agarose gel electrophoresis as described in
2.3.2.
'Reconstruction' experiments were performed to establish the sensitivity of the test
employing plasmid pJS382. Serial dilutions of pJS382 were amplified with or
without the addition of 500 ng of normal sheep kidney genomic DNA.
4.2.6 Southern blotting.
Specificity of the amplified product was determined by Southern hybridisation with a
32P end labelled oligonucleotide probe. The probe (PA= 5'GGCTTGCTGCTGG
AAAAGTACT3'; nt 1726-1747 of JSRV) was designed to anneal to an internal
region of the amplified product. Southern blotting was performed as described in
2.3.16 with a hybridisation temperature of 42°C and washings at 50°C with 0.1 x
ssc.
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4.2.7 Cloning of gag-PCR products.
The products of five independent PCR-gag reactions using kidney cDNA from an
unaffected sheep were pooled before cloning in pGEM-T (Promega) as described in
2.3.10 - 2.3.13. Seven clones were selected and sequenced using the T7-sequencing
kit (Pharmacia) as described in 2.3.15.
Plasmid DNA from one of the clones (eruJSRV-gagl) was also used as source of
endogenous DNA in 'reconstruction' experiments explained in the results session.
4.2.8 Restriction enzyme digestion.
A 25 p.1 aliquot of the PCR-gag product were digested with 13 U of Seal
(Boehringer) employing the appropriate incubation buffer supplied by the
manufacturers (PCR buffer was ignored) at 37°C for 2-4 hours. The digestion
products were analysed alongside the corresponding mock-digested PCR products,
by electrophoresis in a 2% agarose gel stained with ethidium bromide.
4.3 Results.
4.3.1 Detection of enJSRVs-gag transcripts.
The analysis of cDNA samples from both tissues collected from SPA-affected
animals and unaffected control sheep was performed by RT-PCR-gag.
A product of the expected size (229 bp) was detected in all 65 cDNA tissues tested.
cDNA from primary cultures of foetal lamb lung and kidney cells produced the same
visible amplimer whereas dog lung tissues and an equine dermis cell line were
consistently negative. All the samples were treated with DNAse to exclude DNA
contamination. In addition, all the samples were tested in parallel omitting reverse
transcriptase from the reaction mix; no signal was obtained from any of these
samples. Neither were signals obtained from the aliquots of the samples which were
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treated with RNAse (Fig 4.1a). The specificity of the amplimers was confirmed by
Southern hybridisation with an oligonucleotide probe that hybridised to an internal
portion of the PCR product (Fig. 4.1 b).
Lung fluid of SPA-affected sheep contains JSRV particles (see chapter 3), therefore
it may be assumed that the RNA detected in these materials is of exogenous origin
while the RNA detected from tissues of unaffected control animals is transcribed
from endogenous viruses. The results of these experiments therefore demonstrated
that transcripts of endogenous origin are transcriptionally active in a variety of sheep
tissues.
4.3.2 Differentiation between endogenous and exogenous transcripts.
The working hypothesis of this experiment was that JSRV is an horizontally
transmitted virus and is distinguished from its endogenous counterparts.
To identify possible differences between endogenous and exogenous RNA, the RT-
PCR products obtained from the kidney of an unaffected control animal were cloned
and sequenced. Seven clones were sequenced and four different sequences (enJSRV
gag1-4) were obtained. The four enJSR V sequences were compared with each other
and with the published sequences, JSRV (York et al, 1992) (South African isolate)
and pCAl (Flecht et aR 1994) (Peruvian isolate) by computer analysis using the GCG
"pileup" program (Genetic Computer Group, 1994). The South African and the
Peruvian isolate were 90% similar in the stretch of sequence considered. The enJSRV
clones were highly homologous to each other (95 - 99% homology), 95-98%
homologous to the South African isolate and 85-88% to the Peruvian isolate.
Comparison of the restriction map of the six sequences revealed a Seal restriction site
in JSRV and pCAl that was absent in all the enJSRV clones (Fig 4.2).
To confirm this observation, RT-PCR products from 16 lung fluids, 5 tumours and
44 non-tumour tissues were digested with Seal. Successful digestion, indicated by
the presence of two smaller fragments of 131 and 98 bp. was observed with all 16
lung fluid samples. 5 out of 5 tumours and faintly in 3 out of 5 mediastinal lymph
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nodes from SPA-affected sheep (Fig 4.3). No Seal sensitive product was observed
with any other tissue of either healthy controls or SPA-affected sheep. The results are
summarised in Table 4.1.
These findings established for the first time a molecular marker for the exogenous
form of JSRV.
The ENTV sample was successfully amplified by PCR-gag but it was not digested
by Seal treatment.
4.3.3 Lack of detectable JSRV at DNA level.
PCR products obtained by direct amplification of tumour and kidney genomic DNA
with primers PI and P2 followed by Seal digestion did not show any cut product by
electrophoresis in an agarose gel stained with ethidium bromide. The sensitivity of
the PCR-gog/Scr/I digestion to detect exogenous sequences against a background of
endogenous sequences was assessed by 'reconstruction' experiments. In the first
series of experiments the capacity of gag-PCRJScal to detect exogenous sequences
(e.g. plasmid JS382 DNA) with or without a background of 500 ng of genomic DNA
was compared. The two characteristic bands of 131 and 98 bp were still visible when
10 - 102 copies of pJS382 were amplified by PCR-gr/g followed by Seal digestion.
However, no visible product was visible when 10" copies of pJS382 were amplified
along with 500 ng of kidney DNA (Fig. 4.4). In a second set of experiments a fixed
2 ••••27
quantity (10" copies) of pJS382 were amplified with serial dilution (10 - 10 ) of
enJSRV-gagl. After Seal digestion, exogenous sequences were detected only when











1 2345678 + - A B W
22 9 - + + mmm**mw
Fig. 4.1: JSRV-gag PCR. RT-PCR gag showing the amplification of a product of
the expected size from tissues of both SPA-affected and unaffected control sheep
(top). JS382, plasmid containing the target sequence used as positive control; LT,
lung tumour from a SPA-affected sheep; NL, normal lung and K, kidney from an
unaffected control sheep. Treatment of the RNA sample with DNAse or RNAse is
indicated.
The bottom panel shows a Southern blot of JSRV-gag RT-PCR products employing
a radiolabeled oligonucleotide probe (probe A). Lanes 1-4, lung tumours from SPA-
affected sheep; lanes 5-8, tissues from unaffected control sheep. Lane 5, lung; lane 6,
spleen; lane 7, kidney; lane 8, mediastinal lymph node. +, positive control is plasmid









































































































































Fig. 4.3: Typical results of RT-PCR, followed by Seal digestion, of total RNA
from SPA-affected sheep tissues. Sample 1, lung fluid; sample 2, lung tumour;
sample 3, mediastinal lymph nodes; sample 4, kidney (samples 1 to 4 were collected
from the same animal. U= mock digested PCR products. C= PCR product digested
with Seal. M= molecular weight marker IX (Boehringer).
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Tab. 4.1 : Tissues examined by RT-PCR gag followed by Seal digestion in SPA-
affected and unaffected control sheep.











Lung fluid 16/16 16/16 - -
Tumour/Lung 5/5 5/5 4/4 4/0
Kidney 3/3 3/0 3/3 3/0
Thymus 2/2 2/0 3/3 3/0
Bone marrow 3/3 3/0 3/3 3/0
Spleen 2/2 2/0 3/3 3/0
Mediastinal lymph
nodes
5/5 5/3 3/3 3/0
Leukocytes 5/5 5/0 5/5 5/0
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Fig. 4.4: Sensitivity of JSRV-£«g PCR followed by Seal digestion. Serial
dilutions of plasmid JS382 containing the JSRV gag template were amplified with
(bottom) or without (top) a background of 500 ng of sheep genomic DNA collected
from an unaffected control sheep. The estimated number of plasmid copies is
indicated at the top of each gel. Lanes: U, mock-digested PCR product; C, PCR
product digested with Seal, M, molecular weight marker IX (Boehringer).
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4.4 Discussion.
In this chapter, compelling lines of evidence have been presented which collectively
demonstrate a specific association between the exogenous form of JSRV and SPA.
It was shown that the exogenous form of JSRV was distinct from endogenous JSRV
transcripts as identified by the presence of a Seal restriction site in gag (nt position
1729 [nucleotide position referred to York et al, 1992]). Furthermore, this site was
conserved in strains of exogenous JSRV from geographically dispersed countries,
confirming and extending data linking these viruses to each other and to SPA
(Herring et al, 1983; Sharp and Herring, 1983; Payne et al, 1986; Rosadio 1988b; He
et al, 1992).
Exogenous JSRV RNA was found only in tumour, lung fluid and draining lymph
nodes of SPA-affected sheep, which is in agreement with the immunological data
shown in chapter 3, which concluded that epithelial tumour cells are major sites of
replication for JSRV. Lung fluid and tumour from SPA-affected sheep are the only
materials that have been used successfully to reproduce the tumour experimentally in
sheep and goats (Martin et al 1976; DeMartini et al, 1987; Sharp et al, 1983; Sharp
et al, 1986; Verwoerd et al, 1980). These findings, therefore, point to exogenous
JSRV as a strong candidate for the aetiological agent of SPA.
The failure to detect Seal sensitive sequences at the DNA level is probably due to the
high proportion of endogenous template compared to exogenous, resulting in a small
proportion of Seal sensitive product. Theoretically, there may be 20 endogenous
copies compared to possibly only one exogenous copy per neoplastic cell. Moreover,
neoplastic cells are approximately only 40-50% of the total number of cells present in
the neoplastic tissue, therefore increasing the ratio of endogenous to exogenous
sequences. The results obtained with the 'reconstruction' experiments seem to
support this hypothesis. However, until the exogenous JSRV provirus is detected in
tumour DNA and not in non-tumour DNA from the same SPA-affected sheep, it will
not be possible to rule out that the exogenous virus derives from an endogenous virus
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which is transcriptionally silent in non-tumour tissues and is activated either as a
pre-neoplastic or post-neoplastic event.
The presence of transcriptionally active enJSRVs raises questions about their
potential role in SPA. As mentioned in 3.4 endogenous retroviruses have been
demonstrated in mice, chicken and cats to be involved in recombination events with
exogenous retroviruses and between themselves leading to the generation of
oncogenic retroviruses or viruses with a broader host range (Weiss et al, 1973;
Hartley et al, 1977; Stoye et al, 1991; Golovkina et al, 1994; McDougall et al, 1994;
Bai et al, 1995). The possibility of recombination events between the exogenous
form of JSRV and its endogenous homologues cannot be ruled out.
An interesting finding outlined in this chapter, was the detection of exogenous JSRV
RNA in 3 out of 5 mediastinal lymph nodes of SPA-affected sheep. Previous
immunological studies (chapter 3) detected JSRV particles in only 1 out of 12
regional lymph nodes of SPA-affected sheep. The detection of the exogenous JSRV
in the majority of regional lymph nodes by RT-PCR may reflect the presence of
metastases, although these were not detected by histological examination (performed
by Dr. M. De las Heras, data not shown), or may reflect the presence of the virus in
the lymph drained by the regional lymph nodes at levels below the detection limit of
the immunological techniques. Due to the lack of data on the immune response to
JSRV we cannot determine whether the presence of JSRV in the lymph nodes is
related to an active immune response towards the virus.
To date, JSRV has not been isolated in vitro and therefore classical approaches to
demonstrate the aetiology of SPA have been impossible. However, the results
reported in this chapter show that exogenous JSRV RNA is distinct from its
endogenous JSRV-related transcripts and is consistently and exclusively
demonstrated in lung tumours of SPA-sheep. This association would support the
hypothesis that JSRV is an horizontally transmitted virus directly involved in the
aetiology of SPA.
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Interestingly ENTV has been amplified by PCR-gag underlining the similarity with
JSRV. However, the nasal tumour virus lacks apparently the Seal site which could
indicate that these two viruses although related have to be considered distinct.
Ill
Chapter 5.
Detection of JSRV Provirus in Tumour Genomic DNA.
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5.1 Introduction.
In chapter 3 the presence of JSRV particles and antigens in the epithelial tumour cells
of the SPA-affected sheep was described. In chapter 4, JSRV RNA was differentiated
from its endogenous counterparts by the presence of a unique Seal site in a fragment
of gag and was detected only in the respiratory tissues of SPA-affected sheep. In both
cases the detection of JSRV was restricted to sheep affected by SPA and never in
healthy control animals.
To demonstrate firmly that the exogenous JSRV, present in tumour and lung fluid of
SPA-affected sheep, is a horizontally transmitted virus and does not derive from a
reactivated enJSRV it is necessary to detect JSRV in tumour DNA and exclude its
presence in non-tumour (e.g. kidney) DNA collected from the same SPA sheep.
The initial approach was to detect the exogenous virus by a selective PCR
amplification, based on the assumption that if one of the primers was designed on the
exogenous-specific Scc/I restriction site the reaction will successfully amplify only
the exogenous JSRV. Specific amplification of sequences differing by as little as a
single nucleotide, known as 'allele-specific PCR' (Ugozzoli and Wallace, 1991) or
"mismatch amplification mutation assay (MAMA)' (Cha et al, 1992) , has been
applied successfully on a number of occasions for polymorphism analysis and for the
detection of rare mutations (Newton et al. 1989: Wu et al. 1989; Ehlen and Dubeau.
1989; Nichols et al, 1989; Ferrie et al, 1992).
Primer-template complexes containing mismatches have lower melting temperatures
than perfectly matched complexes and, consequently, a PCR performed at the
appropriate annealing temperature will promote amplification only of the stably
annealed primer-template. While single internal mismatches have no significant
effect on PCR product yield, those at the 3' end of the primers enhance specificity
since DNA polymerases extend mismatches much less efficiently than correct
matches (Petruska et al, 1988; Perrino et al, 1989; Creighton et al, 1992) and Taq
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DNA polymerase lacks a 3'-» 5' exonuclease activity (Tindall et al, 1988; Eckert et
al, 1990).
A second approach to detect exogenous JSRV at the DNA level has been the result of
an extensive collaboration with Dr. DeMartini's Laboratory at the Department of
Pathology of the College of Veterinary Medicine and Biomedical Sciences at
Colorado State University, who made available an LTR sequence obtained by PCR
amplification of one of the enJSRVs. The endogenous LTR sequences appeared to
have major differences in the U3 region compared to the only exogenous LTR
sequence published by York et al (1992). After a preliminary confirmation of this
finding, it was reasoned that it would be possible to design an exogenous-specific
primer in the U3 region of JSRV and amplify a portion of the proviral JSRV
comprising the LTR and gag (downstream the exogenous-specific Seal site). In that
way. detection of exogenous JSRV would be confirmed by the presence of the
extensively characterised Seal site.
5.2 Materials and Methods.
5.2.1 Genomic DNA extraction.
Genomic DNA was extracted from lung tumour and kidney samples of four SPA-
affected animals and from lung and kidneys of three unaffected controls as described
in 2.3.21. DNA was also isolated from primary cultures of normal sheep skin
fibroblasts for the analysis of the enJSRVs LTRs (see below).
Plasmids JS382 (York et al, 1992) and enJSRV-gag 1 containing, respectively, the
exogenous and endogenous gag template were used as DNA sources for the
reconstruction experiments of the allele-specific PCR.
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5.2.2 Allele-specific PCR (AS-PCR).
Three sets of reactions were performed (Fig 5.1). In the first reaction (#1), primer PI
(sense primer for the PCR-gag described in chapter 4) was coupled with primer
P3960 (antisense, position 1747-1726; 5"-GGCTTGCTGCTGGAAAAGTACT-3').
The last nucleotide of P3960 (T) is complementary to the unique 'A' of the Seal site
of JSRV (Fig. 5.1 [A]) and creates a T:G mismatch with the (known) sequences of
enJSRV(Fig. 5.1 [B]). In the second reaction (#2), primer PI was coupled with primer
P4030 (antisense, position 1747-1726; 5'-GGCTTGCTGCTGGAAAAGTAAT-3').
Primer P4030 creates a T:G mismatch with the endogenous sequences the same as
P3960 (Fig. 5.1 [B]) but has an additional arbitrary mismatch at the penultimate base
(an 'A' instead of a 'C') which further increases the instability of the primer. In the
third reaction (#3), primer P2 (antisense primer for the PCR-gurg described in Chapter
4 was coupled with primer P4749 (sense, position 1700-1726; 5'-
GCATTACAAGGAAAAAGCATAAAAGGA-3').
Templates in the PCR reactions were used either as 10 fold dilutions (from 106 to 10
copies) of plasmid JS382 and enJSRV-gag\ in the reconstruction experiments or as
matched tumour and kidney genomic DNA samples as above (5.2.1). One hundred
and 500 ng of each sample were used in each reaction.
With the exception of Taq DNA polymerase [Boehringer] (1.25 U per reaction) and
the PCR buffer (2.75 mM MgCF , 50 mM KC1, 10 mM Tris-HCl) the other
parameters were varied and optimised to achieve the best specificity of the reaction.
The concentration of dNTPs varied between 50 and 200 pM and the primers
concentration between 0.2 pmol and 6.25 pmol. The addition of DMSO to the
reaction varied from 0 to 10%. Other variables were the number of cycles (25, 30, 35)
used and the annealing temperature (57°C to 65°C). Other parameters in the cycles
were identical to that of the PCR-gag.
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a)
PI 3 ' -TaATGA 5'<-P4 03 0
► 3 ' -TCATGA 5 ' <—P3 96 0
JSRV 5 ' AAAGAAGTACT
3 ' TTTCTTCATGA
P4749—>5 ' AAAGGA-3 ' <
P2
b;
PI 3'- taATGA 5'<-P4030
> 3'- tCATGA 5 ' <—P3 96 0
enJSRV
5 ' AAAGAGGTACT 3
3 ' AAAGACGTACT 5
P4 74 9—>5 ' AAAGGa- 3 '
P2
Reaction #1= PI + P3960
Reaction #2= P2 + P4030
Reaction #3= P2 + P4749
Fig. 5.1: Allele-specific PCR strategy. The exogenous JSRV target is schematically
represented in (A) while (B) represents the endogenous one. The Seal site is
represented in bold. Note that the 3' end of P4030. P3960 and p4749 is
complementary to JSRV but not to enJSRV (mismatches of the primers are indicated
in lower case). The second last base of primer P4030 has an arbitrary mismatch with
both templates.
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5.2.3 Amplification and sequencing of endogenous LTRs.
One hundred ng of genomic DNA isolated from sheep skin fibroblasts was used for
PCR amplification of endogenous LTRs (PCR-LTR). Primers were designed at the
5' end of the U3 (sense - P3 - CTGCGGGGGACGAC, position 7179-7193 [York et
al, 1992]) and at the 3' end of U5 (antisense - P4 - CTGCCGCGACCAGCA,
position 111-125). The buffer employed was 10 mM Tris pH 8.9, 50 mM KC1, 2 mM
MgCL with 200 pM each dNTP, 100 ng primers and 1 U of Taq (Boehringer). PCR
cycles employed were an initial step of 94°C for 2 min and then 40 cycles of 94°C
for 1 min, 58°C for 1 min, 72°C for 1 min with a final extension of 72°C for 2.5 min.
The products of three independent PCR reactions were pooled and then cloned in the
TA cloning system (Invitrogen) following the manufacturer's instructions. Three
resultant clones were sequenced by the dideoxy chain termination method employing
a Li-Cor automated sequencer. The nucleotide sequence of the PCR clones of the
LTRs are deposited in GenBank under accession numbers Z66531, Z66532, and
Z66533 (enJSRVLTR 1-3).
The work described in this paragraph was performed by Dr. R.G. Dalziel (Veterinary
Pathology Department, Royal (Dick) School of Veterinary Studies, University of
Edinburgh).
5.2.4 Hemi-nested LTR-gr/g PCR.
In the first round of amplification, 250-500 ng of tumour and kidney high molecular
weight DNA was amplified by PCR employing the Expand™ Long Template PCR
system (Boehringer) which uses a mixture of Taq and Two DNA polymerases. The
sense primer (-P5- TGGGAGCTCTTTGGCAAAAGCC - nucleotide positions 7210-
7224) was designed on the basis of nucleotide sequence differences between the
endogenous LTR sequences and the JSRV sequence. Primer P2 (antisense primer of
the PCR-gpg described in chapter 4) was employed as antisense primer. Reactions
were carried out in a 50 pi volume containing 50 mM Tris-HCl, pH 9.2, 160 mM
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(NH4)2S04, 2.25 mM MgCl2, 2% (v/v) DMSO, 0.1% (v/v) Tween® 20, 500 pM each
dNTP, 300 nM each primer, template DNA and 2.625 U of enzyme mix. Cycles were
as follows: 1 cycle at 92°C for 2 min, 30 cycles at 92°C for 10 sec, 61°C for 30 sec
and 68°C for 90 sec (plus a progressive increment of 20 seconds from cycle 11
onwards), and a final extension of 68 °C for 7 min.
One pi of product of the first round of amplification was used in the second round of
PCR which was the same as the PCR-gag described in chapter 4. Half the product of
the second stage PCR was digested with Seal as described above. The strategy of the
hemi-nested LTR-gag PCR is illustrated in Fig 5.2.
Products of the first and the second rounds of heminested PCR were visualised by
electrophoresis in 1 and 2% agarose gels respectively.
5.3 Results.
5.3.1 Allele-specific PCR.
An allele-specific PCR approach was attempted in order to successfully amplify
exogenous JSRV at DNA level. To demonstrate that JSRV has an exogenous origin
only and it is not a reactivated endogenous virus it is necessary to detect JSRV at
DNA level in tumour but not in non-tumour (e.g. kidney) DNA collected from the
same sheep. The efficiency of an allele-specific PCR depends largely on the position
and nature of the primer:template duplex. Three primers were designed with their
5'end complementary to the putative exogenous-specific Seal site in gag and used in
three different sets of reactions (Fig. 5.1) coupled to PI or P2 described in Chapter 4.
Under stringent conditions the AS-PCR should have been able to detect only the
exogenous provirus (e.g. with the unique Seal site). An endogenous (enJSRV-gagl)
and an exogenous (pJS382) clone were used in reconstruction experiments to
optimise the AS-PCR conditions.
Reaction #1 did not distinguish between the exogenous and the endogenous template



















Fig. 5.2: PCR strategy and localisation of primers. (A) RT-PCR gag employing primers PI and P2
amplified a product of 229 bp. (B) PCR for the amplification of endogenous LTR employed primers
P3 and P4 and generated products of 442/444 bp. (C) Hemi-nested LTR-gag PCR. The first round of
amplification used primer P5 (internal to the LTR) and gag primer P2 . 1 pi of this reaction was used
in the second round of amplification which used primers PI and P2.
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#2 and 3 were able to preferentially amplify the exogenous plasmid DNA. The best
conditions found for the two reactions were the following: 10 mM-Tris-HCl, 50 mM
KC1, 2.75 mM MgCl2 with 50 pM each dNTP, 6% DMSO, 6.25 pmol of each
primer and 1.25 U of Taq polymerase (Boehringer) in a 50 pi reaction. Each sample
subjected to 94 °C for 1 min followed by 35 cycles of 94°C for 45 sec, 63°C for 1
min and 72°C for 1 min with a final extension of 72°C for 2 min.
Both reaction #2 and #3 were able to amplify 10J copies of endogenous clones but
not 104 while they amplified 103 copies of exogenous plasmid pJS382 (Fig 5.3a).
The AS-PCR was then applied to genomic DNA. Neither lung tumour nor kidney
genomic DNA were successfully amplified with either reaction #2 or #3 at the above
specified conditions, implying that the PCR reactions were not sensitive enough to
detect the exogenous virus when genomic DNA was present as background (5.3b).
5.3.2 Amplification and sequencing of endogenous LTRs.
PCR products of approximately 450 bp were obtained from the amplification of
DNA from cultured sheep primary skin fibroblast cultures employing primers P3
(end of U3) and P4 (end of U5). Products were cloned as described in materials and
methods and three clones were completely sequenced (Fig.5.4).
The enJSRV LTRs appeared to be longer (442 to 445 bp) than the published
exogenous LTR (397 bp) which showed two large deletions at positions 198 and 261
of 30 and 16 base pairs respectively (nucleotide positions as in Fig.5.4). The
nucleotide sequence of the three enJSR V LTR were 83 to 90% identical and were 69
to 76% homologous to the JSRV LTR sequence (York el al, 1992). Major
differences between enJSRVs and JSRV LTR were found in the U3 and in particular
in the 5" portion of the U3 where the homology was around 50%. The R regions of
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Fig. 5.3: Example of the results obtained with the AS-PCR (reaction #2). In the top panel are
shown reconstruction experiments with endogenous (enJSRV) and exogenous (JS382) clones. The
estimated number of copies is indicated in each lane. M= DNA molecular marker VI (Boehringer);
W= distilled water. In the bottom panel are shown experiments with genomic DNA from lung tumour




























































































































































































































































5.3.3 Detection of JSRV provirus in tumours of SPA-affected sheep.
As it was shown in chapter 4. PCR products obtained by direct amplification of
tumour genomic DNA with primers PI and P2 followed by Seal digestion did not
show any cut product by electrophoresis in an agarose gel stained with ethidium
bromide. The failure to detect Seal sensitive sequences at DNA level may be due to
the high proportion of endogenous template compared to exogenous, resulting in a
small proportion of Seal sensitive product.
To preferentially amplify exogenous proviral DNA sequences we designed a hemi-
nested PCR. The first round of amplification used a sense primer (P5) based on an
area of sequence divergence between endogenous LTR clones and the exogenous
LTR sequence (JSRV) and the antisense primer (P2) of the RT-PCR gag. A product
of about 2 kb was visible in an ethidium bromide agarose gel from 3 out of 4 SPA
tumour DNAs whilst no signal was obtained in 4 out of 4 kidney DNAs of the same
animals or from lung and kidney of three unaffected control animals. A second
round of amplification, using primers of the RT-PCR {gag) followed by Seal
digestion, enabled the detection of Seal sensitive sequences in all four tumours
examined, whilst only spurious bands were detected in non-tumour samples of SPA-
affected or non-affected sheep (Fig. 5.5).
5.4 Discussion.
The aim of the studies conducted in this chapter was to prove that JSRV is an
exogenous virus and does not derive from a reactivated cnJSRV.
In chapter 4. a Seal restriction site in gag was established as an exogenous-specific
marker for JSRV RNA. Experiments therefore, were concentrated on finding this
marker at the DNA level. The initial approach to utilise an allele-specific PCR was
unsuccessful although it was proved theoretically possible. In reconstruction
experiments, two of the three PCR reactions were able to preferentially amplify the
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Fig. 5.5: Detection of exogenous JSRV sequences in tumour and kidney DNA of
the same SPA-affected sheep. The gel is divided in two halves with the tumour
sample on the left and the kidney sample on the right as indicated. Lanes 1: 500 ng
lung tumour or kidney genomic DNA amplified directly by PCR-gag employing
primers PI and P2; lanes lc: PCR product shown in lane 1 cut with Sea/; lanes 2:
first round of amplification of hemi-nested LTR-gzig PCR employing primers P5 and
P2; lanes 3: second round of amplification, employing primers PI and P2, of 1 pi of
the PCR product shown in lanes 2; lanes 3c: PCR product of lanes 3 cut with Seal.
The minus (-) represents the negative control. M= Boheringer molecular weight
markers VI (left) and IX (right).
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However, the two reactions were not sensitive enough to pick up the exogenous virus
in tumour DNA with the endogenous viruses as background. More primers could
have been designed and tried but the availability of endogenous LTR sequences,
where major differences were found with respect to the LTR sequence characterised
by York et al (1992), made possible a more straightforward approach based on a two-
step PCR (hn-LTR-gag PCR).
One of the two primers, employed in the first step of the hn-LTR-gag, was designed
in the JSRV U3 which theoretically should correctly anneal only to exogenous
template. Indeed, PCR products were obtained only from tumour DNA and not from
the matched kidney samples of SPA-affected sheep. To demonstrate the exogenous
origin of the template, an aliquot of this reaction was re-amplified by PCR-gag
followed by Seal digestion. The product obtained in the second step was entirely
sensitive to treatment with Seal. JSRV was thus demonstrated to be an horizontally
transmitted virus specifically associated with SPA.
Differences in the LTR sequences between JSRV and the three enJSRVs PCR-
derived clones were mainly present in the U3. A putative NF-1 motif in exogenous
JSRV LTR (nt 7220-7223), which overlaps the exogenous specific PCR primer P5, is
altered/lost in the endogenous LTRs and two tandemly repeated sequences (position
7347 to 7365 and 7366 to 7384 in JSRV sequence [York et al, 1992]) appear to be
lost by means of an insertion of 30 nucleotides in the endogenous U3. Differences in
the nucleotide sequence in these regions could potentially diminish/alter the LTR
function and thus reduce the pathogenicity of enJSR Vs compared to the exogenous
counterpart as demonstrated in other retroviral systems (Lenz and Haseltine 1983;
DeGroseillers and Jolicoeur, 1984; Speck et al, 1990; Hallberg et al, 1991; Plumb et
al, 1991; DeGroseillers et al, 1993; Morrison et al, 1995; reviewed by Fan. 1990 and
1994).
The results obtained in this chapter and in the preceding two strongly suggest an
aetiological role for JSRV in the induction of the tumour.
It is theoretically possible that JSRV is an exogenous non-pathogenic virus which
actively replicates in type II pneumocytes only after their transformation. In this
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context JSRV would infect SPA-affected sheep only after type II pneumocytes were
transformed by other causes. Such a scenario seems extremely unlikely due to the
100% detection of JSRV in SPA cases in unrelated geographical areas and by the
lack of detection of JSRV in unaffected control animals.
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Chapter 6.
Jaagsiekte Retrovirus Establishes a Disseminated Infection




Results presented in chapter 4 and 5 have demonstrated that JSRV is an exogenous
virus specifically associated with SPA and distinct from the transcriptionally active
endogenous retroviral sequences present within the ovine genome (sheep endogenous
retroviruses, enJSRVs [syn: enJSRV]). A Seal restriction site in gag has been defined
as a molecular marker for the exogenous JSRV which has been consistently
demonstrated in tumour and in draining lymph nodes of a proportion of SPA-affected
sheep. JSRV was not detected outside the respiratory tissues of SPA-affected sheep
nor in any tissue of control sheep (see chapter 4). Nevertheless, co-amplification of
endogenous and exogenous sequences could have masked the detection of low copies
of exogenous JSRV due to the relatively high background formed by enJSRVs.
To address this question an exogenous JSRV-specific hemi-nested PCR which
amplified a segment of the U3 region of JSRV was designed. The anatomical
distribution of JSRV in tissues collected from sheep with naturally and
experimentally-induced SPA was then investigated.
6.2. Materials and Methods.
6.2.1 Samples employed in this study.
Samples of heparinised venous blood, lung fluid, lung, lung tumour, mediastinal
lymph nodes, pre-scapular lymph nodes, mesenteric lymph nodes, spleen, femoral
bone marrow, thymus, kidney and skin were collected during the post-mortem
examination or immediately before (blood and lung fluid) from seventeen naturally
SPA-affected sheep, six experimentally infected lamb and fifteen age- and breed
matched control animals. Most of the samples were those collected for the
investigations outlined in Chapters 4 and 5.
Tissue samples were snap-frozen in liquid nitrogen and stored at -70°C . Lung fluid
samples were clarified by centrifugation at 10.000 x g for 1 h at 4°C and then stored
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at -70°C. Plasma (5 ml) was clarified by centrifugation at 10,000 x g for 1 h at 4°C.
The supernatant was then centrifuged at 100,000 x g for 1 h at 4°C. The pellet was
resuspended in 500 pi of solution D and stored at -20°C. Peripheral blood
mononuclear cells (PBMC) were isolated from venous blood by centrifugation over
Lymphoprep™ at 800 x g for 30 min; aliquots of 4x106 cells were stored at -70°C
until RNA and DNA was extracted. Total RNA was extracted from 50 pi aliquots of
lung fluid, 200-500 mg of lung tumour or from the plasma samples using the acid
guanidinium thiocyanate-phenol-chloroform extraction method as described in
2.3.18. PolyA+ RNA was obtained from 100 mg of all other tissues and from 4 x 106
PBMC using the Microfast Track kit (Invitrogen) as described in 2.3.19. Genomic
DNA was extracted from 10-25 mg of tissues and from 4 x 106 PBMC using the
Qiagen Tissue Amp kit as described in 2.3.21.
6.2.2 Amplification and sequencing of JSRV LTR.
The 5' LTR of a UK strain of JSRV was amplified from 500 ng of lung tumour
genomic DNA isolated from a natural case of SPA using primer P5 and P2. These,
formed the first primer pair of a hemi-nested LTR-gag PCR used to amplify proviral
JSRV as described in 5.2.4. Briefly, the forward primer (P5) is located almost at the
5' end of the U3 while the reverse primer anneals to gag (P2) so that all but the first
33 bp of the JSRV 5' LTR are amplified (Fig. 5.2). In Chapter 5, primer P5 was
demonstrated to be specific for the exogenous form of JSRV. The PCR products of
three independent reactions were pooled and cloned in pGEM-T (Promega) as
described in 2.3.10. Six selected clones (pGEM-T LTR-gag) were demonstrated to be
of exogenous origin by the presence of a unique Seal site in gag (data not shown).
The region corresponding to the LTR of JSRV was then sequenced in both directions
by the dideoxy chain termination method, employing a Li-Cor automated sequencer
at the Sequencing Service facility of the Veterinary Pathology Department of the
Royal (Dick) School of Veterinary Studies (University of Edinburgh, UK).
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6.2.3 cDNA synthesis.
cDNA synthesis was carried out using total RNA derived from ultraspeed pellets of
plasma (5 ml) or 50 pi of clarified lung fluid as template. For analysis of other
samples, 2 pg of total RNA from tumour samples or 1 pg poly A+ RNA from other
tissues and PBMC were used as template. RNA was diluted in 13.5 pi of diethyl
pyrocarbonate-treated distilled water and denatured at 65°C for 10 min and cooled on
ice. One microlitre (40 U) of rRNAsin (Promega), 2 pi of 25mM each
deoxynucleoside triphosphate (dNTP), 2.5 pi of 100 mM dithiothreitol, 2.5 pi (A260,
62.5 U/ml [Oswel] of random hexamers, 2.5 pi of 10X reaction buffer (500 mM Tris-
HC1 [pH 8.3], 75 mM KC1, 3 mM MgCl2) and 1 pi of MoMuLV reverse transcriptase
(50U/pl -Stratagene) were added. Reverse transcriptase (RT) was omitted in control
samples to check for DNA contamination of the RNA preparations. The reaction
mixture was then incubated at 37°C for 1 h, and the RT inactivated by incubation at
94°C for 3 min.
6.2.4 Exogenous-specific JSRV U3 and U3 hemi-nested (hn) PCRs.
Primer P5 was paired with an antisense primer (P6, 5'-CACCGGATTTTTACAC
AATCACCGG-3') in the U3 region at nucleotide positions 7385-7361 where there
are major sequence differences between JSRV and enJSRVs. In this region, the
endogenous sequences carry a 30 bp insertion compared to the exogenous sequences
(Fig. 6.1). The JSRV U3-PCR reaction was optimised using DNA from a LTR-gag
pGEM-T plasmid as template. The buffer used was 10 mM Tris-HCl, 50 mM KC1,
2.5 mM MgCl2 (pH 9.2) with 200 pM each dNTP. 6.25 pmol of each primer, 1.25 U
of Taq polymerase (Boehringer) in a 50 pi reaction. Five hundred ng of genomic
DNA or 3 pi of cDNA were used as template in the reaction. Each sample was
subjected to 94°C for 1 min followed by 35 cycles of 94°C for 30 sec. 59°C for 1
min and 72°C for 1 min with a final extension 72°C for 3 min.
129
Total RNA extracted from 22 lung tumour and lung fluid samples from 16 different
naturally acquired and 4 experimentally induced SPA cases were tested to verify the
ability of JSRV-U3 PCR to detect different isolates of JSRV. In addition, genomic
DNA extracted from lung tumour and matched kidney samples of four sheep with
SPA was tested to verify that JSRV U3-PCR does not amplify enJSRVsequences.
To verify the specificity of the PCR products, twenty-five pi of the PCR product was
resolved by electrophoresis in 1.5% agarose gels and transferred to nylon
membranes overnight by established procedures (Sambrook et al, 1989). Membranes
were then fixed, pre-hybridised and probed overnight at 42 °C with 10 pmol each of
two digoxygenin (DIG) 5'-labelled oligonucleotides (P-7, 5'-GGCACTGCTTCAC
AGAAATATCAGGAAATCTGATT-3' [position 7316-7350]; P8, 5'-TTTTTAAA
AGCTCTTAAGGCTCGGATGTTTGCTT-3' [position 7280-7313]) (Oswel) in Dig
Easy Hyb (Boehringer) hybridisation buffer. Washings were performed in 0.1 X SSC
at 52°C). The hybridised probe was then immunologically detected using the DIG
Nucleic Acid detection Kit (Boehringer) as described in 2.3.9.
To improve the sensitivity of the JSRV-U3 PCR, a primer internal to the PCR
product, primer P-9 (5'-TGATATTTCTGTGAAGCAGTGCC-3\ position 7316-
7338) was synthesised and paired with primer P-5 in a second round hemi-nested
PCR (JSRV U3-hn PCR). One pi of the product of the first round of amplification
was added to 49 pi of 1 X PCR buffer (1.25 U of Taq polymerase [Boehringer], 2.5
mM MgCE, 50 mM KC1, 10 mM Tris HC1, 200 pM each dNTP and 6.25 pmol of
each primer). PCR cycles employed were 94"C for 1 min and 35 cycles of 94°C for
30 sec, 57°C for 1 min and 72°C for 1 min, with a final extension of 72°C for 3 min.
Amplified products were detected by electrophoresis of 25 pi aliquots through a 2%
agarose gel containing 0.5 pg/ml of ethidium bromide.
The sensitivity of the JSRV U3-PCR and U3-hn PCR, against a background of
endogenous-related sequences, were compared with each other and with the JSRV
gag-PCR followed by Seal digestion (described in chapter 4). 'Reconstruction'
experiments were performed using serial dilutions (10? to 10"' copies) of clone
pGemT-LTR-gc/g (which contains the U3 through gag of JSRV provirus) with and
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without the addition of 500 ng of normal sheep kidney DNA as a source of enJSRV
sequences. In addition, 100 copies of pGEM-T LTR-gag plasmid, plus serial
dilutions (102 - 107 copies) of enJSRV-LTR plasmids were tested.
6.2.5 Template control PCRs.
Each cDNA sample which was negative after the U3-hn PCR was tested for the
presence of GAPDH transcripts to verify the integrity of the RNA template. Primers
were designed on a consensus sequence between the rat and human GAPDH (C.
Mclnnes, personal communication). The sense primer (5'-TCACCACCATGGAG
AAGGCT-3') was based on exon 4 of the human gene and the reverse primer was
based on exon 7 (5'-TTCATTGTCATACCAGGAAA-3') (Tokunaga et al, 1987).
The buffer employed was 10 mM Tris-HCl, 50 mM KC1, 2.5 mM MgCE (pH 8.9)
with 200 pM each dNTP, 6.25 pmol of each primer, 1.25 U of Taq polymerase
(Boehringer). Cycles employed were 94 °C for 1 min and 35 X (94°C for 45 sec,
52°C for 1 min and 72 °C for 1 min and 30 sec with a final extension of 72°C for 5
min).
Parallel samples in which the addition of RT was omitted in the cDNA synthesis step
were also tested to rule out DNA contamination. Amplified products were detected
by electrophoresis of 25 pi aliquots through 1% agarose gels in IX TBE buffer in the
presence of 0.5 pg/ml of ethidium bromide.
A DIG-labelled internal probe (5'DIG-CTCATGACCACAGTCCATGCCATCAC
GCC-3') was used to confirm the specificity of the amplified product. Southern
blotting and detection of hybridised probe was essentially as described above for U3-
PCR.
DNA samples which were negative after hn-U3 PCR were checked by amplification
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301 TTTCTTAGCGAAGACGCTCCGTTCTCTCCCTGTGCAGGTGCGACTCTTGC 350
380 TTGTGCTGGTCGCGGCAGG 398
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351 TTGTGCTGGCCGCGGCAGG 369
Fig. 6.1. Sequence alignment of the LTR of the South African isolate
[JSRV(SA)] (York et al, 1992) and of the UK isolate of JSRV [JSRV(UK)].
Enhancer- like sequences, TATA box and the poly adenylation sites are indicated. A
tandem repeat is underlined by arrows (—»). Open arrows (=>) indicate limits of U3,
R and U5.
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6.3.1 Sequencing of JSRV LTR and designing of JSRV exogenous-specific
primers.
To better design an exogenous specific-PCR the LTR of a UK strain of JSRV was
sequenced and compared with the sequence of a South African strain of JSRV and to
the LTR of enJSRVs (York et al, 1992; Palmarini et al, 1996). The LTR of the UK
strain of JSRV [JSRV(UK)] was 89% homologous to the LTR of the South African
strain [JSRV(SA)] (Fig. 6.1) (York et al, 1992) and 76 to 79% homologous to
enJSRV loci (Fig. 6.2). Major sequence divergence between exogenous and
endogenous viruses was confirmed in the U3 region. In particular, a 30 bp deletion in
the U3 of JSRV(SA) compared to the endogenous loci was also confirmed in
JSRV(UK). Primer P-6 was designed across the deletion such that at the optimal
annealing temperature this primer should anneal efficiently only with the exogenous
sequences. The alignment of the U3 of JSRV and enJSRVs sequences and the relative
positions of the primers employed in this study are indicated in Figure 6.2.
The JSRV LTR sequence of the UK strain has been deposited in GenBank under
accession number Z71304.
6.3.2 Specificity and Sensitivity of JSRV U3 and hemi-nested-U3 PCRs.
Twenty-two cDNA samples of lung fluid and lung tumour were examined by PCR
using primers P-5 and P-6. A product of the expected size of 176 bp was obtained
with all samples. To demonstrate the PCR product was derived only from JSRV and
not from enJSRV, matched genomic DNA samples of lung tumour and kidney from
four SPA-affected animals were examined. An amplified product was obtained from
tumour DNA and not from the corresponding kidney sample, proving that the JSRV-
U3 PCR is exogenous-specific (Fig. 6.3 [top]). Hybridisation with the DIG-labelled
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internal oligonucleotides P-7 and P-8 confirmed that the products originated from
JSRV-LTR (Fig. 6.3 [bottom]).
The sensitivity of the U3-PCR was determined by 'reconstruction' experiments,
testing mixtures of exogenous JSRV and enJSRV templates described in Materials
and Methods. JSRV U3 PCR successfully amplified 102 - 103 JSRV template copies
in a background of 500 ng of normal sheep genomic DNA and 102 JSRV template
copies in a background of 107 copies of enJSR F-LTR.
The sensitivity of the U3-PCR was increased by using primer P-6 and primer P-5 in
a second round PCR. A product of 133 bp was detected from the re-amplification of
all the lung fluid and lung tumour PCR products but not from the kidney samples.
The U3-hn PCR detected an estimated single molecule of template in a background
of 500 ng of normal sheep genomic DNA (Fig. 6.4). In contrast, as described in
chapter 4, PCR-gog followed by Seal digestion was at least 10? times less sensitive
than the U3-hn PCR because 107 copies of exogenous clone were not detected against
a background of 500 ng of normal sheep kidney DNA. Furthermore exogenous
sequences were detected by the U3-hn PCR only when the ratio of
exogenous/endogenous sequences was 1:10 but not > 1:100.
The U3-hn PCR amplified only exogenous sequences and was specific for all strains
of JSRV tested.
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Fig. 6.3: Specific amplification of JSRV by U3-PCR. (Top panel) Lanes 1, 3 and 5
are the product of amplification of 500 ng of lung tumour genomic DNA from three
cases of SPA; lanes 2, 4 and 6 are the matched kidney samples. Lanes 7 and 8 are
cDNA of lung of healthy control sheep; lane 9 is lung tumour cDNA, and lane 10 is
lung fluid cDNA. + and - indicate pGEM-T LTR-gag and water respectively used as
positive and negative controls. Lane M contains molecular weight marker IX
(Boehringer). (Bottom panel) Southern hybridisation of lung fluid samples from five
SPA cases ( lanes A-E) and probed with DIG-labelled probes P7 and P8. + and -
indicate pGEM-T LTR-gag and water respectively used as positive and negative
controls.
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Fig. 6.4: Sensitivity of JSRV U3-hn PCR. Serial dilutions of pGem-T LTR-gag
containing the JSRV LTR template were amplified with a background of 500 ng of
sheep genomic DNA collected from an unaffected control sheep. The number of
copies is indicated at the top of the gel. Lanes: I, first step of JSRV U3-hn PCR; II,
second step of U3-hn PCR; M, molecular weight marker IX (Boehringer).
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6.3.3 Detection of proviral DNA and JSRV transcripts in non-tumour tissues
of SPA-affected sheep.
Following the successful development and validation of the U3-hn PCR, the
anatomical distribution of JSRV in SPA-affected sheep was analysed. Table 6.1
summarises the results obtained.
JSRV RNA and proviral DNA was found consistently in the mediastinal lymph
nodes of SPA-affected sheep (10/10). In addition, JSRV-RNA was found in 7/9
spleens, 4/8 bone marrows, and in 2/4 thymuses (Fig.6.5). Proviral DNA was found
more rarely in these tissues. PCR products were detected in 2/8 spleens, and 3/7
bone marrows. Among the non-regional lymph nodes analysed all were negative for
proviral DNA, but two mesenteric lymph nodes of the five analysed were positive at
the RNA level. Pre-scapular lymph nodes (n=4) were always negative . PBMC were
found positive for JSRV RNA in the 3/7 samples but proviral DNA was not detected
in any. Plasma samples were always negative.
Apart from lymphoid tissues, JSRV was detected at both the DNA and RNA level in
only one kidney of 9 tested and in none of four skin samples . No differences were
observed in the anatomical JSRV distribution between the naturally-acquired and the
experimentally-induced SPA cases.
JSRV was not detected in 27 samples examined from 15 unaffected control animals.
These samples included polyA+ RNA prepared from lung (n=5), mediastinal lymph
nodes (n=7), thymus (n=l) and PBMC (n=4). In addition, samples from lung (n=3),
mediastinal lymph nodes (n=l), spleen (n=2), thymus (n=l), bone marrow (n=l) and
kidney (n=2) were tested for proviral DNA.
All the samples that were negative in the U3-hn PCR were positive for the
amplification of GAPDH cDNA or enJSRV gag DNA, demonstrating that the
templates were not degraded, and PCR inhibitors were not present after the nucleic
acid extraction.
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Table 6.1. Results of the JSRV U3-hn PCR on tissues of sheep affected by SPA.















Lung tumour/lung fluid 18/18 6/6 4/4 4/4 22/22 10/10
Mediastinal lymph nodes 6/6 6/6 4/4 3/3 10/10 9/9
Other lymph nodes 2/9 0/9 na na 2/9 0/9
Spleen 4/5 0/5 3/4 2/3 7/9 2/8
Bone marrow 2/5 2/4 2/3 1/3 4/8 3/7
Thymus na na 2/4 0/4 2/4 0/4
Kidney 1/6 1/6 0/3 0/3 1/9 1/9
Skin 0/4 0/4 na na 0/4 0/4
Plasma 0/2 / 0/6 / 0/8 /
PBMC 3/7 0/6 na na 3/7 0/6
* Sheep with naturally acquired SPA
fSheep with experimentally induced SPA
I polyA+ selected RNA
^ genomic DNA
II (number of positive samples/number tested)
na = not available
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Fig. 6.5: Example of the results of JSRV U3-hn PCR in an SPA-affected animal.
1, indicates the first step of the U3-hn PCR while 2 represents the second round of
the reaction. Lane A, lung tumour cDNA; lane B, kidney cDNA; lane C, spleen
cDNA (note the faint product obtained in the first step); lane D skin cDNA; lane E,
lung cDNA from an unaffected control animal. Lane M contains molecular weight
marker IX. W is the negative control (water) of the hn-U3 PCR.
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6.4 Discussion.
Studies described in the previous chapters, using immunological and molecular
techniques, demonstrated that JSRV is an exogenous virus, which does not arise from
reactivation of an endogenous locus. These studies identified the lungs, particularly
the epithelial tumour cells, as a major site of JSRV replication, although viral RNA
was demonstrated in the draining mediastinal lymph nodes of a proportion of SPA-
affected sheep. These observations have been extended in the present study as a
result of developing a highly sensitive assay for exogenous JSRV and show that
JSRV RNA and proviral DNA is present not only in the draining lymph nodes but
also in several anatomically dispersed lymphoid tissues and PBMCs. This
distribution of JSRV in infected animals is, therefore, similar to that reported for
other type B and type D retroviruses, in which both lymphoid and non-lymphoid
tissues are infected (Bentvelzen & Brinkhof, 1980; Kozma et al, 1980; Bryant et al,
1986; Lackner et aL 1988).
Although quantitative assays were not employed in the present studies, the estimated
sensitivity of the different PCR assays confirmed that JSRV was expressed at much
higher levels in SPA tumours than in the lymphoid tissues, particularly those at the
non-local sites. Thus, there are clear parallels with the high levels of MMTV
transcription associated with the development of breast carcinoma in mice (Varmus
et al, 1973; Bramblett et al, 1995). The transcriptional activity of MMTV appears to
be determined by the interaction of a number of factors involving regulatory
elements within the LTR. including at least one region implicated in elevated
transcription in the mammary epithelium (Lefebre et al, 1991; Mink et al, 1992; Mok
et al, 1992), and the absence of tissue-specific factors such as NBP in mammary
tissue (Bramblett et al, 1995). Similar putative regulatory sequences, such as NF-1
and C/EBP binding sites, have been identified in the JSRV LTR (York et al, 1992) as
well as many point mutations and large deletions compared to endogenous loci as
described in Chapter 5. Other retroviruses with LTR deletions have been reported to
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have a transcriptional advantage (Hsu et al, 1988) and the biological significance of
these structures in JSRV awaits the development of permissive culture systems.
The interaction between type B and type D retroviruses and lymphoid cells has been
demonstrated to be an important feature in the pathogenesis of these viruses. B
lymphocytes have a central role in the pathogenesis of MMTV and infection of the
mammary gland requires a functional immune system. MMTV initially appears to
infect B lymphocytes and is then delivered to the mammary gland through T-B cell
interactions (Tsubura et al, 1988; Golovkina et al, 1992; Held et al, 1994). The
simian type D retrovirus, SRV 1, which induces simian acquired immunodeficiency
syndrome in macaques (Gardner et al, 1994), has a broad in vivo lymphoid tropism
involving lymphocytes and mononuclear cells. Infection leads to both T and B
lymphocyte depletion although monocyte and macrophage function appears
unaffected (LeGrand et al, 1985; Maul et al, 1988).
The significance of infection of lymphoid tissues by JSRV in the overall
pathogenesis of SPA is unknown at present. As only sheep with clinical SPA were
examined it is not known whether lymphoid infection precedes, or is a sequel to,
JRSV replication in the pulmonary epithelium. Further studies will be required to
define which cell types are involved and at which stages during the protracted time
between infection and the appearance of clinical illness. Similarly, it is not clear
whether sheep infected with JSRV develop immunodeficiency, although this
possibility is supported by anecdotal reports of the increased susceptibility to
secondary bacterial pneumonias (Sharp and Martin, 1983; Verwoerd, 1990) and a
lymphopaenia in SPA-affected sheep (Rosadio and Sharp, 1992). The apparent
absence of circulating antibodies to JSRV in sheep with SPA has been reported
(Sharp and Herring, 1983; Verwoerd, 1990) although a recent study, using a
recombinant Mason-Pfizer monkey virus major capsid protein, has produced
conflicting results (Kwang et al, 1995).
One of the major obstacles to progress in research on JSRV has been the lack of an in
vitro culture system. The present study has clearly demonstrated permissive infection
of lymphoid cells by JSRV, cell types which have been used successfully for the
142
propagation of many retroviruses and which, therefore, could provide a permissive
substrate for JSRV replication.
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Chapter 7.
General Discussion and Conclusions.
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7.1 Summary of the results obtained and general discussion.
In this final chapter, the results obtained during the course of this project will be
summarised and discussed taking into account also results obtained by other
investigators in the last three years. Important areas of research on SPA where almost
no data are available at the moment, such as the immune response towards JSRV or
the mechanisms of oncogenesis, will also be discussed. Possible approaches towards
the understanding of these events will be proposed.
• Sites of JSRV replication.
Studies on the aetio-pathogenesis of SPA were hampered for a number of years by
the lack of immunological reagents and techniques to detect JSRV, the major
candidate to be the aetiological agent of SPA. After the sequencing of one strain of
JSRV (York, et al 1992), new possibilities for research were created.
The sites of viral replication were among the first aspects to be investigated in this
project. In Chapter 3, it has been described how immunological reagents and
techniques for the detection of JSRV were developed and then applied to investigate
the sites of JSRV translation and assembly. Using a JSRV-specific blocking-ELISA,
viral particles were detected only in lung fluid and tumour extracts of SPA-affected
sheep. The infected cells were identified by immunohistochemistry as the
recognisable transformed epithelial cells (Palmarini et al, 1995). Employing these
techniques. JSRV was not detected outside the tumour and its secretions in SPA-
affected sheep and was never detected in unaffected control animals.
The detection of JSRV constantly and exclusively in SPA-affected sheep suggested a
causal association between this virus and the onset of the neoplastic sequelae.
However, the presence in the sheep genome of JSRV-related endogenous retroviruses
complicated a straightforward interpretation of the results obtained. No information
was available to explain the relationship between the exogenous JSRV, transmitted
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with the lung fluids by SPA-affected sheep, and its endogenous counterparts
{enJSRVs).
• JSRV is distinct from its endogenous counterparts.
In Chapter 4, it was shown that enJSRVs are not only present in the sheep genome
but are transcriptionally active in a wide variety of tissues in both normal and SPA-
affected sheep (Palmarini et al, 1996a). It was, therefore, necessary to establish that
JSRV was not an endogenous virus. At that stage, different scenarios could have
been envisaged:
i) SPA could be induced by JSRV. alone or in association with unknown co-factors,
through horizontal transmission between sheep;
ii) JSRV could be the "helper" virus of an uncharacterised acutely transforming
retrovirus (the primary cause of SPA);
iii) SPA could be induced by the reactivation of one of the enJSRVs, in a similar way
to the induction of mammary tumours in the European GR strain of mice. Here, a
single endogenous virus which behaves as a dominant locus, Mtv-2, induces both
the early appearance of mammary tumours and the presence of MMTV virions in
milk (Muhlbock and Bentvelzen, 1969; Van Nie et al, 1977; Morris et al, 1986);
iv) SPA could be caused by an unidentified infectious agent and the presence of
JSRV in tumour cells could be only "accidental" and not necessarily linked to the
induction of neoplasia as for example the presence of endogenous RD-114 in
feline lymphoid tissues and neoplasms (Niman et al, 1977a, b and 1980).
In order to investigate these different hypotheses it was first necessary to characterise
JSRV and its endogenous counterparts.
As described in Chapter 4, by sequencing part of the gag gene of enJSRVs, a Seal
restriction site was established as a molecular marker of the exogenous JSRV.
Restriction enzyme digestion of gag-PCR products obtained from several lung fluid
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samples from Scotland and Spain confirmed that Seal was indeed present in different
isolates of JSRV in addition to the South African and Peruvian isolates (York et al.
1992; Hecht et al, 1994). This molecular marker was subsequently found to be
conserved in different isolates in South Africa (D. York, personal communication),
Spain (M. Garcia, personal communication), USA and Kenya (Bai et al, 1996). In
addition, major differences between JSRV and enJSRVs were found in the LTRs and
in particular in the U3 region (Palmarini et al, 1996a; Bai et al, 1996). In all
retroviruses this region of the LTR contains the transcriptional promoter and
enhancer elements. Sequence variations in the enhancer region affect retroviral
expression, tissue-specificity and oncogenicity (Des Groseillers et al, 1983; Weber
and Schaffner, 1985; Cullen et al, 1985; Stocking et al, 1986; Ishimoto et al, 1987;
Golemis et al, 1989; Ryden et al, 1989; Greuel et al, 1990; Speck et al, 1990;
llallberg et al, 1991; Lefebre et al, 1991; Mink et al, 1992; Mok et al, 1992).
Therefore, it is not surprising to find variations in the U3 between JSRV and
enJSRVs. Differences in the U3 between pathogenic exogenous retroviruses and non¬
pathogenic endogenous counterparts have been shown, for example, in the avian
leukosis virus group between the non-pathogenic endogenous RAV-0 and the
leukemogenic RAV-1 (Robinson et al 1982 and 1985; Brown et al, 1988). Chimaeric
constructs indicated that the RAV-1 LTR was necessary for the viral leukaemogenic
potential, although other viral genes also were important. Similar examples have
been described in some MuLVs (DesGroseillers et al 1983; Lenz and Haseltine,
1983; DesGroseillers and Jolicoeur, 1984; Lenz et al 1984).
The differences between JSRV and enJSRVs LTR were made use of to develop a
PCR assay for the detection of JSRV at DNA level (Chapter 5). The detection of
exogenous proviral DNA in tumour but not in matched kidney DNA from SPA-
affected animals (Palmarini et al, 1996a) proved that JSRV is an exogenous
horizontally transmitted virus and does not derive from the reactivation of an
endogenous virus.
The finding that some enJSRVs are transcriptionally active does suggest the
possibility that the exogenous virus could have recombined with some enJSRVs. The
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contemporary presence of exogenous and endogenous transcripts in the neoplastic (or
pre-neoplastic) cells could lead to copackaging of the two different molecules.
Recombination would then occur by reverse transcriptase switching during DNA
synthesis in the following round of infection. Retrovirus recombination is a well
established mechanism and can occur either after co-infection of two distinct
exogenous retroviruses or between an exogenous and an endogenous virus (Goodrich
and Duesberg, 1990; Hu and Temin, 1990; Coffin 1990b).
Although recombination between exogenous and endogenous viruses cannot be ruled
out, it was important that JSRV and enJSRVs were found to be distinct entities and
that JSRV was found specifically associated with SPA tumours. The establishment of
JSRV molecular markers allowed, for the first time, studies on the virus-host
interaction at a molecular level.
• JSRV establishes a disseminated infection of the lymphoid tissues.
The designing of JSRV exogenous-specific primers and the development of a
sensitive exogenous-specific PCR allowed further investigation of the sites of JSRV
replication and in this way identification of novel sites of JSRV replication.
JSRV was demonstrated to establish ? disseminated infection of the lymphoid tissues
of SPA-affected sheep (Chapter 6; Palmarini et al, 1996b). The mediastinal lymph
nodes, which drain the lungs, were shown consistently to be infected by JSRV.
JSRV transcripts were detected also in a proportion of spleen, thymus, bone marrow
and peripheral blood mononuclear cells. Proviral JSRV DNA also was detected in
these tissues, although in a much lower proportion of cases (Palmarini et al, 1996b).
Preliminary results indicate that JSRV infects both adherent cells (mainly
macrophages) and lymphocytes (B and T-cells [CD4^ and CD8+]). These data were
obtained employing the U3-hn PCR (described in chapter 6) in MACS sorted
mediastinal lymph nodes cells from two terminal cases of SPA. Quantitative analysis
of the samples by limiting dilution analysis estimated a higher proviral load in the
"adherent" cells (one provirus for 3.500 to 5,400 cells) compared to the lymphocytes
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(one provirus per 9.300 to 42.136 cells) (Palmarini M., Holland M., Dalziel R.G. and
Sharp J.M. unpublished results). However, more samples need to be analysed to
confirm these data.
• Is the dissemination of JSRV in the lymphoid tissues significant in the
pathogenesis of SPA?
It is difficult to answer this question when only scant data about the immune
response towards JSRV are available.
SPA-affected sheep do not show an appreciable humoral immune response towards
JSRV. No circulating antibodies have been detected by western blotting when a
ultracentrifuged pellet of lung fluid was probed with SPA-affected sheep sera (Sharp
and Herring, 1983; Verwoerd, 1990). Apparently contrasting results have been
obtained by indirect ELISAs based on recombinant CA protein of MPMV or of
ENTV coupled to GST. The use of these tests showed differences in the percentage
of sero-positivity between flocks with a history of SPA or chronic respiratory
diseases and flocks where SPA was never described (Kwang et al, 1995; Rosati et al,
personal communication). However, the interpretation of these results is doubtful. No
major differences were obtained in a blind trial when sera of SPA-affected sheep
were compared with sera from healthy control sheep (included sheep from the
Falkland Islands where SPA has never been described (A. Coe, personal
communication) (S. Rosati. M. Palmarini and J.M. Sharp, unpublished data). The
presence of antibodies in SPA-affected sheep has therefore to be further investigated.
Assuming that the results obtained by western blotting truly reflect the lack of a
humoral immune response towards JSRV. it could be hypothesised that SPA-sheep
are immunotolerant towards JSRV. However, the lack of circulating antibodies in a
retroviral infection does not necessarily reflect the lack of an immune response. For
example, an HIV-specific cytotoxic T cell response in HIV-exposed and seronegative
Gambian sex workers has been recently described (Rowland-Jones et al, 1995).
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It is useful however to speculate on possible tolerance in sheep towards JSRV as this
would have important biological implications.
Immunotolerance of sheep to JSRV could be explained as a result of expression of
enJSRVs during ontogeny. In this case endogenous viral proteins would be
recognised as "self' and induce the clonal deletion of lymphocyte precursors specific
for the virus. Because the degree of self tolerance reflects the concentration of
antigen reaching the thymus (Sprent and Webb, 1995) sheep would be more or less
tolerant towards JSRV depending on the level and sites of enJSRVs expression.
Results in contrast with this hypothesis have been obtained by Sharp (unpublished
data) who induced an antibody response in sheep immunised with recombinant CA-
JSRV suspended in incomplete Freund's adjuvant. However, it is known that
tolerance to natural self-antigens, such as insulin and thyroglobulin, can be broken by
an "unnatural" stimulus such as the injection of a high concentration of antigen
suspended in adjuvant (Romball and Weigle, 1984; Whiteley et al. 1990).
The induction of tolerance due to the expression of endogenous retroviruses has been
shown in other models. M-MuLV is integrated into the germline of a particular strain
of mice (C57BL/6 Mov-13) and is expressed during the ontogeny in lymphoid and
non-lymphoid tissues. When such mice are infected with M-MuSV, no antibody or
CTL response is seen and a high incidence of T-cell lymphoma occurs (Ronchese et
al, 1984). Another example is given by studies conducted by McMahon et al (1986)
in the RSV system. In the FP line of chickens there are high levels of expression of
an endogenous retroviral envelope glycoprotein (subgroup E) (Weiss et al, 1971).
When these chickens are infected with either a subgroup B strain of RSV (which
cross-react with subgroup E) or with a subgroup G (which does not cross-react) they
develop a sarcoma at the wing web site. However, a high percentage of only the
subgroup B-infected chickens exhibit distal sarcomas and they do not develop
antibodies towards the envelope subgroup B protein in contrast to the substantial
titres generated in the subgroup G. This difference is explicable on the basis of the
tolerogenicity of endogenous viral glycoprotein.
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In the SPA model the lack of an immune response could also be due to a viral-
induced immunosuppression. A possible immunosuppressive role has been
hypothesised for JSRV due to the fact that SPA-affected sheep are increasingly
susceptible to secondary bacterial pneumonias (Sharp and Martin, 1983; Verwoerd,
1990) and to a report of lymphopoenia in these animals (Rosadio and Sharp, 1992).
These last observations have been made in a small number of sheep at the terminal
stage of the disease. The extensive lesions in the lungs, the frequent secondary
bacterial infections and the consequent respiratory impairment could be, by
themselves, the cause of immunosuppression.
Epidemiological data suggest that some form of "resistance'' in sheep develops after
SPA is introduced for the first time in a particular territory. In endemic areas SPA
has an incidence between 1 and 5% (see 1.2) but when SPA was first introduced in
Iceland there were losses in some flocks between 50 and 80% in the first two years
after which it gradually decreased (Dungal et al, 1938). An analogous situation
happened in Kenya (Shirlaw, 1959; Wandera. 1967) and in Peru (Rosadio, personai
communication) where the disease spread in an epidemic fashion before
subsequently dropping. The initial epidemic spread and the subsequent decline of the
incidence of an infectious disease could be attributed either to a protective immunity
that arises in the susceptible population or natural selection of a less virulent strain of
the infectious agent.
Appropriate recombinant proteins are much needed to evaluate the humoral and
moreover the cellular immune response towards JSRV.
• Which cells are first infected by JSRV?
Infection by JSRV is thought to spread horizontally among sheep through the
respiratory route and therefore through the inhalation of aerosol or droplets of lung
fluid containing JSRV by a susceptible sheep in close contact with an SPA-affected
sheep. No data support a transmission from mother to foetus. JSRV was never
detected in lung, thymus and spleen collected from foetuses (n=3) derived from
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sheep with SPA and analysed by JSRV U3-hn PCR (Palmarini, M., and Sharp, J.M.,
unpublished data).
The horizontal transmission through the respiratory route is confirmed by the sites of
the tumours in naturally arising SPA-cases. Lesions are localised predominantly in
the apical lobes of the lungs. Further evidence supporting the respiratory route of
infection is given by the experimental model of SPA: lambs are successfully
infected only by the intratracheal inoculation of lung fluid.
It is conceivable that, initially, JSRV infects the epithelial cells of the lungs where it
is able to replicate actively and eventually transform these cells. After a few rounds
of replication, antigen presenting cells (APCs) could phagocytose JSRV and carry
the virus to the mediastinal lymph nodes draining the lungs where JSRV could be
presented more or less efficiently to lymphocytes and then through the recirculation
of these cells be disseminated to other lymphoid tissues.
If the infection of the lymphoid cells with JSRV happens after the infection and
transformation of the epithelial cells it could be hypothesised that it is not a necessary
step for the virus to induce disease but more probably a consequence of the immune
system of the host to respond to the viral infection.
As has been shown previously (chapter 6; Palmarini et al, 1996b) both JSRV RNA
and proviral DNA have been detected in lymphoid cells and this suggest that the
virus is able to perform at least the first steps of its replication cycle in these cells.
It is possible that JSRV infection of the lymphoid cells precedes JSRV replication
and transformation of the epithelial cells of the lungs. In this case the infection of the
lymphoid cells could be seen as a "necessity" for JSRV to induce transformation of
type II pneumocytes.
This hypothesis is based on some characteristics which are shared between the JSRV
and MMTV systems. Like JSRV, MMTV is associated with an epithelial neoplasm
which represents the main site of viral replication. In addition, MMTV causes a
disseminated infection of the lymphoid tissues where low levels of viral replication
are detectable (Matsuzawa et al, 1995).
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MMTV exploits the immune system to reach the mammary gland and induce tumour.
The infectious MMTV is transmitted through the milk from mother to baby and
taken up by the neonatal gut epithelium where viral proteins are detectable. It then
infects B cells of the Peyer's patches which (Karpetian et al, 1994) stimulate a large
proportion of T cells of the animal through the MMTV Sag (Acha-Orbea and
MacDonald, 1993; Held et al, 1994; Huber, 1995). T cells (carrying the Sag-specific
Vp region) then provide a positive feed-back (by cytokine production) for the few
infected B cells to proliferate and in this way expand MMTV infection (Waanders et
al, 1993) which finally reaches the mammary gland. Mice lacking B-cells cannot be
infected (Beutner et al, 1994). In mice lacking Sag-reactive T-cells, viral
amplification does not occur which results in a loss of the virus before it can reach
the mammary gland of lactating females and be transmitted to the offspring (Tsubura
et al, 1988; Golowkina et al, 1992; Held et al, 1993a). MMTV therefore requires an
intact immune system to be able to reach the mammary gland which is the only place
12
where virus production has been clearly detected (about 10 particles per ml of milk:
Acha-Orbea. 1996).
However, the pathogenesis of MMTV-induced mammary carcinoma and SPA differs
in an important aspect: the sites of entry of the two viruses with respect to the
accessibility of their target cells for transformation. While MMTV enters through the
digestive tract and then has to "travel" to reach the mammary gland, JSRV enters
through the respiratory route and therefore type II pneumocytes and the Clara cells
are readily accessible, although a previous transit of JSRV in the lymphoid tissues of
the upper respiratory tract (e.g. tonsils) cannot be ruled out.
In addition, MMTV Sag expression plays a central role in the interaction with the
immune system of the host and no data are available in this respect for JSRV.
Analysis of the sites of JSRV replication in the early stages of the infection might
elucidate the temporal relationship between infection of the epithelial cells, infection
of the lymphoid cells and transformation.
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• What are the mechanisms of oncogenesis?
The mechanisms by which JSRV transforms its target cells are unknown and can
only be speculated on at the present time.
JSRV has the genomic organisation of a replication competent retrovirus with no
oncogenes. Thus, a likely possibility is that JSRV transforms type II pneumocytes by
insertional mutagenesis. To test this hypothesis it will be necessary to analyse the
sites of viral integration in several SPA tumours collected from different affected
animals and verify if common integration sites occur.
Tumours which arise by insertional mutagenesis usually have a long incubation
period (see 1.7.2; Teich. 1984; Fan, 1994) because retroviral integration is considered
essentially a random event (Luciw and Leung, 1992) and multiple replicative cycles
will have to occur before the virus integrates near an oncogene. In addition, this is
generally only one of a series of events which have to occur before cell
transformation is triggered.
The incubation period in naturally-acquired SPA is not known with certainty.
However, on the basis of old epidemiological studies (Sigurdsson, 1954) and on the
observation that in nature SPA is a disease affecting mainly adult sheep (Sharp and
Martin, 1983; Verwoerd, 1990) the incubation period seems to be ranging from
months to years. Therefore, naturally acquired SPA seems therefore to fit the
insertional mutagenesis model.
In the experimentally-induced SPA however, the clinical manifestations of SPA are
achieved in approximately four weeks by intratracheal inoculation of lung fluid in
new-born lambs (Verwoerd et al, 1980; Sharp et al, 1983; DeMartini et al, 1987).
Such short incubation periods are generally seen in tumours induced by acutely
transforming retroviruses (Bishop and Varmus, 1984; Rasheed, 1995) and not by
retroviruses which act by insertional mutagenesis. However, it is only possible to
reproduce efficiently the disease with this short incubation period only when new¬
born lambs are used for the experimental infection. Experimental infection of lambs
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of 10 weeks of age does not induce efficiently SPA and when it does occur, an
incubation period of several months is invariably seen (Rosadio, 1987).
The differences in the incubation period between the natural and the experimental
model in new-born lambs could be due to different factors related to the virus and/or
to the host itself.
First of all, the dose of the virus could have a direct and/or indirect effect over the
length of the incubation period. It is difficult to have a precise figure regarding the
dose of inoculum because no quantitative assays for JSRV are available at the
moment. However, an approximate idea can be obtained by comparing the relative
quantity of lung fluid used as inoculum (although the same amount of lung fluid
collected from different animals can contain a different number of JSRV virions).
Lambs are experimentally infected with the equivalent of 75 ml of lung fluid (75 ml
of lung fluid ultracentrifuged and resuspended in 5 ml PBS; see chapter 2) while in
nature it is reasonable to expect that sheep become infected with a few microlitres of
lung fluid through aerosol or close contact between infected and uninfected sheep.
Thus, the dose of virus used for the experimental reproduction of SPA is presumably
several fold higher than the dose of virus transmitted in nature.
A "direct" effect of infection with a high virus dose would be the infection of a
greater number of cells at the initial stages resulting in a faster progression of the
disease.
An "indirect" effect of a high virus dose could be related to its effect on the host
immune system. A high dose of virus in the inoculum could tolerise new-born lambs
towards JSRV or impair their immune response and allow tumour to progress more
rapidly. In adult sheep the presence of an antiviral immune response could explain
the difficulty in experimentally reproducing the disease in adult sheep and the long
incubation period in naturally acquired SPA.
This hypothesis is supported by the data accumulating on the MLV system. It has
been known for a long time that the most efficient way to induce leukaemia with
MuLV is through infection of new-born mice (Gross, 1951). Mice infected with
MuLVs as new-borns generally show no virus-specific CTLs or circulating
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antibodies (Oldstone et al, 1972; Chieco-Bianchi et al, 1974 and 1988; Green , 1984;
Korostoff et al, 1990) and even when they raise antibodies to MuLV infection, this
humoral response does not appear to influence the pathogenesis in vivo (Fan. 1994).
In contrast, when adult mice are infected, an antiviral CTL response controls virus
production and the appearance of disease (Chieco-Bianchi et al, 1988; Robertson et
al, 1992).
Another possibility is that the differences in incubation period of SPA could be
related to the cells target of JSRV. Epithelial lung cells could either express a JSRV
receptor more abundantly or have an higher mitotic rate in new-born lambs. This last
factor could facilitate JSRV infection and expression. It is well established that
retroviral expression and continued viral expression is more efficient in dividing cells
(Varmus et al, 1977; Humpries et al, 1981; Brown, 1990).
• The ENTV system and its similarity with JSRV.
As discussed in 1.1.10, many of the hallmarks of SPA have been found in ovine and
caprine enzootic nasal tumour (ENT). These include (i) the experimental
reproduction of the disease using cell-free filtrates of tumour homogenates and nasal
exudates (Cohrs, 1953; De las Heras et al, 1995), (ii) the evidence in the tumour cells
of type-A and type-D particles, (iii) the detection of particle-associated reverse
transcriptase activity and (iv) capsid protein in the tumour that cross-reacts with
MPMV (De las ITeras et al, 1991b; Vitellozzi et al, 1993) and JSRV capsid protein
(see Chapter 3).
Cousens et al (1996) amplified and sequenced a portion of ENTV-gag from sucrose
gradient purified virions from three different nasal exudate samples (from three
different farms) of ENT. Successful amplification was obtained employing the same
primers used in the JSRV-PCR-gurg (Chapter 4). Sequence analysis showed that
ENTV sequences were 83 to 92% similar to JSRV sequences and 83 to 92% similar
to enJSR Vs sequences. The ENTV sequences lacked the Seal site that is a marker for


















Fig. 7.1: Phylogenetic tree constructed from portions of the gag gene of JSRV
(JSRVfSA] and JSRV [Peru]) (York et al, 1992; Hecht et al, 1994), ENTV
(Cousens et al, 1996) and enJSRVs (SERV) (Palmarini et al, 1996a). From Cousens
et al, 1996.
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were absent in enJSRVs. These sites were present exclusively and consistently in
ENTV from tumour tissues and exudates from ENT cases. Thus, ENTV is related to
JSRV yet apparently distinct from it.
Phylogenetic analysis of these sequences showed that the JSRV and enJSRV
sequences are more similar to each other than they are to the ENTV sequences (Fig.
7.1).
The consideration that these similar but distinct viruses are associated with similar
but distinct epithelial tumours of the respiratory tract of small ruminants, support the
hypothesis that these viruses are the primary cause of neoplasia.
7.2 Significance of SPA as a unique model of retroviral-induced lung cancer.
Retroviruses are an invaluable model system for understanding carcinogenesis and
regulation of normal cell growth. Studies of spontaneous retrovirus-induced animal
and human lymphomas have contributed immensely to our knowledge on cancer, yet
relatively little information is available concerning retroviral causes and mechanisms
of epithelial cell neoplasm which, in man, are much more frequent than lymphomas
(Silverberg et al, 1990).
SPA represents a unique model of a naturally-occurring epithelial neoplasm which is
associated aetiologically with a retrovirus. Interestingly, SPA shares certain
characteristics with human bronchio-alveolar cell carcinoma (BAC) (Perk and Hod,
1982; Gazdar and Linnoila, 1988). Like SPA, BAC is a relatively well-differentiated
tumour arising from type-11 pneumocytes or Clara cells, the neoplastic tissues are
preferentially localised at the periphery of the lungs and the lesions tend to be
multifocal (Liebow. 1960). The multifocality of BAC has been explained either as
the result of intrapulmonary lymphatic spread (metastasis) or a combination of
aerosolization and aspiration (implantation) (Liebow, 1960).
The incidence of BAC is increasing dramatically in the US where it represents up to
a quarter of primary lung carcinomas (Barsky et al, 1994a). The causes of BAC are
unknown. However, several characteristics differentiate BAC from other primary
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human lung tumours such as its relatively high incidence in females, its occurrence in
non-smokers and in a relatively young age-group (Liebow, 1960; Ives et al, 1983).
These features of BAC could suggest an aetiology distinct from other primary lung
carcinomas.
A viral aetiology has been postulated for the similarity of BAC with SPA (Perk and
Hod, 1982). Recently, multifocal BAC cases have been demonstrated to have a
multiclonal origin (Barsky et al, 1994b); a multifocal-multiclonal neoplasia could be
explained as viral-induced. The search for a retrovirus in BAC could well be fruitful.
An immunohistochemical analysis of a group of human lung tumours including
BAC, adenocarcinomas and epidermoid carcinomas has been recently performed
(De las Heras, M., Palmarini, M., Hasleton, P., Minguijon, E., Gimenez-Mas, J.A.,
Dalziel, R.G.. Egan, J., Larsson, E., and Sharp, J.M. manuscript in preparation)
employing the rabbit antiserum to JSRV-CA described in Chapter 3 (Palmarini et al,
1995). Interestingly, a strong positive reaction has been obtained in the cytoplasm of
the neoplastic cells in five out of the eight BAC cases examined. With the exception
of a single adenocarcinoma all the other samples tested were negative including a
control group of primary pulmonary hypertension cases.
These results can have different explanations:
i) the rabbit antiserum cross-reacts aspecifically with antigens present in the BAC
cells;
ii) one of the HERVs is abundantly expressed in BAC tumour cells. HERV-K for
example has 35% aminoacid identity with JSRV Gag;
iii) a novel human JSRV-related virus is associated with BAC.
Of course, immunohistochemistry cannot provide conclusive results and more studies
are much needed to explore these different scenarios. Preliminary indications can be
obtained by western blotting (employing the same rabbit anti JSRV-CA serum) and
RT-activity analysis of fresh frozen BAC tumour extracts. These tests would confirm
the results obtained and represent a first step towards further studies at the molecular
level.
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Studies on the aetiology and pathogenesis of SPA could provide an invaluable
model for BAC. The pathway of oncogenesis between the two tumours may be
similar even if the hypothesis of a BAC-associated retrovirus should be proved
wrong. For example the int oncogenes were identified solely by their association
with MMTV-induced mammary tumours in mice and at least one of these oncogenes,
int-2, is activated in some human cancers (Peters et al, 1989; Peters, 1991; Meyers
and Dudley, 1992).
SPA might represents also a model to understand the biological relevance of human
endogenous retroviruses. The major understanding of endogenous retroviruses have
been obtained in inbred strains of mice or in selected lines of chickens which not
necessarily reflects the biological function of endogenous retroviruses in humans
which is, like sheep, an outbred animal species.
7.3 SPA as a model to investigate retrovirus-herpesvirus interaction.
Herpesviruses and retroviruses are notorious for causing a wide spectrum of disease
with clinical courses ranging from acute to chronic, as well as persisting in the host
in latent forms which are not accessible to the host immune system (Weiss et al,
1984; Wildy, 1986; Roizman et al, 1992).
Early studies on SPA showed an association with a herpesvirus (see 1.5; Mackay
1969a and 1969b; De Villiers et al, 1975; Martin et al, 1979) designated OHV-1.
Subsequent studies discarded OHV-1 as an aetiological agent of SPA on the basis of
epidemiological data and on the failure to experimentally reproduce SPA in sheep
after inoculation of OHV-1 (Martin et al, 1976; Scott, 1984). Subsequently, the
increasing evidence supporting JSRV as the aetiological agent of SPA has deterred
investigators looking at the involvement of OHV-1 in the pathogenesis of SPA.
However, it was intriguing that co-inoculation of JSRV and OHV-1 induced more
extensive neoplastic lesions than the inoculation of JSRV alone (Martin et al, 1976).
The strict association of retroviruses and herpesviruses with neoplastic diseases has
generated considerable interest in studying the possibility that they could interact at
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the cellular level in induction or progression of disease (Evermann et al, 1992). The
occurrence of AIDS and the frequent concomitant infections with several
herpesviruses, such as EBV, CMV, HSV-1, E1HV-6 and more recently HHV-8
renewed interest in understanding possible synergistic actions of these two groups of
viruses (Fauci et al, 1984; Salahuddin et al, 1986; Ablashi et al, 1987; Collier et al,
1989; Lusso et al, 1989; Watson, 1990; Schulz and Weiss, 1995). Synergism
between herpesviruses and retroviruses can be attributed primarily to opportunistic
infections due to immune compromising effects of one or both virus types. Elowever,
interaction at the cellular level also has been shown. Coinfection of cells with human
CMV and HIV, for example, may augment HIV gene expression and virus
production (Ho et al, 1990) and similarly, the infection of primary CD4+ and CD8+ T
lymphocytes by EBV enhances HIV expression (Guan et al, 1996).
The interaction of CMV with HIV has been shown recently to be linked to the
expression of a CMV-associated superantigen which enhances HIV-1 replication in
CD4+ T cells bearing Vpi2 TCRs (Dobrescu et al, 1995a and 1995b). Viral
replication in targeted VP subsets may serve to promote a biologically relevant viral
reservoir.
Immediate-early genes of HSV-1 are capable of transactivating HIV-LTR linked to
reporter genes in cultured cells (Ostrove et al, 1987). HHV-6, which is
predominantly a CD4+ T-lymphotropic virus (Lusso et al, 1988), also is capable of
transactivating the HIV-1 LTR and productively coinfecting individual human T
cells with HIV-1, causing an accelerated cytopathicity (Lusso et al, 1989).
Other well established examples of retrovirus-herpesvirus interactions have been
shown once again with avian viruses. Lymphoid leukosis (LL) and Marek's disease
(MD) are two distinct diseases of poultry caused by two different viruses. LL is a
neoplasia of B lymphocytes caused by a retrovirus, the avian leukosis virus (ALV)
(Purchase and Payne. 1984). MD is characterised by peripheral nerve demyelination
and the formation of T lymphomas and it is caused by a herpesvirus, Marek's disease
virus (MDV) (Payne, 1982). Coinfection of chicken with both ALV and MDV alters
the disease processes associated with the individual viruses. The incidence of
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Marek's disease was increased when chickens infected with pathogenic strains of
MDV were also infected with ALV (Frankel and Groupe, 1971; Jakovleva and
Maruzenko, 1979). Conversely, a vaccine strain of MDV enhanced the development
of LL in chickens experimentally infected with ALV (Bacon et al, 1989). In the latter
case an increase in the numbers of tumours per chicken as well as the frequency of
metastatic tumours was observed. The non-pathogenic strain of MDV has been
detected in ALV-transformed bursal B cells but not in normal B cells (Fynan et al,
1992) after experimental coinfection with the two viruses, ft is possible that portions
of the MDV genome transactivate the ALV LTR in the same way shown between
MDV and Rous sarcoma virus (Banders and Coussens, 1994). Such a mechanism of
transactivation could either enhance the ALV titre or the transcription of oncogenes
under the control of the proviral promoter.
SPA therefore could serve as an animal model to elucidate the nature and potential
effects of direct herpesvirus-retrovirus. This may have some implications in human
medicine e.g. to investigate the pathogenesis of some HIV-associated herpesvirus
infections.
7.4 Future priorities of SPA research.
In these last years there has been a significant improvement in the understanding of
the biology of JSRV. JSRV has been completely sequenced (York et al, 1992), the
sites of viral replication have been established (Palmarini et al, 1995 and 1996b) and
the exogenous transmissible form of JSRV has been differentiated from the
transcriptionally active enJSRVs (Bai et al, 1996; Palmarini et al, 1996a).
Investigators working on SPA now have the possibility to design experiments which
will be able to define the aetio-pathogenesis of this important animal model.
SPA research can be arbritarily divided into three main areas:
i) studies on JSRV itself;
ii) mechanisms of oncogenesis;
iii) virus-host interaction:
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-immune response towards JSRV virus;
-influence of enJSRVs on the pathogenesis of SPA.
i) Studies on JSRV.
One of the main obstacles to developing the SPA model has been the lack of an in
vitro system for JSRV .
One way to prove the aetiology of SPA is to construct an infectious molecular clone
(IMC) and experimentally reproduce the disease in neonatal lambs by direct
inoculation of the IMC. Several approaches can be attempted to obtain an IMC.
One possibility is to derive an IMC from a genomic library constructed from the JS-7
cell line which derived from an SPA tumour (Jassim, 1988). Direct inoculation of JS-
7 cells in young lambs, both at low and at high passage, reproduced SPA (Jassim,
1988). The cell line has been karyotyped and by inoculating lambs of the opposite
sex, the tumours that developed were demonstrated not to have arisen from
transplantation of the cell line (Jassim, 1988). The cell line, therefore, carries an
infectious provirus and preliminary results seem to indicate that there is a single
provirus integrated in this particular cell line (Palmarini M. and Sharp J.M.,
unpublished data). The use of a cell line instead of tumour could overcome the
cloning of defective proviruses which can arise during retroviral replication as
established in other systems such as ALV, HTLV and MuLV (Shields et al, 1978;
Fung et al, 1981; Hiramatsu and Yoshikura, 1986; Robinson and Gagnon, 1986;
Oshima et al, 1991).
The genomic library could be screened with exogenous-JSRV-specific
oligonucleotides probes designed in the U3 of JSRV where major differences were
shown between exogenous and endogenous LTRs (see chapter 5; Palmarini et al,
1996; Bai et al, 1996).
Obtaining a replication competent JSRV-IMC would be of great advantage for the
SPA field. First, it would greatly assist research to identify the role of JSRV in the
aetiology of SPA and second it would allow mapping of determinants of
pathogenesis by construction of mutated clones.
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A proviral clone also would allow confirmation of the only published complete
sequence of JSRV (York et al, 1992). That sequence was obtained by sequencing
clones of a cDNA library obtained from gradient purified lung secretions of a SPA
sheep and by RT-PCR amplification of the missing portions of the JSRV genome. Of
particular interest would be establishing whether the open reading frame (ORF-X)
overlapping JSRV pol is a real gene or is an unusually long open reading that has
arisen by chance. Sequencing of this region from isolates collected from unrelated
geographical regions will help to address this issue.
ii) Mechanisms of oncogenesis.
The mechanisms of oncogenesis have to be completely elucidated. A priority towards
this goal is to establish if SPA tumours are monoclonal/oligoclonal and establish if
common integration sites occur between different tumours. If common integration
sites exist in different tumours, this would be an indication of insertional
mutagenesis. If instead integration sites are not localised to a few regions it may be
speculated that other mechanisms are responsible for oncogenesis in SPA. Virus-cell
flanking regions could be cloned either from a tumour genomic library or through a
PCR approach (Sorensen et al, 1993) again utilising exogenous specific
probes/primers in the U3. These flanking regions then could be used as probes in
Southern blot analysis for comparison of pairs of tumour and non-tumour genomic
DNAs digested with various restriction enzymes. Southern blots of non-tumour DNA
would give an indication of the restriction map around the restriction site while blots
of tumour DNA would show if JSRV insertion altered the mobility of the fragments.
iii) Virus-host interaction.
The interaction between JSRV and the host immune system is not known. Two basic
questions have to be answered: are sheep tolerant towards JSRV or does JSRV
induce an immune response?
The availability of the complete sequence of the JSRV genome will allow the
generation of recombinant proteins which can be used to assess the humoral and
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cellular immune response towards JSRV. The expression of JSRV recombinant
proteins in eukaryotic instead of prokaryotic systems will avoid contamination of the
protein preparations with LPS which interferes with tests designed to measure the
cellular mediated immune response.
Simple ELISAs will establish whether or not sheep have antibodies towards JSRV.
Experiments performed so far have included unaffected sheep as negative controls.
However, sheep which do not show classical macro/microscopic SPA lesions are not
necessarily free from infection with JSRV; unaffected sheep sera are therefore not
sufficient as negative controls. It will be necessary to include control groups from
sheep farmed in Australia or Iceland (where SPA has never been detected or it has
been eradicated from more than 40 years) to enable correct interpretation of the
results obtained.
Cellular mediated immunity could be investigated using the same recombinants in
lymphoproliferative and cytokine (e.g. y-interferon) assays. CTL responses would be
more difficult to assess because CD8+ cells recognise autologous MHC-I (Male et al,
1987) and there is little information available about MHC haplotypes in sheep.
The sites of viral replication in the early stages of the disease also have to be
established as, to date, only sheep with SPA at the terminal stages of the disease have
been investigated (Palmarini et al, 1996a and 1996b). Analysis of viral integration
and expression in experimentally infected lambs in the very first days post-infection
could address this issue.
Another aspect that could elucidate the interaction between JSRV and its host is to
further investigate the expression of enJSRVs for their possible influence on the
pathogenesis of SPA. In particular, it should be investigated when and where
enJSRVs are expressed during ontogeny.
The knowledge of humoral and cellular immune responses towards JSRV, the sites
of viral replication and a better characterisation of enJSRVs expression will greatly
advance our understanding on the interaction between JSRV and its host.
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7.5 Conclusions
Sheep pulmonary adenomatosis is a unique model of a contagious epithelial
neoplasm in an outbred animal species.
The results obtained during the course of this project have provided compelling lines
of evidence which specifically associate jaagsiekte sheep retrovirus with SPA. The
most plausible theory to explain this absolute association is that JSRV is 'the'
aetiological agent of SPA or that it is at least primarily involved in the aetio-
pathogenesis of the disease, perhaps as a virus helper of an as yet, uncharacterised
acutely transforming retrovirus.
Several key aspects of the pathogenesis of SPA, such as the mechanisms of
oncogenesis and the immune response towards JSRV, have still to be elucidated.
However the improvements in the understanding of the biology of JSRV made in
these last three years makes possible to design experiments to address these questions
in the immediate future.
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Appendix I. Commonly used buffers
Laemmli
electrode buffer
25 mM Tris, 192 mM glycine, 3.5 mM SDS, pH 8.3
Laemmli sample
buffer [X2]
0.5 M Tris/HCl pH 6.8, 4% SDS, 8% P-mercaptoethanol, 20%
[w/v] sucrose, 0.002% [w/v] bromophenol blue
L-broth lOg tryptone, 5g yeast extract, 5g NaCl per 1
L-agar L-broth containing 15g agar per 1
MOPS |10X] 0.2M MOPS 3-[N-Morpholino] propanesulphonic acid , 50 mM
sodium acetate and 10 mM EDTA, pH7
PBS 137 mM NaCl, 2.7 mM KC1, 4.3 mM Na2HP04-7H20, 1.4 mM
KH2P04, pH 7.3
Solution D 4M guanidinium thiocyanate, 25 mM sodium citrate, pH 7; 0.5%
sarcosyl, 0.1 M (3-mercaptoethanol
SSC |20X] 3M NaCl, 0.3M sodium citrate, pH 7
TBE 45 mM Tris/borate, 1 mM EDTA, pH 7.3
TBS 100 mM NaCl, 10 mM Tris/HCl, 0.1 mM EDTA, pH 7.5
TE 10 mM Tris-HCl, 1 mM EDTA, pH 8.0
TNE 100 mM NaCl, 10 mM Tris, 1 mM EDTA
T ris/glycine
blotting buffer
25mM Tris, 192 mM glycine, 20% [v/v] methanol. pH 8.3
Washing fluid B PBS, 0.5% (w/v)Tween 20, ImM EDTA, 350 mM NaCl
208
Appendix II. Oligonucleotides used in this project.











P8 7280-7313 TTTTTAAAAG CTCTTAAGGCTCGGATGTTTGCTT
P9 7316-7338 TGATATTTCTGTGAAGCAGTGCC
PA 1726-1747 GGCTTGCTGCTGGAAAAGTACT
*= position referred to the JSRV sequence (York et al, 1992; GenBank accession #
M80216).
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Epithelial tumour cells in the lungs of sheep with pulmonary adenomatosis
are major sites of replication for Jaagsiekte retrovirus
M. Palmarini,1 P. Dewar,1 M. De las Heras,2 N. F. Inglis,1 R. G. Dalziel3 and J. M. Sharp1*
1 Moredun Research Institute, 408 Gilmerton Road, Edinburgh EH 17 7JH, UK, 2 Department of Veterinary Pathology,
Faculty of Veterinary Medicine, Zaragoza University, C/. Miguel Servet 177, 50013 Zaragoza, Spain
and 3 Department of Veterinary Pathology, Royal (Dick) School of Veterinary Studies, Edinburgh University,
Summerhall, Edinburgh, UK
Sheep pulmonary adenomatosis (SPA) is a naturally
occurring contagious lung tumour of sheep which has
been associated aetiologically with a type D- and B-
related retrovirus (Jaagsiekte retrovirus; JSRV). To
improve understanding of the aetio-pathogenesis of
SPA, the distribution and the sites of JSRV replication
in sheep with naturally or experimentally induced SPA
or in unaffected controls were identified. New immuno¬
logical reagents were produced and a blocking enzyme-
linked immunosorbent assay (B-ELISA) and an immuno-
histochemical technique for the detection of JSRV
major capsid protein at the tissue and cellular levels were
developed. JSRV was detected only in the respiratory
tract of sheep affected by pulmonary adenomatosis and
specifically in the transformed epithelial cells of the
alveoli of SPA-affected sheep.
Introduction
Retroviruses related to the type D viruses of primates
have been demonstrated in the house shrew (Tsutsui et
a/., 1985; Aoyama et al., 1988), sheep (Sharp & Herring,
1983; He et al., 1992; De las Heras et al., 1993), cattle
(York et al., 1989) and goats (De las Heras et al., 1991).
Of these type D viruses, only the simian retroviruses and
the small ruminant retroviruses have been associated
with any disease (Marx & Lowenstine, 1987; Sharp,
1987). The small ruminant viruses have been associated
with three contagious tumours, sheep pulmonary adeno¬
matosis (syn. SPA, jaagsiekte, ovine pulmonary car¬
cinoma) (Sharp & Angus, 1990), enzootic nasal tumour
of sheep (De las Heras et al., 1993) and enzootic nasal
tumour of goats (De las Heras et al., 1991), all of which
arise from secretory epithelial cells in the respiratory
tract.
Each of these tumours has been shown consistently to
contain a retrovirus with morphological, biochemical
and immunological properties similar to type D retro¬
viruses and cell-free tumour extracts can be used to
reproduce these diseases experimentally (Cohrs, 1953;
Martin et al., 1976; Verwoerd et ah, 1980; Sharp et al.,
1983; DeMartini et al., 1988; De las Heras et al., 1995).
* Author for correspondence. Fax +44 131 6648001. e-mail
sharm@mri.sari.ac.uk
Further, the incubation period of experimentally induced
sheep pulmonary adenomatosis (SPA) can be reduced to
a few weeks or days (Verwoerd et al., 1980; Sharp et al.,
1983) and has been shown to be inversely related to the
reverse transcriptase activity in the inoculum (Verwoerd
et al., 1985). Although several lines of evidence implicate
a retrovirus, known as Jaagsiekte retrovirus (JSRV) in
the aetiology of SPA (reviewed by Sharp, 1987),
obtaining definitive proof by classical approaches has
been impeded by the absence of a cell culture system to
propagate JSRV and a lack of reagents and techniques to
undertake studies on the pathogenesis of the disease.
Recently, one strain of JSRV has been cloned and the
full-length genomic sequence determined (York et al.,
1991, 1992). This virus exhibits the typical genomic
organization of a replication-competent type D retro¬
virus with LTR, gag, pro, pol and env regions; there are
no apparent sequences commonly associated with trans¬
formation (York et ah, 1992). Southern hybridization
has revealed that numerous related sequences are present
in the genomes of both unaffected sheep and goats (York
et ah, 1992; Hecht et ah, 1994), which raises the question
of whether JSRV is involved in the aetiology of SPA or
is an endogenous homologue reactivated during the
neoplastic process. The availability of one sequence of
JSRV permitted new approaches in the investigation of
the aetio-pathogenesis of SPA. Studies were undertaken,
therefore, to examine the distribution and sites of
replication of JSRV in SPA-affected and unaffected
0001-3373 © 1995 SGM
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sheep to better define the role of type D retroviruses in
the aetiology of SPA.
Methods
Subcloning and expression of clone Js382. Standard molecular
biology procedures were used as described by Sambrook el al. (1989)
and will not be reported in detail. Plasmid pBluescript-Js382 containing
a part of the JSRV gag gene (bases 953 to 3030 of the nucleotide
sequence published by York et al., 1992) was a gift from G. Querat
(Marseilles, France). Briefly, the insert fragment was excised by £coRI,
subcloned into plasmids pMSIS (Sherf el al., 1990; supplied by M.
Shreiber) and pGEXl/.T (Pharmacia) and expressed in E. coli host
strain NM522 as /5-galactosidase (/?gal-CA, plasmid pMCA) and
glutathione ^-transferase (GST-CA, plasmid pGCA) fusion proteins
respectively.
Confirmation that the gag gene was in the correct reading frame was
obtained by sequencing across the vector-insert junction, as well as
testing clones for production of /i-galactosidase and GST fusion
proteins of the appropriate size by Western blotting (immunoblot)
analysis with a goat antiserum to Mason-Pfizer monkey virus major
capsid protein (MPMV-CA) (ref. 75S-148, National Cancer Institute
Repository) (Sharp & Herring, 1983).
Transformed bacteria were grown and induced with isopropyl f-D-
thiogalactopyranoside (IPTG) for the expression of recombinant
proteins. Bacteria were pelleted (5000# for 10 min) and resuspended in
20 ml TE (10mM-Tris pH 7-5, 1 mM-EDTA). Phenylmethylsulphonyl
fluoride (2 mM) was added before lysing the cell suspension in a French
press at 1500 p.s.i. (10-35 MPa). The lysate obtained was sonicated and
clarified at 100000 g at 4 °C for 10 min.
/?gal-CA fusion protein was purified by affinity chromatography
using a 4 ml column of aminobenzyl l-thio-/i-galactopyranoside
(ABTG) agarose (Sigma) as previously described (Cameron et al.,
1994). GST-CA was purified by affinity chromatography using a 4 ml
column of glutathione-Sepharose (Pharmacia) as recommended by the
manufacturers.
The yield of soluble /igal-CA was approximately 9 mg/1 of bacterial
culture at about 75% purity as estimated by SDS-PAGE. GST-CA
could not be eluted with free glutathione from the Sepharose beads as
recommended by the manufacturers and was therefore further used
coupled to the beads to immunize rabbits.
Production of rabbit polyclonal antiserum to JSRV-CA. A specific
rabbit antiserum to JSRV-CA was prepared by immunizing rabbits
with 500 pg /igal-CA combined with Freund's incomplete adjuvant.
After 15 days the rabbit was boosted with 500 pg of GST-CA bound
to the glutathione-Sepharose beads. A third injection of GST-CA
(500 pg) was given after 4 weeks and the rabbit was bled 15 days after
the last injection.
To avoid non-specific reactions in the B-ELISA and in the
immunohistochemical study, the antiserum obtained was absorbed
overnight at 4 °C with a lysate of IPTG-induced NM522(pMSlS) cells.
The serum was then centrifuged at 100000 g for 30 min to pellet any
bacterial debris, aliquoted and stored at —20 °C until used.
By Western blotting the rabbit antiserum recognized the two
recombinant proteins /(gal-CA and GST-CA, as well as the native
25 kDa CA in JSRV. There was no reaction with any other protein in
sucrose gradient purified JSRV (data not shown).
Sources and preparation of samples. In this study, SPA sheep were
defined as animals which showed typical clinical signs, particularly the
production of an abundant sero-mucoid fluid (lung fluid) from the
nostrils when the rear limbs were elevated above the head, and
confirmed by macroscopic and histological examination of the lungs.
To determine the best conditions for the B-ELISA and to assess its
specificity and its inter- and intra-assay variability the following
samples were employed: (a) two different pools of lung fluid (LFP#1
and 2) collected from several SPA sheep (in these samples the presence
of JSRV was confirmed by Western blotting); (b) sucrose gradient
purified maedi-visna virus (MVV); (c) a lysate of NM522(pMSlS) cells
induced with IPTG to provide a /I-galactosidase control; (d) a lysate of
NM522(pGexl/.T) cells induced with IPTG to provide a GST control.
LFP# 1 was filtered through a double layer of gauze and clarified by
centrifugation at 10000 g for 1 h at 4 °C. The resultant supernatant was
aliquoted and stored at —70 °C until use.
JSRV was extracted from LFP#2 as described by Herring et al.
(1983). Briefly, LFP#2 was filtered, clarified and the supernatant was
then centrifuged at 100 000 g through a double layer of glycerol
(25/50%, v/v) for 1 h at 4 °C. An aliquot of the supernatant was stored
at —70 °C before and after the ultracentrifugation step. The resultant
pellet was resuspended in TNE buffer (100mM-NaCl, 10mM-Tris,
1 mM-EDTA) and further purified by isopycnic centrifugation on 20 to
55% (w/w) sucrose gradients. The gradient was fractionated and each
0-5 ml fraction was resuspended in 4-5 ml TNE buffer, centrifuged at
100000 g for 1 h at 4 °C and the resultant pellet resuspended in 100 pi
TNE.
For analysis of the distribution of JSRV in affected and unaffected
animals, samples were collected from: (a) nine sheep naturally affected
by SPA; (b) 16 lambs, experimentally infected as previously described
(Sharp et al., 1983); (cj 16 age and breed-matched controls.
Samples of lung, lung tumour, mediastinal and retropharyngeal
lymph nodes, thymus, tonsils, Peyer's patches, spleen, bone marrow
and kidney were collected during the post-mortem examination or
immediately before the sheep were killed (lung fluid and heparinized
blood samples). Lung fluid samples were filtered, clarified at 10000#
for 1 h at 4 °C and the resultant supernatants were stored at —70 °C.
Plasma samples (8 ml per sample) were further centrifuged at 100000 g
for 1 h at 4 °C and the pellets resuspended in 65 pi of TNE before
storing at — 70 °C until use. Leukocytes were obtained from blood
samples in which the red cells had been lysed. Each leukocyte sample
(7 x 10? cells) was diluted in TNE, freezed/thawed three times, and
clarified and centrifuged as described above. After the ultra¬
centrifugation step, pellets were resuspended in 65 pi of TNE and
stored at —70 °C.
Tissues samples were homogenized [10% (w/v) suspension in TNE].
filtered, clarified and centrifuged as above. All tissue samples were
concentrated 400 times except tonsils which were concentrated only
100 times due to the small size of this organ. Tissues extracts were kept
at —70 °C until further use.
Blocking enzyme-linked immunosorbent assay (B-ELISA). The SPA
B-ELISA (Engvall & Perlmann, 1971) depends on the presence of
JSRV in the test samples to inhibit the binding between purified
/Igal-CA and the rabbit antiserum to JSRV-CA.
Equal volumes of the test sample and washing fluid B [WFB; PBS,
0-5% (w/v), Tween 20, 1 mM-EDTA and 350 mM-NaCl] were reacted
at room temperature for 1 h in order to disrupt the envelope of JSRV
and release the capsid of the virions. WFB was also used as washing
buffer for the ELISA plates and as dilution buffer for the reagents of
the reaction. The optimal concentrations of /Igal-CA and the rabbit
antiserum were determined before use. Microtitre plates were coated
with 100 pi of purified y?gal-CA (1-5 pg/ml), diluted in carbonate buffer
(pH 9-6), by absorbing overnight at 4 °C in a humid chamber. After
incubation, the plates were washed with WFB and blocked by
incubation for 1 h at 37 °C with a 1 % (w/v) solution of bovine serum
albumin in PBS.
The antiserum and test samples were reacted first in a V-bottom
"transfer' plate (65 pi of 1:800 dilution of rabbit antiserum to JSRV-
CA+65 pi of test samples pre-treated with WFB) for 1 h at 37 °C.
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Thereafter, 100 |tl of the resulting mixture (rabbit serum + sample) was
transferred to the pre-coated ELISA plates, which had been washed
three times with WFB.
The ELISA plates were incubated at 37 °C for 1 h and, after washing,
100 pi of pig antiserum to rabbit IgG conjugated to horse-radish
peroxidase (DAKO; 1:1000 in WFB) was added to each well. After
incubation at 37 °C for 1 h, the plates were washed again with WFB
and 100 |tl of substrate (o-phenyldiamine; Sigma)+ 0-05 % H.,0, (30%,
v/v) was added to each well. The colour development was stopped with
2-5 m-H,S04 and the plates read using a Dynatech MR5000 apparatus
at 490 nm.
Samples were tested in duplicate in each test. Controls included wells
with no inhibitor (0% blocking), and wells with neither inhibitor nor
serum (100% blocking), the missing component being replaced with
diluent (WFB).
Results are expressed as a percentage blocking value calculated using
the following formula
% blocking value = [(OD0-ODtest)/(OD0-OD100)] x 100
where OD0 is the OD at 0% blocking control, OD100 is the OD at
100% blocking control and ODtest is the OD of the test sample.
The intra-assay standard deviation was evaluated testing LFP#1
across the ELISA plate in five different plates and calculating the mean
between the standard deviations obtained in each plate. The inter-assay
standard deviation was calculated assaying LFP#1 in ten independent
tests performed on different days. LFP#1 was located in the same wells
on the ELISA plate on each occasion.
Western blotting. Western blotting was performed on the purified
/?gaI-CA and GST-CA and on LFP# 1 sucrose gradient purified
fractions employing goat antiserum to MPMV-CA and the rabbit
antiserum to JSRV-CA as described previously (Sharp & Herring,
1983).
Immunohistochemistry, Tissue samples used in immunohisto-
chemistry studies were collected during the post-mortem examination
from four SPA-affected sheep (three experimentally infected lambs and
one natural case of SPA) and three uninfected controls. The same
tissues as collected for the B-ELISA were fixed in 10% neutral buffered
formalin, processed routinely in an automatic tissue processor,
embedded in paraffin wax and sectioned at 4-6 pm. Selected sections
were stained immunohistochemically using a commercial avidin-biotin
peroxidase complex kit (Vectastain ABC kit; Vector Laboratories) as
recommended by the manufacturers except that sections were treated
additionally with 01 % (w/v) trypsin in TBS for 30 min at 37 °C. The
rabbit antiserum to JSRV-CA was used as primary antibody at the
predetermined optimal dilution of 1:50. This serum was substituted
with TBS to control for the endogenous peroxidase activity of the tissue
or with rabbit pre-immunization serum to check for non-specific
reactions. Carazzi's haematoxylin was used as a counterstain.
Results
Development and validation of the B-ELISA
A series of experiments was performed to demonstrate
that the blocking values obtained in the B-ELISA were
the result of the interaction between JSRV-CA and the
rabbit antiserum produced in this study and not due to
non-specific reactions.
The analysis of the 18 fractions of LFP#2 separated by
isopycnic centrifugation showed that the greatest
% blocking values corresponded to fractions having a
buoyant density between 1-16 g/ml to 1-19 g/ml, with a
















































Fig. 1. Percentage blocking value of LFP#2 after isopycnic centri¬
fugation in 20 to 55% (w/w) sucrose gradients. The continuous line
shows the % blocking values; the broken line shows density (g/ml)
after sucrose gradient centrifugation.
(Sharp & Herring, 1983) (Fig. 1). The same fractions
analysed by Western blotting, employing a goat anti¬
serum to MPMV-CA and the rabbit serum produced in
this study showed a single polypeptide with an Mr of
about 25000, the predicted Mt of JSRV-CA.
In LFP#2 the blocking value before ultra-
centrifugation was 63% which was reduced to 10% for
the post-centrifugation supernatant demonstrating that
the blocking activity was particle-associated, and did not
arise as a result of antibodies specific for JSRV-CA that
might have been present in the lung fluid. In other
experiments maedi-visna virus, another retrovirus of
sheep which is occasionally found to coinfect SPA-
affected animals (Rosadio et ai, 1988n, b), the /?-
galactosidase control and the GST control gave
% blocking values less than 7.
These data demonstrate that the blocking value of the
SPA B-ELISA depends on the presence in the test
samples of the major capsid protein (CA) of JSRV.
The intra-assay standard deviation was + 1-6% while
the inter-assay standard deviation was ±4-6%.
Distribution of JSR V viral particles in tissue extracts of
SPA-ajfected and unaffected sheep
Following the successful development of the B-ELISA to
detect JSRV-CA, this assay was used to examine the
anatomical distribution of JSRV in sheep. The samples
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Table 1. Results of the B-ELISA on tissues of SPA affected and unaffected sheep
Sample
SPA + * SPA-t
% blocking value (±SE) % blocking value ( + SE) n
Lung tumour/lung 77-8 ( + 4-8)§ 13 17 (±1-8) 13
Lung fluid 68-4 (±3-3) 15 - -
Maediastinal lymph nodes 15-2 ( + 3-7) 12 6-2 (±2-1) 8
Retropharyngeal lymph nodes 6-6 (±1-4) 8 7-0 ( + 2-4) 7
Tonsils 4-7 ( + 2-3) 9 3-7 (±1-5) 9
Bone marrow 40-2 (±4-06) 6 45-2 ( + 5-7) 6
Thymus 18-7 (±3-8) 7 13-1 ( + 2-7) 13
Peyer's patches 12-6 ( +1) 5 7-8 (±2-7) 6
Spleen 18-7 ( + 2-7) 9 16-1 ( + 3-9) 8
Kidney 6-5 (±2-9) 8 8-3 ( + 4-1) 7
Plasma 10-8 ( + 3) 10 7-6 ( + 3-1) 5
Leukocytes 12-4 ( + 2-2) 10 13-4(4-1-1) 5
* SPA-affected animals,
f Unaffected controls.
J Number of samples tested.
§ Standard error of the mean.
Fig. 2. (a, b) Immunohistochemistry of a lung section of a sheep affected by SPA (bars, 40 pm; magnification 250 x ). The dark staining
represents the positive reactions and is confined to the cytoplasm of the transformed cells of the adenoma. No staining is apparent inthe extracellular airway spaces. A papillary projection of the tumour in the bronchiolus is visible in (b). The dark staining is confined
to the neoplastic cells. No staining is observed in the interstitial cells or in the untransformed alveolar cells and bronchiolar cells.
tested were obtained by ultracentrifugation and therefore
reflected the presence of JSRV viral particles. Statistical
analysis of the differences between SPA-affected and
unaffected animals was undertaken using Student's t-
test. Results are summarized in Table 1.
Only tumour and lung samples showed a significant
difference between affected and unaffected sheep (P <
0-00001). The mean % blocking value of tumour samples
was 77-8 with values ranging from 41 to 93 while normal
lung samples had a mean % blocking value of 17 with a
range from 0 to 33.
A % blocking value of 36 was selected as the highest
negative value calculated from the mean blocking value
of control lungs plus 2-5 standard deviations. When this
value was used no false positive or false negative samples
were observed.
No significant difference was observed between the
mean blocking values obtained using lung tumour
samples collected from natural or from experimentally
induced cases of SPA. Lung fluid samples from SPA
cases showed a high % blocking value (mean = 68-4)
with values ranging from 49 to 92 but because healthy
sheep do not produce collectable quantities of lung fluid
no direct control for this sample could be obtained. The
closest control for the lung fluid samples was broncho-
alveolar lavages from unaffected sheep, in which
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% blocking values were always under 18 (data not
shown).
In all the other tissues examined there was no
statistically significant difference between SPA-affected
and unaffected sheep with the exception of a single
maediastinal lymph node sample, collected from a
natural case of SPA. This sample had a % blocking value
of 53, markedly greater than the mean % blocking value
of equivalent tissues in control animals (6-25).
Bone marrow samples showed a high mean blocking
value in both affected and unaffected controls. The mean
% blocking values were 40-2 for SPA sheep and 45-2 for
the unaffected controls. These high % blocking values
are probably an artefact due to the nature of the sample
after processing. The preparation of this tissue as
described in Methods resulted in a viscous pellet which
therefore could have blocked the reaction non-
specifically. Further dilutions or sucrose gradient purified
samples resulted in the almost complete loss of blocking
activity and no specific reaction in this tissue was found
by immunohistochemistry (see below) or Western blot¬
ting.
Cellular localization of JSRV-CA
Immunohistochemical analysis showed that JSRV major
capsid protein was detected in the cytoplasm of
recognizable alveolar neoplastic cells in all four SPA
lungs examined (Fig. 2a, b). There was no staining of the
epithelial non-transformed cells nor of the interstitial
cells. Specific staining in the extracellular airway spaces
was observed very rarely. No specific staining was
detected in any other tissue.
Discussion
The results of this study using immunological techniques
have shown that JSRV virions and CA were detected
only in the respiratory tract of sheep affected by SPA.
These findings have confirmed earlier reports describing
type D retrovirus antigens or reverse transcriptase
activity in respiratory tissues of SPA sheep (Perk et al.,
1974; Martin et al., 1976; Herring et al., 1983; Sharp &
Herring, 1983; Verwoerd et al., 1983; Rosadio et al.,
1988 a) and extended these observations by demon¬
strating that JSRV was not detected in 172 samples from
eight other tissues from 41 sheep, although viral
expression, below the detection limit of the B-ELISA,
may be occurring in other tissues.
Immunohistochemistry supported the above con¬
clusion and further indicated that JSRV replication
occurred primarily in the transformed epithelial cells in
the pulmonary alveoli of SPA sheep. A notable exception
was the positive result obtained with a single lymph node
from a field case of SPA that probably arose as a
consequence of metastatic events, which are known to
occur in a proportion of cases (Nobel et al., 1969).
Although immunohistochemical studies employing a
heterologous antiserum to MPMV-CA detected putative
JSRV antigens in the alveolar lumina, rather than
intracellularly (Payne et al., 1986), and therefore conflict
with those reported here, the observations of the present
communication, obtained with an homologous anti¬
serum, are in agreement with earlier ultrastructural
studies describing intracytoplasmic type A particles in
the epithelial tumour cells and, associated with these
cells, a few extracellular particles with typical type D
morphology (Perk et al., 1971; Sharp et al., 1983; Payne
et al., 1983).
The above findings point to the epithelial tumour cells
in the alveoli as the major site of translation and
assembly of JSRV and highlight the strict association
between JSRV and the tumour. These findings, therefore,
provide further support for the notion that JSRV is the
aetiological agent of SPA. Although most type D
retroviruses appear not to be pathogenic, a simian type
D retrovirus (SRV 2) has been associated aetiologically
with retroperitoneal fibromatosis in macaques (Bryant et
al., 1986) and the other sheep and goat type D-related
viruses have been implicated in epithelial tumours (De
las Heras et al., 1991, 1993, 1995; Vitellozzi et al., 1993).
Thus, in contrast to other retrovirus models involving
leukaemogenic viruses, these sheep and goat retroviruses
may represent unique models of oncogenic retroviruses
associated with the development of naturally occurring
epithelial carcinomas (Cremer & Gruber, 1992).
Whilst the circumstantial evidence implicating JSRV
in neoplasia is compelling, the existing information does
not rule out other possibilities in which it may, or may
not, be involved in the neoplastic processes. JSRV may
be acting only as a helper for some other replication-
defective, acutely transforming retrovirus or result from
reactivation of endogenous viral sequences as a conse¬
quence of neoplasia, as seen with other endogenous
retroviruses (Weiss et al., 1985). The presence of up to 15
to 20 copies per genome of sequences related to the gag,
pol and env genes of JSRV (York et al., 1992; Hecht et
al., 1994) introduces major complications, particularly as
endogenous retroviruses have been demonstrated in
mice, chickens and cats to be involved in recombination
events leading to the generation of oncogenic retroviruses
(Stoye et al., 1991; Golovkina et al., 1994; McDougall et
al., 1994; Bai et al., 1995). The occurrence of such events
in SPA could be indicated by the apparent lack of serum
antibodies to JSRV-CA in affected sheep or their
unaffected flockmates (Sharp & Herring, 1983). It is
clear, therefore, that further studies will be required to
determine the role of JSRV in the aetiology of SPA and
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the relationship between the exogenous and endogenous
viruses.
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Sheep pulmonary adenomatosis ([SPA] ovine pulmonary carcinoma) is a transmissible lung cancer of sheep
that has been associated etiologically with a type D- and B-related retrovirus (jaagsiekte retrovirus I.JSRV]).
To date it has been impossible to cultivate JSRV in vitro and therefore to demonstrate the etiology of SPA by
a classical approach. In addition, the presence of 15 to 20 copies of endogenous JSRV-related sequences
(enJSRV) has hampered studies at the molecular level. The aim of this study was to investigate whether the
expression of exogenous JSRV was specifically associated with neoplasia in SPA-affected animals. Initially, we
found that enJSRVs were transcribed in a wide variety of normal sheep tissues. Then, by sequencing part of the
gag gene of enJSRV we established a Seal restriction site in gag as a molecular marker for the exogenous form
of JSRV. Restriction enzyme digestion of PGR products obtained from the amplification of cDNA from a total
of 65 tissues collected from SPA-atfected and unaffected control sheep revealed that the exogenous form of
JSRV was exclusively and consistently present in tumor tissues and lung secretions of the affected animals. In
addition, exogenous JSRV provirus was detected only in DNA from SPA tumors and not from nontumor tissues
of the same animals. This study has demonstrated clearly that the exogenous form of JSRV is specifically
associated with SPA tumors.
Retroviruses are an invaluable model system for under¬
standing carcinogenesis and the regulation of normal cell
growth. Studies of spontaneous retrovirus-induced animal and
human lymphomas have contributed immensely to our knowl¬
edge of the onset of cancer (5), yet relatively little information
is available concerning retroviral causes and mechanisms of
epithelial cell neoplasms which, in humans, are much more
frequent than lymphomas (39).
Sheep pulmonary adenomatosis (SPA; also known as jaag¬
siekte and ovine pulmonary carcinoma) represents a unique
model of a naturally occurring epithelial neoplasm which is
associated etiologically with a retrovirus (6, 35). Interestingly,
SPA shares certain characteristics with human bronchoalveo-
lar cell carcinoma (13, 29), which is only weakly associated with
smoking (10, 16, 21) and which has dramatically increased in
prevalence since 1955 and now represents 24% of lung cancers
(3).
Several lines of evidence implicate retroviral involvement in
the etiology of SPA. SPA has been reproduced experimentally
by inoculating sheep with cell-free lung secretions (lung fluid)
or tumor extracts from SPA-affected animals (7, 24, 36, 42).
These materials have been shown consistently to contain a
retrovirus with morphological, biochemical, and immunologi¬
cal properties similar to type D and B retroviruses (20, 30, 32,
38). This virus, known as jaagsiekte retrovirus (JSRV; also
known as SPA retrovirus and ovine pulmonary carcinoma ret¬
rovirus), exhibits the typical genomic organization of a repli¬
cation-competent retrovirus with long terminal repeat (LTR),
gag, pro, pol, and env regions and no apparent sequences com¬
monly associated with transformation (43). Despite the clear
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association between JSRV and pulmonary adenomatosis, clas¬
sical approaches to demonstrate an etiological role for this
virus have been hampered by the lack of a cell culture system
to propagate JSRV.
Recently, the link between JSRV and SPA was strengthened
further by the demonstration that lung and transformed pul¬
monary epithelial cells of SPA-affected sheep are major sites of
virus replication. JSRV particles or antigens have never been
detected in tissues of unaffected control sheep (27). In addi¬
tion, the presence of 15 to 20 copies of endogenous JSRV-
related sequences (enJSRV) in the normal sheep genome has
hampered analysis at the molecular level (19, 43). No infor¬
mation is available about enJSRV sequences and their degree
of similarity with the exogenous JSRV. Therefore, the possi¬
bility cannot be excluded that expression of the exogenous
virus in neoplastic cells is the result of the reactivation of an
enJSRV as a downstream event of the neoplasia.
The aim of this study was to investigate expression of JSRV
in tumor tissues and whether it is specifically associated with
neoplasia. Initially, the expression of JSRV-related sequences
in tissues of SPA-affected and unaffected control sheep was
determined by reverse transcription-PCR (RT-PCR). Differ¬
entiation between exogenous and endogenous RNA species
was evaluated by sequencing and/or restriction enzyme diges¬
tion of PCR products obtained from viral pellets and tumors of
SPA-affected sheep and tissues of unaffected sheep. Compar¬
ison between tumor and nontumor genomic DNA collected
from the same SPA-affected animals was then performed in
order to determine whether the exogenous proviral JSRV was
detectable only in genomic DNA from tumor tissues.
MATERIALS AND METHODS
Sources and preparation of samples. In this study, SPA-affected sheep were
defined as animals which showed typical clinical signs, particularly the produc-
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TABLE 1. Tissues examined by RT-PCR (gag) followed by Sea I digestion in SPA-affected and unaffected control sheep
SPA+" SPA-'
Tissue PCR Seal digestion PCR Seal digestion
(no. tested/no. positive) (no. tested/no. sensitive) (no. tested/no. positive) (no. tested/no. sensitive)
Lung fluid 16/16 16/16
Tumor/lung 5/5 5/5 4/4 4/0
Kidney 3/3 3/0 3/3 3/0
Thymus 2/2 2/0 3/3 3/0
Bone marrow 3/3 3/0 3/3 3/0
Spleen 2/2 2/0 3/3 3/0
Mediastinal lymph node 5/5 5/3 3/3 3/0
Leukocytes 5/5 5/0 5/5 5/0
Total 41/41 41/24 24/24 24/0
a SPA-affected sheep.
h Unaffected control sheep.
tion of abundant seromucoid fluid (lung fluid) from the nostrils when the rear
limbs were elevated above the head. Diagnosis was confirmed by macroscopic
and histological examination of the lungs. Both naturally SPA-affected animals
and lambs infected by intratracheal inoculation of concentrated lung fluid, as
previously described (36), were used in this study. In addition, age- and breed-
matched controls were employed.
A total of 16 lung fluid samples were collected during clinical examinations of
SPA-affected sheep and processed as already described (38). Briefly, 5 to 10 ml
of lung fluid was filtered through a double layer of gauze and clarified by
centrifugation at 10,000 X g for 1 h at 4°C. The supernatant was then centrifuged
at 100,000 X g through a double layer of glycerol (25 and 50% [vol/vol]) for 1 h
at 4°C, and the resultant pellet was resuspended in 500 pi of solution D (4 M
guanidinium thiocyanate, 25 mM sodium citrate [pH 7], 0.5% sarcosyl, 0.1 M
0-mercaptoethanol) and stored at -20°C until use. Leukocytes were obtained
from 10 blood samples in which the erythrocytes had been lysed. A total of 107
cells for each sample were resuspended in 500 pi of solution D and stored at
—20°C.
Tissues from five lung tumors, four normal lungs, eight mediastinal lymph
nodes, five thymus glands, six bone marrow samples, five spleens, and six kidneys
of both SPA-affected and unaffected sheep were collected at postmortem exam¬
ination (Table 1) and snap-frozen in liquid nitrogen before storage at -70°C.
Dog lung tissues were treated as the sheep tissues and used as negative controls.
An equine dermis cell line and primary fetal lamb lung and kidney cells were
employed as further controls in this study. Cells (107) were resuspended in 500
pi of solution D and stored at —20°C.
RNA extraction. Total RNA from ultraspeed pellets of lung fluid (2.5 to 5.0
ml), sheep tissues, and dog lung tissues (0.2 to 0.5 g), leukocytes, equine dermis
cells, and fetal lamb lung and kidney cells (107 cells) was extracted by the acid
guanidinium thiocyanate-phenol-chloroform method (4). Each RNA sample was
treated with 10 U of DNase I, RNase free (Boehringer), as suggested by the
manufacturer.
DNA extraction. High-molecular-weight genomic DNA was extracted by es¬
tablished procedures (34) from lung tumor and kidney samples from four of the
five SPA-affected animals and from lung and kidney tissues from three of the
four unaffected controls. DNA was also isolated from primary cultures of normal
sheep skin fibroblasts for analysis of the LTRs (see below). Briefly, pulverized
tissue or cell pellets were lysed in TES buffer (10 mM Tris, 0.1 M EDTA, 0.5%
sodium dodecyl sulfate [pH 8]) followed by digestion with RNase A (Sigma; 20
pg/ml) for an hour at 37°C with gentle mixing, then 100 pi (20 pg/ml) of
proteinase K was added and incubated at 60°C overnight. Separate phenol and
chloroform-isoamyl alcohol (24:1) extractions were followed by isopropanol pre¬
cipitation. High-molecular-weight DNA was harvested by spooling it onto glass
pipettes and was washed twice with 70% ethanol on ice, dried, resuspended in
TE buffer (10 mM Tris, 1 mM EDTA [pH 8]), and stored at 4°C.
RT-PCR (gag). Synthesis of cDNA was carried out in 25-pl reaction volumes
as follows. Total RNA (2 pg from tissues, leukocytes, and cell culture samples or
total RNA obtained from ultraspeed pellets of 5 to 10 ml of lung fluid) was
diluted in 13.5 pi of diethyl pyrocarbonate-treated distilled water. RNA was
denatured at 65°C for 10 min and then cooled on ice. One microliter (40 U) of
rRNAsin (Promega)-2 pi of 25 mM each deoxynucleoside triphosphate (dNTP)-
2.5 pi of 100 mM dithiothreitol—2.5 pi (A2M), 62.5 U/ml [Boehringer]) of random
hexamers-2.5 pi of 10X reaction buffer (500 mM Tris-HCl [pH 8.3], 75 mM KC1,
3 mM MgCl2)-l pi of StrataScript reverse transcriptase (50 U; Stratagene) was
added. The addition of the reverse transcriptase was omitted in control samples
to check for DNA contamination of the RNA preparations. The reaction mixture
was incubated at 37°C for 1 h, and then the enzyme was inactivated by incubation
at 94°C for 3 min.
Amplification of the resultant cDNA was carried out by PCR. Primers were
designed on the basis of the complete sequence of JSRV (43) and the pCAl
sequence of gag (19). Primers PI and P2 (Fig. 1A) spanned a 229-bp region
internal to the gag gene (position 1598 to 1826 of JSRV) (43) (sense [PI],
5'-GCTGCTTTRAGACCTTATCGAAA-3'; antisense [P2], 5'-ATACTGCAG
CYCGATGGCCAG-3'). Three microliters of cDNA was added to 47 pi of lx
PCR buffer (1.25 U of Taq polymerase [Boehringer], 2.75 mM MgCl2, 50 mM
KC1, 10 mM Tris-HCl, 200 pM each dNTP, 6.25 pmol of each primer). PCR
cycles employed were 94°C for 1 min and 35 cycles of 94°C for 45 s, 57°C for 1
min, and 72°C for 1 min, with a final extension of 72°C for 2 min in a Perkin-
Elmer GenAmp 2400 thermal cycler.
PCR was optimized for the detection of 1 to 10 copies of target DNA, using
plasmid pJS382 (courtesy of G. Querat) containing part of the JSRV gag gene
(nucleotide 953 to 3029) as template. Amplified products were detected by
electrophoresing 25-pl aliquots through a 2% agarose gel in lx TBE buffer in
the presence of 0.5 pg of ethidium bromide per ml.
The products of five independent PCR -gag procedures with kidney cDNA















FIG. I. PCR strategy and localization of primers employed in this study. (A)
RT-PCR (gag), employing primers PI and P2, amplified a product of 229 bp. (B)
PCR for the amplification of endogenous LTRs employed primers P3 and P4 and
generated products of 442 to 444 bp. (C) Heminested LTR-gag PCR. The first
round of amplification used primer P5 (internal to the LTR) and gag primer P2.
One microliter of this reaction mixture was used in the second round of ampli¬
fication. which used primers PI and P2.
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i ......... 100
JSRV GCTGCTTTGAGACCTTATCGAAAAAAGGGAGATCTATCTGATTTTATTCGCATTTGTGCTGATATTGGACCCTCCTACATGCAAGGCATTGCTATCGCAG
pCAl A T C G T G
enJSRV gagl G C
"2 G G C
"3 G C C
"4 A G C T
Seal
101 . . / . . . . . 200
JSRV CAGCATTACAAGGAAAAAGCATAAAAGAAGTACTTTTCCAGCAGCAAGCCCGGAACAAGAAAGGACTTCAAAAGTCAGGTAATTCGGGTTGCTTTGTTTG
pCAl G G A A A TATA G A A C
enJSRV gagl G T
"2 G T
"3 T G T A TA
"4 G T GC G T







FIG. 2. Comparison of enJSRV gag sequences and exogenous pCAl (19) with JSRV (43). Indicated are base ditferences with JSRV. Primers used are underlined,
while the boldface bases indicate the exogenous-specific Seal site.
mega), following the manufacturer's protocol. Seven clones were selected and
sequenced with the T7 sequencing kit (Pharmacia), as recommended by the
manufacturer.
Restriction enzyme digestion. Twenty-five microliters of the PCR-gag product
was digested with 13 U of Seal (Boehringer), employing the appropriate incu¬
bation buffer supplied by the manufacturer (PCR buffer was ignored), at 37°C for
2 to 4 h. The digestion products were analyzed alongside the corresponding
mock-digested PCR products, by electrophoresis in a 2% agarose gel stained
with ethidium bromide.
Amplification and sequencing of endogenous LTRs. One hundred nanograms
of high-molecular-weight genomic DNA isolated from sheep skin fibroblasts was
used for PCR amplification of endogenous LTRs (PCR-LTR). Primers (Fig. IB)
were designed at the 5' end of U3 (sense [P3], CTGCGGGGGACGAC, position
7179 to 7193 [43]) and at the 3' end of U5 (antisense [P4], CTGCCGCGAC
CAGCA, position 111 to 125 [43]). The buffer employed was 10 mM Tris (pH
8.9), 50 mM KC1, 2 mM MgCl2, with 200 p,M each dNTP, 100 ng of primers, and
1 U of Taq (Boehringer). PCR cycles employed were an initial step of 94°C for
2 min and then 40 cycles of 94°C for 1 min, 58°C for 1 min, 72°C for 1 min, with
a final extension of 72°C for 2.5 min.
The products of three independent PCRs were pooled and then cloned in the
TA cloning system (Invitrogen), according to the manufacturer's instructions.
Three resultant clones were sequenced by the dideoxy chain termination method,
employing a Li-Cor automated sequencer.
Heminested LTR-gag PCR. In the first round of amplification, 250 to 500 ng of
tumor and kidney high-molecular-weight DNA was amplified by PCR, employing
the Expand Long Template PCR system (Boehringer), which uses a mixture of
Taq and Pwo DNA polymerases. The sense primer (P5, TGGGAGCTCTTTG
GCAAAAGCC, nucleotide position 7210 to 7224 [43]) was designed on the basis
of nucleotide sequence differences between the endogenous LTR sequences (1)
and the JSRV sequence (43). Primer P2 was employed as antisense primer (Fig.
1C). Reactions were carried out in a 50-p.l volume containing 50 mM Tris-HCl
(pH 9.2), 160 mM (NH4)2S04, 2.25 mM MgCl2, 2% (vol/vol) dimethyl sulfoxide,
0.1% (vol/vol) Tween 20, 500 p,M each dNTP, 300 nM each primer, template
DNA, and 2.625 U of enzyme mix. Cycles were as follows: 1 cycle at 92°C for 2
min; 30 cycles at 92°C for 10 s, 61°C for 30 s, and 68°C for 90 s (plus a progressive
increment of 20 s from cycle 11 onward); and a final extension of 68°C for 7 min.
One microliter of the product of the first round of amplification was used in
the second round of PCR which was the same as the PCR-gag procedure de¬
scribed above. Half the product of the second-stage PCR was digested with Sea I
as described above.
Products of the first and second rounds of heminested PCR were visualized by
electrophoresis in 1 and 2% agarose gels, respectively.
Nucleotide sequence accession numbers. The nucleotide sequences of the
PCR clones of enJSRVgag fragments and LTRs are deposited in GenBank under
accession numbers Z49800, X92180, X92181, X92182 {enJSRV gagl to -4) and
Z66531, Z66532, Z66533 {enJSRV LTRs 1 to 3).
RESULTS
Detection of enJSRV gag transcripts and differentiation be¬
tween endogenous and exogenous transcripts. RT-PCR (gag),
using the primer pair PI and P2, was used to examine respi¬
ratory and other tissues from both SPA-affected and unaf¬
fected sheep for the presence of JSRV gag transcripts. The
results are summarized in Table 1.
A product of the expected size (229 bp) was detected in all
65 sheep tissue samples tested. Primary cultures of fetal lamb
and kidney cells produced the same visible amplimer, whereas
dog lung tissues and an equine dermis cell line were consis¬
tently negative. To exclude DNA contamination in the total
RNA preparations, the same samples were tested in parallel,
omitting reverse transcriptase from the reaction mix; no signal
was obtained from any of these samples.
The specificity of the amplimers was confirmed by Southern
hybridization with an oligonucleotide probe from a region of
JSRV gag internal to the PCR product (data not shown).
Previous studies have shown consistently that lung fluid and
lung tumor tissues from SPA-affected sheep contain JSRV
particles and antigens (18, 20, 27, 38); therefore, it may be
assumed that the RNA detected in these materials is of ex¬
ogenous origin, while the RNA detected from tissues of
unaffected control animals is transcribed from endogenous se¬
quences. RT-PCR using primers PI and P2 therefore demon¬
strated that transcripts of endogenous origin are widely ex¬
pressed in sheep tissues.
To identify possible differences between endogenous and
exogenous RNA, the RT-PCR products obtained from kidneys
of an unaffected control animal were cloned and sequenced.
Seven clones were sequenced, and four different sequences
(enJSRVgagl to -4) were obtained.
The four enJSRV sequences were compared with each other
and with the published exogenous sequences of JSRV (43)
(South African isolate) and pCAl (19) (Peruvian isolate) by
computer analysis using the GCG Pileup program (14) (Fig. 2).
The South African and the Peruvian isolates were 90% similar
in the stretch of sequence considered. The enJSRV clones were
highly homologous to each other (95 to 99% similarity), 95 to
98% similar to the South African isolate, and 85 to 88% similar
to the Peruvian isolate. Comparison of the restriction maps of
the six sequences revealed a Sea I restriction site in JSRV and
pCAl that was absent in all the enJSRV clones. To confirm this
observation, RT-PCR products from 16 lung fluid samples and
44 nontumor tissues were digested with Seal. Successful diges¬
tion, indicated by the presence of two smaller fragments of 131
and 98 bp, was observed with all 16 lung fluid samples, 5 of 5
tumors, and faintly in 3 of 5 mediastinal lymph nodes from
SPA-affected sheep. No Seal-sensitive product was observed
with any other tissue (Fig. 3).
These findings confirm the complete correlation between
the Seal site and the exogenous virus.







FIG. 3. Typical results of RT-PCR, followed by Seal digestion, of total RNA
from SPA-affected sheep tissues. Samples: 1, lung fluid; 2, lung tumor; 3, medi¬
astinal lymph nodes; 4, kidney (samples 1 to 4 were collected from the same
animal). Lanes: U, mock-digested PCR products; C, PCR product digested with
Seal; M, molecular weight marker IX (Boehringer).
Amplification and sequencing of endogenous LTRs. PCR
products of approximately 450 bp were obtained from the
amplification of DNA from cultured sheep primary skin fibro¬
blast cultures by employing primers P3 and P4. Products were
cloned as described in Materials and Methods, and three
clones were completely sequenced (Fig. 4).
The enJSRV LTRs appeared to be longer (442 to 445 bp)
than the published exogenous LTR (397 bp) which showed
two large deletions of 30 and 16 bp at positions 198 and
261, respectively (nucleotide positions as in Fig. 4). The nucle¬
otide sequences of the three enJSRV LTRs were 83 to 90%
identical and were 69 to 76% similar to the JSRV LTR se¬
quence (43).
Detection of exogenous JSRV in tumors of SPA-affected
sheep. PCR products obtained by direct amplification of tu¬
mor genomic DNA with primers PI and P2 followed by
Seal digestion did not show any cut product by electrophoresis
in an agarose gel stained with ethidium bromide, and hybrid¬
ization of Southern blots with an internal probe did not resolve
this issue (data not presented). The failuie to detect Seal-
sensitive sequences at the DNA level may be due to the high
proportion of endogenous template compared with exogenous
template, resulting in a small proportion of Seal-sensitive
product. Theoretically, there may be 20 endogenous copies
compared with possibly only 1 exogenous copy per neoplastic
cell. Moreover, neoplastic cells arc approximately only 40 to
50% of the total number of cells present in the neoplastic
tissue, therefore increasing the ratio of endogenous to exoge¬
nous sequences.
To preferentially amplify exogenous proviral DNA se¬
quences (with the Seal restriction site) we designed a hemi-
nested PCR. The first round of amplification used a sense
primer (P5) based on an area of sequence divergence between
endogenous LTR clones and the exogenous LTR sequence
(JSRV) and the antisense primer (P2) of the RT-PCR (gag). A
product of about 2 kb was visible in an ethidium bromide
agarose gel from three of four SPA tumor DNAs, while no
signal was obtained in four of four kidney DNAs of the same
animals or from lung and kidney tissues of three unaffect¬
ed control animals. A second round of amplification, using
primers of the RT-PCR (gag) followed by Sea I digestion, en¬
abled the detection of Seal-sensitive sequences in all four tu¬
mors examined, while only spurious bands were detected
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FIG. 4. Sequence alignment of enJSRV LTR clones with the JSRV LTR (43). Letters indicate differences with the consensus sequence. A period (.) indicates
deletions. Primers used to obtain enJSRV clones are underlined.
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FIG. 5. Detection of exogenous JSRV sequences in tumor and kidney DNAs of the same SPA-affected sheep. Lanes 1 to 5 represent experiments performed with
lung tumor genomic DNA. Lanes: 1, 500 ng of lung tumor genomic DNA amplified directly by PCR-gag, employing primers PI and P2; 2, PCR product shown in lane
1 cut with Seal; 3, first round of amplification of heminested LTR-gag PCR, employing primers P5 and P2; 4, second round of amplification, employing primers PI and
P2, of 1 pi of the PCR product shown in lane 3; 5, PCR product of lane 4 cut with Seal. Lanes 6 to 10 represent experiments performed with kidney genomic DNA.
Lanes: 6, 500 ng of kidney genomic DNA amplified directly by PCR-gag, employing primers PI and P2; 7, PCR product of lane 6 cut with Seal; 8, first round of
amplification of heminested LTR-gag PCR, employing primers P5 and P2; 9, second round of amplification, employing primers PI and P2; 10, PCR product shown in
lane 10 cut with Seal. Lane 11 contains a negative control, lanes M contain Boehringer molecular weight markers VI (left) and IX (right).
DISCUSSION
This study has provided compelling lines of evidence which
collectively demonstrate a specific association between the ex¬
ogenous forms of JSRV and SPA.
It was shown clearly that the exogenous form of JSRV was
distinct from endogenous JSRV transcripts as identified by the
presence of a Sea I restriction site in gag (nucleotide position
1729 [43]). Furthermore, this site was conserved in strains of
exogenous JSRV obtained from geographically dispersed
countries, supporting data linking these viruses to each other
and to SPA (18, 20, 27, 28, 33, 38).
Exogenous JSRV RNA was found only in tumors, lung fluid,
and draining lymph nodes of SPA-affected sheep, which is in
agreement with results of an earlier immunological study,
which concluded that epithelial tumor cells are major sites of
replication for JSRV (27). Lung fluid and tumor tissues from
SPA-affected sheep are the only materials that have been used
successfully to reproduce the tumor experimentally in sheep
and goats (7, 24, 36, 37, 42). These findings, therefore, point to
exogenous JSRV as a strong candidate for the etiological agent
of SPA, although they do not rule out possibilities such as
reactivation of an enJSRV as a downstream event of neoplasia.
However, the demonstration of exogenous JSRV provirus only
in tumor DNA provides irrefutable evidence that this virus is
specifically associated with neoplasia. Endogenous JSRV tran¬
scripts were present in a wide variety of tissues from both
SPA-affected and unaffected sheep, although downstream
translation may be very low or absent, because CA protein was
not detected in nontumor tissues (27).
Nevertheless, the presence of transcriptionally active enJSRVs
raises a question about their potential role in SPA. In mice,
chickens, and cats, endogenous retroviruses have been dem¬
onstrated to be involved in recombinational events leading to
the generation of oncogenic retroviruses or viruses with a
broader host range (2, 12, 15, 25, 41). The possibility of re-
combinational events between the exogenous form of JSRV
and its endogenous homologs cannot be ruled out. To clarify
this point, further characterization of endogenous and exoge¬
nous JSRV sequences will be essential as limited sequence
data are available (19, 43).
Comparison of LTR sequences between JSRV and three
enJSRV clones derived from sheep skin fibroblasts revealed
differences in putative enhancer sites. A putative NF-1 motif in
exogenous JSRV LTR (nucleotides 7220 to 7223), which over¬
laps the exogenous-specific PCR primer P5, is altered and/or
lost in the endogenous LTRs, and two tandemly repeated
sequences (positions 7347 to 7365 and 7366 to 7384 in the
JSRV sequence [43]) appear to be lost by means of an inser¬
tion of 30 nucleotides in the endogenous U3. Differences in the
nucleotide sequences in these regions could potentially dimin¬
ish the LTR function (8, 9, 11, 12, 17, 22, 23, 26, 31, 40) and
thus reduce the pathogenicity of enJSRV.s compared with the
exogenous counterpart, as demonstrated in other retroviral
systems.
An interesting finding of this study was the detection of
exogenous JSRV RNA in three of five mediastinal lymph
nodes of SPA-affected sheep. Previous immunological studies
detected JSRV particles in only 1 of 12 regional lymph nodes
of SPA-affected sheep (27). The detection of the exogenous
JSRV in the majority of regional lymph nodes by RT-PCR may
reflect the presence of metastases, although these were not
detected by histological examination (data not shown), or may
reflect the presence of the virus in the lymph drained by the
regional lymph nodes at levels below the detection limit of the
immunological techniques. Because of the lack of data on the
immune response to JSRV, we cannot determine whether the
presence of JSRV in the lymph nodes is related to an active
immune response to the virus.
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To date, JSRV has not been isolated in vitro, and therefore
classical approaches to demonstrate the etiology of SPA have
been impossible. However, the results reported in this commu¬
nication show that exogenous JSRV is consistently and exclu¬
sively demonstrated in tumors and lung fluids, which have been
used as inocula to induce SPA on numerous occasions (7, 24,
36, 42).
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Jaagsiekte retrovirus establishes a disseminated infection of
the lymphoid tissues of sheep affected by pulmonary
adenomatosis
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Jaagsiekte retrovirus (JSRV) is an exogenous type D-
related retrovirus specifically associated with a
contagious lung cancer of sheep (sheep pulmonary
adenomatosis; SPA). Recently, epithelial tumour
cells in the lungs of SPA-affected sheep were
identified as major sites of JSRV replication by
immunological techniques and RT-PCR amplification
of part of JSRV gag. JSRV was not detected outside
the lungs and their draining lymph nodes. However,
low levels of JSRV expression in non-respiratory
tissues could have been masked by co-amplification
of endogenous JSRV-related sequences, which were
differentiated from JSRV by the lack of a Seal
restriction site in the PCR product. To further
investigate the pathogenesis of SPA, an exogenous
virus-specific hemi-nested PCR was developed uti¬
lizing primers in the U3 region of JSRV LTR, where
major differences between endogenous and ex¬
ogenous sequences exist. This technique was shown
to be ^ 105-fold more sensitive than the previous
gag PCR/Scal digestion method. Using this new
assay the tissue distribution of JSRV in sheep with
natural and experimentally induced SPA was ana¬
lysed. Proviral DNA and JSRV transcripts were found
in all tumours and lung secretions of SPA-affected
sheep (n = 22) and in several lymphoid tissues. The
mediastinal lymph nodes draining the lungs were
consistently demonstrated to be infected by JSRV
(10/10). JSRV transcripts were also detected in
spleen (7/9), thymus (2/4), bone marrow (4/8) and
peripheral blood mononuclear cells (3/7). Proviral
DNA was also detected in these tissues although in
a much lower proportion of cases. JSRV was not
detected in 27 samples from unaffected control
animals (n = 1 5).
Introduction
Retroviruses isolated from mammalian species have been
invaluable to our present knowledge of cancer initiation and
progression. Animal models have been established, usually in
murine and avian species, and have provided a better
understanding of oncogenic events, particularly in cells of the
lymphoreticular system (Weiss el al., 1985; Fan, 1994).
However, animal models of epithelial neoplasia associated with
retroviruses have been restricted to mouse mammary tumour
and the associated virus, mouse mammary tumour virus
(MMTV) (Gross, 1983). Such models of epithelial neoplasia are
particularly relevant as tumours arising from epithelia are the
most prevalent tumours in man (Silverberg el al., 1990).
Sheep pulmonary adenomatosis (SPA; also known as
jaagsiekte and ovine pulmonary carcinoma) represents a unique
system because it is a naturally occurring epithelial neoplasm
which is closely associated with a retrovirus (Verwoerd el al.,
1985; Sharp, 1987). Moreover, SPA shares certain charac¬
teristics with human bronchiolo-alveolar carcinoma (Perk &
Hod, 1982; Gazdar & Linnoila, 1988) the aetiology of which is
unknown and which is increasing dramatically in prevalence
(Barsky el al., 1994).
The virus associated with SPA, jaagsiekte sheep retrovirus
(JSRV), cannot be cultivated in vitro. JSRV has morphological,
biochemical and antigenic similarity to type D and type B
retroviruses and has a genomic organization typical of a
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replication-competent retrovirus, containing no sequences
commonly associated with transformation (Perk et al., 1974;
Sharp & Herring, 1983; Herring et al., 1983; Rosadio el al.,
1988; York et al., 1992).
Current data point to the involvement of JSRV in the
aetiology of SPA, in particular, the experimental transmission
of the disease only with inocula that contain JSRV (Martin ct
al., 1976; Verwoerd et al., 1980; Sharp et al., 1983; DeMartini
et al., 1987) and the constant association of JSRV with
transformed epithelial cells in the lungs of both naturally and
experimentally SPA-affected sheep (Palmarini et al., 1995).
Recent molecular data have demonstrated that JSRV is an
exogenous virus distinct from the transcriptionally active
endogenous retroviral sequences present within the ovine
genome [sheep endogenous retroviruses; SERVs (synonym:
en]SRV)] (Palmarini et al., 1996; Bai et al., 1996; York et al.,
1992). A Seal restriction site in gag has been defined as a
molecular marker for the exogenous JSRV which has been
consistently demonstrated in tumour and in draining lymph
nodes of a proportion of SPA-affected sheep. JSRV was not
detected outside the respiratory tissues of SPA-affected sheep
nor in any tissue of control sheep (Palmarini et al., 1996).
Nevertheless, co-amplification of endogenous and exogenous
sequences could have masked the detection of low copies of
exogenous JSRV due to the relatively high background formed
by SERVs.
To address this question, an exogenous JSRV specific hemi-
nested PCR which amplified a segment of the U3 region of
JSRV was designed. The anatomical distribution of JSRV in
tissues collected from sheep with naturally and experimentally
induced SPA was then investigated.
Methods
■ Animals. SPA-affected sheep were defined as animals with typical
clinical signs, particularly the production of an abundant sero-mucoid
fluid ('lung fluid') from the nostrils when the rear limbs were elevated
above the head. Diagnosis was then confirmed by macroscopic and
histological examination of the lungs. Seventeen naturally SPA-affected
sheep and six experimentally infected lambs already utilized in a
preceding study (Palmarini et al., 1996) were used. Fifteen age- and breed-
matched animals were selected as controls.
■ Preparation of samples. Samples of heparinized venous blood,
lung fluid, lung, lung tumour, mediastinal lymph nodes, pre-scapular
lymph nodes, mesenteric lymph nodes, spleen, femoral bone marrow,
thymus, kidney and skin were collected during the post-mortem
examination or (blood and lung fluid) immediately before the sheep were
sacrificed. Sterile instruments were used to dissect each individual organ
at post-mortem to avoid cross-contamination. Tissue samples were snap-
frozen in liquid nitrogen and stored at 70 °C. Lung fluid samples were
clarified by centrifugation at 10000 g for 1 h at 4 °C and then stored at
— 70 °C. Plasma (5 ml) was clarified by centrifugation at 10000 g for 1 h
at 4 °C. The supernatant was then centrifuged at 100000# for 1 h at
4 °C. The pellet was resuspended in 500 pi of solution D (4 M-
guanidinium thiocyanate, 25 mM-sodium citrate pH 7-0, 0'5% sarkosyl,
0-1 M-2-mercaptoethanol) and stored at — 20 °C. Peripheral blood
mononuclear cells (PBMC) were isolated from venous blood by
centrifugation over Lymphoprep at 800 g for 30 min; aliquots of 4 x 106
cells were stored at — 70 °C until RNA and DNA were extracted. Total
RNA was extracted from 50 gl aliquots of lung fluid, 200-500 mg of lung
tumour or from the plasma samples using the acid guanidinium
thiocyanate-phenol-chloroform extraction method (Chomczynski &
Sacchi, 1987). Poly(A)+ RNA was obtained from 100 mg of all other
tissues and from 4 x 106 PBMC using the Microfast Track kit (Invitrogen)
according to the manufacturer's instructions. Genomic DNA was
extracted from 10-25 mg of tissues and from 4 x 106 PBMC using the
Qiagen Tissue Amp kit following the manufacturer's instructions.
■ Amplification and sequencing of exogenous LTR se¬
quences. Sequences and nucleotide positions of the oligonucleotide
primers relative to the JSRV genome (York et al., 1992) are indicated in
Table 1. The 5' LTR of a UK strain of JSRV was amplified from 500 ng
of lung tumour genomic DNA isolated from a natural case of SPA using
primers P-I and P-II. These formed the first primer pair of a hemi-nested
LTR-gag PCR used to amplify proviral JSRV (Palmarini et al., 1996).
Briefly, the forward primer (P-I) is located almost at the 5' end of the U3
while the reverse primer anneals to gag (P-II) so that all but the first 33 bp
of the JSRV 5' LTR are amplified. Previously, primer P-I was demonstrated
to be specific for the exogenous form of JSRV (Palmarini et al., 1996). The
PCR products of three independent reactions were pooled and cloned in
pGEM-T (Promega) as described by the manufacturer. Six selected clones
(pGEM-T LTR-gag) were demonstrated to be of exogenous origin by the
presence of a unique Seal site in gag (data not shown). The region
corresponding to the LTR of JSRV was then sequenced in both directions
by the dideoxynucleotide chain termination method, employing a Li-Cor
automated sequencer.
■ cDNA synthesis. cDNA synthesis was carried out using total RNA
derived from ultraspeed pellets of plasma (5 ml) or 50 pi of clarified lung
Table 1. Oligonucleotide primers employed in the PCRs and hybridizations of this study







* Nucleotide positions refer to the JSRV sequence published by York et al. (1992).
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Cons. CTATATATAC TAGCAGCACA ATAAA
Fig. 1. Sequence alignment of the U3 of SERVs (Palmarini et al., 1996), of the South African strain of JSRV [JSRV(SA)] (York et
al., 1 992) and of a UK strain of JSRV [JSRV(UK)]. Letters indicate differences with the consensus sequence. A period (.)
indicates deletions. Lack of sequence data in the JSRV (UK) sequence is indicated with (#). Positions of the primers employed
in the JSRV U3-PCR and hn-U3 PCR are underlined. P-III (asterisk) appears discontinuous only in the figure due to the 30 bp
deletions of JSRV sequences with respect to SERV (enJSRV).
fluid as template. For analysis of other samples, 2 ng of total RNA from
tumour samples or 1 ng poly(A)+ RNA from other tissues and PBMC
were used as template. RNA was diluted in 13*5 jil of diethyl
pyrocarbonate-treated distilled water and denatured at 65 °C for 10 min
and cooled on ice. One microlitre (40 U) of rRNAsin (Promega), 2 jil of
25 mM each deoxynucleoside triphosphate (dNTP), 2*5 ^1 of 100 mM-
DTT, 2-5 [d random hexamers (A260 62*5 U/ml; Oswel), 2-5 \x\ of 10 x
reaction buffer (500 mM-Tris-HCl pH 8*3, 75 mM-KCl, 3 mM-MgCl2) and
1 ^il of MoMuLV reverse transcriptase (50 U/nl; Stratagene) were added.
Reverse transcriptase (RT) was omitted in control samples to check for
DNA contamination of the RNA preparations. The reaction mixture was
then incubated at 37 °C for 1 h, and the RT inactivated by incubation at
94 °C for 3 min.
■ Exogenous-specific JSRV U3 and U3 hemi-nested (hn)
PCRs. Primer P-I was paired with an antisense primer (P-III) in the U3
region at nucleotide positions 7385-7361 (York et al., 1992) where there
are major sequence differences between JSRV and SERVs. In this region,
the endogenous sequences carry a 30 bp insertion compared to the
exogenous sequences (Fig. 1). The JSRV U3-PCR reaction was optimized
using DNA from a LTR-gag pGEM-T plasmid as template. The buffer
used was 10 mM-Tris-HCl, 50 mM-KCl, 2-5 mM-MgCl2 (pH 9'2) with
200 hm each dNTP, 6-25 pmol of each primer and 1'25 U of Taq
polymerase (Boehringer) in a 50 jil reaction. Five hundred nanograms of
genomic DNA or 3 nl of cDNA were used as template in the reaction.
Each sample was subjected to 94 °C for 1 min followed by 35 cycles of
94 °C for 30 s, 59 °C for 1 min and 72 °C for 1 min with a final extension
of 72 °C for 3 min, using a Perkin Elmer GeneAmp 2400 thermal cycler.
Total RNA extracted from 22 lung tumour and lung fluid samples
from 16 different naturally acquired SPA cases and 4 experimentally
induced cases was tested to verify the ability of JSRV-U3 PCR to detect
different isolates of JSRV. In addition, genomic DNA extracted from lung
tumour and matched kidney samples of four sheep with SPA was tested
to verify that JSRV U3-PCR does not amplify SERV sequences.
To verify the specificity of the PCR products, 25 nl of the PCR
product was resolved by electrophoresis in 1-5% agarose gels and
transferred to nylon membranes overnight by established procedures
(Sambrook et al., 1989). Membranes were then fixed, pre-hybridized and
probed overnight at 42 °C with 10 pmol each of two digoxigenin (DIG)
5'-labelled oligonucleotides (P-IV and P-V; Oswel) in DIG Easy Hyb
(Boehringer) hybridization buffer. The hybridized probe was then
detected using the DIG Nucleic Acid Detection Kit (Boehringer) as
recommended by the manufacturers.
To improve the sensitivity of the JSRV-U3 PCR, a primer internal to
the PCR product, primer P-VI, was synthesized and paired with primer P-
I in a second round hemi-nested PCR (JSRV U3-hn PCR). One microlitre
of the product of the first round of amplification was added to 49 )jl of
1 x PCR buffer [1-25 U of Tatj polymerase (Boehringer), 2-5 mM-MgCl2,
50 mM-KCl, 10 mM-Tris-HCl, 200 |im each dNTP and 6-25 pmol of each
primer]. PCR cycles employed were 94 °C for 1 min and 35 cycles of
94 °C for 30 s, 57 °C for 1 min and 72 °C for 1 min, with a final
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extension of 72 °C for 3 min. Amplified products were detected by
electrophoresis of 25 nl aliquots through a 2% agarose gel containing
0'5 jrg/ml of ethidium bromide.
The sensitivities of the JSRV U3-PCR and U3-hn PCR, against a
background of endogenous-related sequences, were compared with each
other and with the previously described JSRV gag PCR followed by Seal
digestion (Palmarini et al„ 1995). 'Reconstruction' experiments were
performed using serial dilutions (10° to 1CT1 copies) of clone pGemT-
LTR-gag (which contains the U3 through gag of JSRV provirus) with and
without the addition of 500 ng of normal sheep kidney DNA as a source
of SERV sequences. In addition, 100 copies of pGEM-T LTR-gag plasmid,
plus serial dilutions (102—107 copies) of SERV-LTR or SERV-gag plasmids
were tested.
Contamination of PCR was minimized by the use of appropriate
controls in each step of the work. Isolation of nucleic acids, preparations
of PCR reactions and analysis of PCR products were conducted in
separate rooms.
■ Template control PCRs. Each cDNA sample which was negative
after the U3-hn PCR was tested for the presence of glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) transcripts to verify the integrity of
the RNA template. Primers were designed on a consensus sequence
between the rat and human GAPDH (C. Mclnnes, Moredun Research
Institute, Edinburgh, personal communication). The sense primer (5'
TCACCACCATGGAGAAGGCT 3') was based on exon 4 of the
human gene and the reverse primer was based on exon 7 (5'
TTCATTGTCATACCAGGAAA 3') (Tokunaga et al, 1987). The buffer
employed was 10 mM-Tris-HCl, 50 mM-KCl, 2-5 mM-MgCl2 (pH 8-9)
with 200 (cm each dNTP, 6'25 pmol each primer and 1-25 U Taq
polymerase (Boehringer). Cycles employed were 94 °C for 1 min and
then 35 cycles of 94 °C for 45 s, 52 °C for 1 min and 72 °C for 1 min 30 s
with a final extension of 72 °C for 5 min.
Parallel samples in which the addition of RT was omitted in the cDNA
synthesis step were also tested to rule out DNA contamination. Amplified
products were detected by electrophoresis of 25 pi aliquots through 1%
agarose gels in 1 x TBE buffer in the presence of 0'5 pg/ml ethidium
bromide. A DIG-labelled internal probe (5' DIG-CTCATGACCACAG-
TCCATGCCATCACGCC) was used to confirm the specificity of the
amplified product. Southern blotting and detection of hybridized probe
were essentially as described above for U3-PCR. DNA samples which
were negative after hn-U3 PCR were checked by amplification of a
portion of SERV gag as previously described (Palmarini et al., 1996).
Results
Sequencing of JSRV LTR and designing of JSRV
exogenous-specific primers
To better design an exogenous virus-specific PCR the LTR
of a UK strain of JSRV was sequenced and compared with the
sequence of a South African strain of JSRV and the LTR of
SERVs (York et al., 1992; Palmarini et al., 1996). The LTR of the
UK strain of JSRV [JSRV(UK)] was 89% homologous to the
LTR of the South African strain [JSRV(SA)] (York et al., 1992)
and 76—79% similar to SERV loci (Palmarini et al., 1995). Major
sequence divergence between exogenous and endogenous
viruses was confirmed in the U3 region. In particular, a 30 bp
deletion in the U3 of JSRV(SA) compared to the endogenous
loci was also confirmed in JSRV(UK). Primer P-III was designed
across the deletion such that at the optimal annealing
temperature this primer should anneal efficiently only with the
M 1 9 10 +
176 bp ■
Fig. 2. Specific amplification of JSRV by U3-PCR. Lanes 1, 3 and 5 are the
product of amplification of 500 ng of genomic DNA from three cases of
SPA; lanes 2, 4 and 6 are the matched kidney samples. Lanes 7 and 8 are
cDNA of lung of healthy control sheep; lane 9 is lung tumour cDNA and
lane 10 is lung fluid cDNA. Symbols ' + ' and ' — ' indicate pGEM-T
LTR-gag and water, respectively, used as positive and negative controls.
Lane M contains molecular mass marker IX (Boehringer).
exogenous sequences. The alignment of the U3 of JSRV and
SERV sequences and the relative positions of the primers
employed in this study are indicated in Fig. 1. The JSRV LTR
sequence of the UK strain has been deposited in GenBank
under accession number Z71304.
Specificity and sensitivity of JSRV U3 and hemi-nested
U3 PCRs
Twenty-two cDNA samples of lung fluid and lung tumour
were examined by PCR using primers P-I and P-III. A product
of the expected size of 176 bp was obtained with all samples.
Hybridization with the DIG-labelled internal oligonucleotides
P-IV and P-V confirmed that the products originated from
JSRV-LTR (data not shown). To demonstrate the PCR product
was derived only from JSRV and not from SERV, matched
genomic DNA samples of lung tumour and kidney from four
SPA-affected animals were examined. An amplified product
was obtained from tumour DNA and not from the cor¬
responding kidney sample, proving that the JSRV-U3 PCR is
exogenous virus specific (Fig. 2).
The sensitivity of the U3-PCR was determined by 're¬
construction' experiments, testing mixtures of exogenous
JSRV and SERV templates described in Methods. JSRV U3
PCR successfully amplified 102-103 JSRV template copies in a
background of 500 ng of normal sheep genomic DNA and 102
JSRV template copies in a background of 10' copies of SERV-
LTR.
The sensitivity of the U3-PCR was increased by using
primer P-VI and primer P-I in a second round PCR. A product
of 133 bp was detected from the re-amplification of all the lung
fluid and lung tumour PCR products but not from the kidney
samples. The U3-hn PCR detected an estimated single molecule
of template in a background of 500 ng of normal sheep
2994
Detection of JSRV in lymphoid tissues
Table 2. Results of the JSRV U3-hn PCR on tissues of sheep affected by SPA
Results are given as number of samples positive of the number tested. In all cases RNA refers to poly(A)+
selected RNA and DNA to genomic DNA.
Tissues
Natural SPA Experimental SPA Tota
RNA DNA RNA DNA RNA DNA
Lung tumour/lung fluid 18/18 6/6 4/4 4/4 22/22 10/10
Mediastinal lymph nodes 6/6 6/6 4/4 3/3 10/10 9/9
Other lymph nodes 2/9 0/9 na na 2/9 0/9
Spleen 4/5 0/5 3/4 2/3 7/9 2/8
Bone marrow 2/5 2/4 2/3 1/3 4/8 3/7
Thymus na na 2/4 0/4 2/4 0/4
Kidney 1/6 1/6 0/3 0/3 1/9 1/9
Skin 0/4 0/4 na na 0/4 0/4
Plasma 0/2 / 0/6 / 0/8 /
PBMC 3/7 0/6 na na 3/7 0/6
na. Not available
genomic DNA. In contrast, gag PCR followed by Seal digestion
was at least 10°-fold less sensitive than the U3-hn PCR because
10:' copies of pGem-T LTR-gag (exogenous clone) were not
detected against a background of 500 ng of normal sheep
kidney DNA. Furthermore, exogenous sequences were detec¬
ted only when the ratio of exogenous/endogenous sequences
was 1:10 but not ^ 1:100.
The U3-hn PCR amplified only exogenous sequences and
was specific for different strains of JSRV.
Detection of proviral DNA and JSRV transcripts in non-
tumour tissues of SPA-affected sheep
Following the successful development and validation of the
U3-hn PCR, the anatomical distribution of JSRV in SPA-
affected sheep was analysed. Table 2 summarizes the results
obtained.
JSRV RNA and proviral DNA was found consistently in
the mediastinal lymph nodes of SPA-affected sheep (10/10). In
addition, JSRV RNA was found in 7/9 spleens, 4/8 bone
marrows and 2/4 thymuses (Fig. 3). Proviral DNA was found
more rarely in these tissues. PCR products were detected in
2/8 spleens and 3/7 bone marrows. Among the non-regional
lymph nodes analysed all were negative for proviral DNA, but
two mesenteric lymph nodes of the five analysed were positive
at the RNA level. Pre-scapular lymph nodes (n = 4) were
always negative. PBMC were found to be positive for JSRV
RNA in 3/7 samples but proviral DNA was not detected in
any. Plasma samples were always negative.
Apart from lymphoid tissues, JSRV was detected at both
the DNA and RNA level in only one kidney of nine tested and
in none of four skin samples. No differences were observed in
the anatomical JSRV distribution between the naturally




Fig. 3. Example of the results of JSRV U3-hn PCR in a SPA-affected animal.
Lanes 1 contain the first step U3 PCR product and lanes 2 contain the
second round of amplification (U3-hn PCR). Lanes A, lung tumour cDNA;
lanes B, kidney cDNA; lanes C, spleen cDNA (note the faint product
obtained in the first step); lanes D skin cDNA; lanes E, lung cDNA from an
unaffected control animal. Lane M contains molecular mass marker IX
(Boehringer). W is the negative control (water) of the hn-U3 PCR.
JSRV was not detected in 27 samples examined from 15
unaffected control animals. These samples included poly(A)
RNA prepared from lung (« = 5), mediastinal lymph nodes
(n = 7), thymus (n = 1) and PBMC (n = 4). In addition,
samples from lung (n = 3), mediastinal lymph nodes (n = 1),
spleen (n = 2), thymus (n = 1), bone marrow (n = 1) and
kidney (n — 2) were tested for proviral DNA.
All the samples that were negative in the U3-hn PCR were
positive for the amplification of GAPDH cDNA or SERV gag
DNA, demonstrating that the templates were not degraded,
and PCR inhibitors were not present after the nucleic acid
extraction.
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Discussion
Previous studies, using immunological and molecular
techniques, demonstrated that JSRV is an exogenous virus,
which does not arise from reactivation of an endogenous locus
(Palmarini et al., 1995,1996). These studies identified the lungs,
particularly the epithelial tumour cells, as a major site of JSRV
replication, although viral RNA was demonstrated in the
draining mediastinal lymph nodes of a proportion of SPA-
affected sheep. These observations have been extended in the
present report as a result of developing a highly sensitive assay
for exogenous JSRV and show that JSRV RNA and proviral
DNA is present not only in the draining lymph nodes but also
in several anatomically dispersed lymphoid tissues and PBMCs.
This distribution of JSRV in infected animals is, therefore,
similar to that reported for other type B and type D
retroviruses, in which both lymphoid and non-lymphoid
tissues are infected (Bentvelzen & Brinkhof, 1977; Kozma et al.,
1980; Bryant el al., 1986; Lackner el al., 1988).
Although quantitative assays were not employed in the
present studies, the estimated sensitivity of the different PCR
assays confirmed that JSRV was expressed at much higher
levels in SPA tumours than in the lymphoid tissues, particularly
those at the non-local sites. Thus, there are clear parallels with
the high levels of MMTV transcription associated with the
development of breast carcinoma in mice (Varmus et al., 1973;
Henrard & Ross, 1988; Bramblett et al., 1995). The tran¬
scriptional activity of MMTV appears to be determined by the
interaction of a number of factors involving regulatory
elements within the LTR, including at least one region
implicated in elevated transcription in the mammary epithelium
(Lefebre et al., 1991; Mink et al., 1992; Mok et al., 1992), and
the absence of tissue-specific factors such as negative regu¬
latory element binding protein (NBP) in mammary tissue
(Bramblett et al., 1995). Similar putative regulatory sequences,
such as NF-1- and C/EBP-binding sites, have been identified in
the JSRV LTR (York et al., 1992) as well as many point
mutations and large deletions compared to endogenous loci
(Palmarini et al., 1996; Bai et al., 1996). Other retroviruses with
LTR deletions have been reported to have a transcriptional
advantage (Hsu et al., 1988) and the biological significance of
these structures in JSRV awaits the development of permissive
culture systems.
The interaction between type B and type D retroviruses
and lymphoid cells has been demonstrated to be an important
feature in the pathogenesis of these viruses. B lymphocytes
have a central role in the pathogenesis of MMTV and infection
of the mammary gland requires a functional immune system.
MMTV initially appears to infect B lymphocytes and is then
delivered to the mammary gland through T cell—B cell
interactions (Tsubura et al., 1988; Golovkina et al., 1992; Held
et al., 1994; Matsuzawa et al., 1995). The simian type D
retrovirus, SRV1, which induces simian acquired immuno¬
deficiency syndrome in macaques (Gardner et al., 1988), has a
broad in vivo lymphoid tropism involving lymphocytes and
mononuclear cells. Infection leads to both T and B lymphocyte
depletion although monocyte and macrophage function ap¬
pears to be unaffected (LeGrand et al., 1985; Maul et al., 1988).
The significance of infection of lymphoid tissues by JSRV in
the overall pathogenesis of SPA is unknown at present. As
only sheep with clinical SPA were examined it is not known
whether lymphoid infection precedes, or is a sequel to, JRSV
replication in the pulmonary epithelium. Further studies will be
required to define which cell types are involved and at which
stages during the protracted time between infection and the
appearance of clinical illness. Similarly, it is not clear whether
sheep infected with JSRV develop immunodeficiency, although
this possibility is supported by anecdotal reports of the
increased susceptibility to secondary bacterial pneumonias
(Sharp & Martin, 1983; Verwoerd, 1990) and lymphopenia in
SPA-affected sheep (Rosadio & Sharp, 1992). The apparent
absence of circulating antibodies to JSRV in sheep with SPA
has been reported (Sharp & Herring, 1983; Verwoerd, 1990)
although a recent study, using a recombinant Mason-Pfizer
monkey virus major capsid protein, has produced conflicting
results (Kwang et al., 1995).
One of the major obstacles to progress in research on JSRV
has been the lack of an in vitro culture system. The present
study has clearly demonstrated permissive infection of lymph¬
oid cells by JSRV, cell types which have been used successfully
for the propagation of many retroviruses and which, therefore,
could provide a permissive substrate for JSRV replication.
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A type D-related retrovirus has been demonstrated in enzootic nasal tumors (ENTs) of sheep and goats. This
retrovirus, ENT virus (ENTV), has antigenic cross-reactivity with the jaagsiekte sheep retrovirus (JSRV),
which is associated with a contagious lung tumor of sheep (sheep pulmonary adenomatosis). Here, we present
the first report of nucleic acid sequence from ENTV which confirms, at the nucleic acid level, that this
retrovirus is related to JSRV yet apparently distinct from it. Reverse transcription-PCR followed by restriction
enzyme digestion specifically identified ENTV. By this technique, ENTV was demonstrated exclusively in tumor
tissues and exudates of animals with ENT. Thus, there is a unique and consistent association between ENT and
the retrovirus, just as there is between JSRV and sheep pulmonary adenomatosis. This gives further weight to
the hypothesis that these retroviruses are the etiologic agents of the tumors.
Enzootic intranasal tumors (ENTs) of sheep and goats are
contagious adenocarcinomas which can also be transmitted
experimentally (3, 6). ENTs have similarities with another con¬
tagious tumor of secretory epithelial cells, known as sheep
pulmonary adenomatosis (SPA, or jaagsiekte ovine pulmonary
carcinoma). Both tumors are associated with retroviruses
which cannot be propagated in vitro. Although no studies have
previously been reported to determine whether ENT and SPA
are different manifestations of disease caused by the same
agent, studies of ENT cases have not found any tumors in the
lungs (7, 19), nor have nasal tumors in SPA-affected animals
been reported.
In the case of SPA, an association with a type B/D retrovirus,
known as jaagsiekte sheep retrovirus (JSRV), is well estab¬
lished (15, 17), and the complete nucleotide sequence of the
retrovirus has been determined (22). Recent reports have dem¬
onstrated that JSRV is related to sheep endogenous retrovi¬
ruses (SERVs), of which there are 10 to 15 copies in the sheep
genome (1, 12, 15). However, reverse transcription-PCR (RT-
PCR)-based techniques, which differentiate JSRV from
SERVs, showed that JSRV is a distinct exogenous virus that is
associated exclusively with SPA tumors (15).
Although studies are at a less advanced stage than for SPA
and JSRV, current evidence points to the association of a type
D-like retrovirus, ENT virus (ENTV), with ENT. The presence
of retrovirus-like particles in ENT of sheep (14, 21) and goats
(7, 19) has been demonstrated by electron microscopy. The
detection of RT activity in fractions from isopycnic gradients
has shown that the retrovirus found in nasal fluid of ENT-
affected goats has the same buoyant density as JSRV (9). In
addition, antigenic cross-reactivity with Mason-Pfizer monkey
virus p27 (8) and recombinant JSRV capsid protein (unpub¬
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Institute, 408, Gilmcrton Rd., Edinburgh EH 17 7JH, United Kingdom.
Phone: (131) 664 3262. Fax: (131) 664 8001. Electronic mail address:
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lished observation) indicates that ENTV has a type D retrovi¬
ral capsid.
The aim of our studies was to develop a PCR-based detec¬
tion technique for ENTV, to confirm its association with ENT,
and to determine the relationship between ENTV and JSRV.
MATERIALS AND METHODS
Source of material. Nasal fluids from four sheep and two goats with naturally
occurring ENT were collected, clarified, and concentrated as described previ¬
ously (8). The resultant pellets were resuspended as a 100-fold concentrate in
TNE buffer (0.01 M Tris-Cl [pH 7.5], 0.1 M NaCl, 0.001 M EDTA). Samples of
ENT and of kidney tissues from the same animals were collected at necropsy and
snap frozen in liquid nitrogen. The ENTs were all low-grade adenocarcinomas,
which were locally invasive but not metastatic, and were from 3- to 4-year-old
animals. Lung fluids from SPA-affected animals were collected as described
previously (18). All samples were stored at —70°C. The ENT-affected sheep were
verified to be negative for SPA by macroscopic and microscopic pathology at
necropsy. The ENT-affected and SPA-affected cases used in this study were from
the same region of Spain. The negative-control animals were from the United
Kingdom, where ENT has never been reported.
Density gradient fractionation. Pellets from nasal fluids of four sheep and two
goats were analyzed by isopycnic ccntrifugation on 20 to 55% (wt/wt) sucrose
gradients (13). Fractions (0.5 ml) were collected, and those with densities be¬
tween 1.17 and 1.19 g/ml (i.e., those fractions shown to contain peak RT activity
[9]) were pooled, diluted in TNE buffer, and centrifuged at 100,000 X g for 1 h
at 4°C. The pellet was resuspended in 0.5 ml of solution D (4 M guanidinium
thiocyanate, 25 mM sodium citrate [pH 7.0], 0.5% sarcosyl [wt/vol], 0.1 M
2-mercaptoethanol) for RNA preparation.
RNA preparation and RT. Total RNA was extracted from pooled sucrose
gradient fractions, from 100 |jl1 of concentrated nasal fluid, from 100 fxl of SPA
lung fluid, or from 0.2 to 0.5 g of tissue by the acid guanidinium thiocyanate-
phenol-chloroform method (2). cDNA was synthesized by random-primed RT as
described previously (15).
gag PGR. The primers and conditions used for PCR of cDNA or of genomic
DNA were exactly as described previously (15): PI (sense), 5'-GCTGCTTTRA
GACCTTATCGAAA-3'; and P2 (antisense), 5'-ATACTGCAGCYCGATGGC
CAG-3'). PCR products were detected by electrophoresis through a 2% agarose
gel in lx Tris-borate-EDTA buffer in the presence of 0.5 |xg of ethidium
bromide per ml.
Cloning of ENTV gag fragments. cDNA from nasal fluid from each of three
ovine ENT cases was amplified by using primers PI and P2. The products of four
independent PCRs for each animal were pooled, gel purified, and cloned into
pGEMT (Promega) according to the manufacturer's protocol. Several clones
selected from each ENT case were sequenced on both strands by using the T7
sequencing kit (Pharmacia), with universal and reverse sequencing primers
(Pharmacia), as recommended by the manufacturer. The sequences obtained
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FIG. 1. Alignment of the sequences of RT-PCR gag products from ovine ENTV with SERV sequences (15) and JSRV sequences from South Africa [JSRV(SA)]
(22) and the United States [JSRV(US)] (12). Only the sequence between the PCR primers is shown. Base differences in comparison with the ENTV consensus (letters)
and restriction sites specific to ENTV or JSRV (boldface) are shown.
were aligned by using the Genetics Computer Group "pileup" program (11). The
phylogenetic tree was constructed by using the DNAML program from version
4.0 of the PHYLIP package (10).
Restriction endonuclease digestion of RT-PCR products. A 3-p.l volume of
10X restriction buffer (Boehringer) and 1 pel (10 U) of restriction endonuclease
(Boehringer) were added to 26 pi of PCR product, and the mixture was incu¬
bated at 37°C overnight. Digestion products were detected by electrophoresis
through a 2% agarose gel in lx Tris-borate-EDTA buffer in the presence of 0.5
pg of ethidium bromide per ml.
DNA extraction. High molecular weight genomic DNA was extracted from
nasal tumor and kidney samples of the same naturally affected animals or from
lung and kidney samples of unaffected controls by cell lysis followed by precip¬
itation of DNA in tissue culture plates, as described by Wu et al. (20).
Nucleotide sequence accession numbers. The nucleotide sequence of one of
the ENTVgag fragment PCR clones, pENTV7.6, is deposited in GenBank under
accession no. Z71758.
RESULTS
Development of a technique for specific detection of ENTV.
Primers PI and P2, which amplify a 229-bp region internal to
the gag gene of JSRV and of SERVs (15), amplified products
of the same size from cDNAs derived from clarified nasal
fluids of four sheep and two goats affected by ENT and from
density gradient-purified virus from the same sources. The gag
RT-PCR product from JSRV isolates cut with .Seal, while that
from SERVs or ENTV did not (data not shown). To look for
an alternative restriction site by which to distinguish ENTV
from SERVs, gag RT-PCR products of three ovine ENT cases,
from different farms, were cloned and sequenced. Alignment
of the sequences (Fig. 1) with the published sequences of
JSRV and SERVs showed a number of bases at which there
appear to be conserved differences between ENTV and JSRV
or SERV. Of particular interest were the presence of a PstI site
(positions 75 to 80) and an AatW site (positions 141 to 146)
unique to the ENTV gag sequences and the lack of the Seal
site (positions 106 to 111) which has been shown to be present
in all JSRV isolates tested to date (15).
Association of ENTV with ENT. To confirm the association
of the virus with ENT and the conservation of the AatW and
Pst\ restriction sites, gag RT-PCR was done with 26 different
samples (typical results are shown in Fig. 2). The product from
nontumor (kidney) tissues of four of the ENT-affected animals
or of four unaffected controls did not cut, as was expected for
endogenously derived amplimers. The product from JSRV, in
lung fluid or tumor samples from SPA affected sheep, also did
not cut withHa/II or Pst I. However, the RT-PCRgag products
M 1 2 3 4 5 6 7 8 9 10 11 12 13 14
b M 1 2 3 4 5 6 7 8 9 10 II 12 13 14
FIG. 2. Detection of ENTV transcripts, gag RT-PCR products after incuba-
liun with /VI (a) ui Auill (b) die sliuwn. Lanes 1, 2, 4, and 5, nasal fluids from
ENT-affected sheep; lanes 6, 8, 9, and 10, tumor tissues from ENT-affected
animals; lanes 5 to 7, nasal fluid, tumor, and kidney samples, respectively, from
the same ENT-affected sheep; lanes 3, 11, and 12, lung fluid, tumor, and kidney
specimens, respectively, from the same SPA-affected animal; lane 13, negative
control; lane 14, pJS382 (JSRV gag clone); lane M, Boehringer marker VI.
















FIG. 3. Phylogenetic tree constructed from the sequences shown in Fig. 1.
from six ENT nasal fluid specimens (from four sheep and two
goats) and six ENT tissue specimens (from four sheep and two
goats) cut with both enzymes, demonstrating the presence of
exogenous ENTV. Amplimers from isopycnic gradient-puri¬
fied fractions were expected to cut completely, as they should
contain no endogenous sequences. However, restriction en¬
zyme digestion was incomplete. The efficiency of the restriction
enzymes was checked by digestion of PCR product amplified
from plasmid pENTV7.6 (sequence shown in Fig. 1) and was
found to be less than expected. Nevertheless, the results show
that AatU- and Psfl-sensitive product was detectable in all
tumor and fluid samples from animals with ENT.
DNAs from tumor and kidney tissues of two sheep and two
goats affected by ENT were used as templates for gag PCR
followed by Pstl orAatll digestion to determine whether these
restriction sites were present in any of the related endogenous
sequences. No Aatll- or ft/I-sensitive product was detected
(results not shown).
Relationship between ENTV, JSRV, and SERVs. Compari¬
son of the 10 ENTV sequences with the published sequences of
JSRV and SERVs showed that the ENTV sequences were 95
to 100% similar to each other, 83 to 92% similar to JSRV
sequences, and 83 to 92% similar to SERV sequences. Figure
3 shows a phylogenetic tree constructed from the gag se¬
quences. The long branch linking the ENTV sequence cluster
to the rest (SERV and JSRV) was significantly greater than 0
(length, 0.09676 nucleotide substitutions per position, i.e.,
about 10% sequence divergence or 22 nucleotide substitutions
in 229 bp). The ordering of the gag fragments within the ENTV
cluster and within the SERV-JSRV cluster was not significant.
The optimum Ts/Tv value was 7.0, suggesting that transitions
are much more common than transversions (e.g., A^-G is 14
times more likely than A—»T). The relative rates at the three
codon positions were 1:1:10, confirming that the first two
codon positions are constrained relative to the third position
(which is likely to be evolving at close to the neutral rate) and
suggesting that the part of the CA protein encoded by this
region of gag does not evolve rapidly.
DISCUSSION
We have previously reported that the presence of a Soil
restriction site within gag is a molecular marker for JSRV (15).
Here, we report that the restriction sites AatU and Pstl within
gag act as unique molecular markers for ENTV. gag RT-PCR
analysis of samples from clinical ENT cases and from unaf¬
fected controls demonstrated that the virus transcripts distin¬
guished by the Aatll and Pstl restriction sites were present
exclusively and consistently in tumor tissues and exudates from
ENT cases. ENTV therefore appears to be a distinct virus
associated with ENT. By analogy with JSRV, ENTV is likely to
be an exogenous virus as opposed to a reactivated endogenous
virus. Our findings that no endogenously derived sequences
containing Aatll or Pstl were detected at either the RNA or
the DNA level support this notion but because of the limita¬
tions of sensitivity of the present technique are not conclusive.
These limitations are highlighted by the fact that we were
unable to demonstrate the presence of ENTV provirus in tu¬
mor tissue DNA. This observation agrees with our findings for
JSRV, for which provirus could not be detected in SPA tumor
DNA by using thegag PCR-Scal technique because of the high
background of endogenous sequences (15). This problem was
overcome by the development of primers specific for exoge¬
nous JSRV which enabled detection of proviral DNA in tumor
tissue. These JSRV primers do not amplify ENTV. and further
sequence data for ENTV are necessary in order to design
specific primers and develop a more sensitive PCR for detec¬
tion of ENTV.
The fact that the Aatll and Pstl sites were conserved in
ENTV whereas the Seal site is conserved in JSRV suggests
that ENTV and JSRV are distinct viruses. This notion is sup¬
ported by the phylogenetic tree, which shows that the JSRV
and SERV sequences are more similar to each other than they
are to the ENTV sequences. However, such short regions of
sequence should not be overinterpreted. It is not possible to
extrapolate the conclusion from this small region of sequence
to predict differences in other regions of the viral genomes, as
it is likely that the gag gene may be the region of greatest
homology between the two viruses, especially since analysis of
the sequences suggests that the gag region is not evolving
rapidly. In addition, the CA proteins of JSRV and ENTV,
encoded by gag, are antigenically related (8). However, anti¬
genic relatedness of other viral components has not yet been
investigated. PCRs which amplify other regions of JSRV and
of SERVs (long terminal repeat, pol, and env) did not amplify
ENTV (data not shown). Caution should be exercised in in¬
terpretation of negative PCR results since minor differences
between two genomes can prevent efficient primer binding;
nevertheless, this result suggests not only that other genes of
ENTV are less similar to those of JSRV and SERVs but also
that ENTV is less similar to SERVs than is JSRV. This agrees
with the phylogenetic tree.
In sheep and goats, ENTs are clinically and pathologically
identical (4, 5), but, until now, there have been no data to
confirm that the same virus affects the two species. Our studies
show that the. Aatll and Pstl sites are present in the gag region
of the viruses from ENT samples of both sheep and goats,
suggesting that the viruses are highly related. Similar intranasal
tumors in other animals including cattle, buffaloes, and pigs
have also been reported (16), and the RT-PCR-restriction
enzyme technique could be used to determine whether these
tumors are also associated with ENTV.
In conclusion, this is the first report of nucleic acid sequence
from ENTV. and it confirms, at the nucleic acid level, that this
retrovirus is related to JSRV yet apparently distinct from it.
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ENTV can be specifically identified by RT-PCR followed by
Aatll or PstI digestion, and, by this technique, ENTV was
demonstrated exclusively and consistently in nasal tumor tis¬
sues and exudates from ENT-affected sheep and goats. The
facts that SPA and ENT are both adenocarcinomas of secre¬
tory epithelial cells but target different areas of the respiratory
tract and that JSRV and ENTV are also similar but distinct
add further weight to the hypothesis that these retroviruses are
the etiological agents of the tumors.
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